[{"title":"Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet","googleId":"-ZTd39R3XYUJ","googleLink":"https://www.nature.com/articles/s41375-018-0077-1","googleCitationCount":220,"googleAuthor":"T Barbui","doi":"10.1038/s41375-018-0077-1","elsevierAuthor":"Barbui T.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"165"},{"title":"Clinical use of lentiviral vectors","googleId":"shCSJgq8hB4J","googleLink":"https://www.nature.com/articles/s41375-018-0106-0","googleCitationCount":208,"googleAuthor":"MC Milone","doi":"10.1038/s41375-018-0106-0","elsevierAuthor":"Milone M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"143"},{"title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","googleId":"16Xpo2xAuEkJ","googleLink":"https://www.nature.com/articles/leu201729","googleCitationCount":289,"googleAuthor":"L Sanoja-Flores","doi":"10.1038/leu.2017.29","elsevierAuthor":"Flores-Montero J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"211"},{"title":"The MLL recombinome of acute leukemias in 2017","googleId":"fYCNSZy--fAJ","googleLink":"https://www.nature.com/articles/leu2017213","googleCitationCount":253,"googleAuthor":"","doi":"10.1038/leu.2017.213","elsevierAuthor":"Meyer C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"182"},{"title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","googleId":"0E8gAvVur34J","googleLink":"https://www.nature.com/articles/leu2017226","googleCitationCount":227,"googleAuthor":"E Liu","doi":"10.1038/leu.2017.226","elsevierAuthor":"Liu E.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"172"},{"title":"Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study","googleId":"6-l1jBUbW8oJ","googleLink":"https://www.nature.com/articles/leu201763","googleCitationCount":180,"googleAuthor":"JP Radich","doi":"10.1038/leu.2017.63","elsevierAuthor":"Hochhaus A.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"136"},{"title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","googleId":"rac7vI3jRP8J","googleLink":"https://www.nature.com/articles/leu2017259","googleCitationCount":163,"googleAuthor":"B Kumar","doi":"10.1038/leu.2017.259","elsevierAuthor":"Kumar B.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"101"},{"title":"Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia","googleId":"UH4XEdR2ECEJ","googleLink":"https://www.nature.com/articles/leu2017265","googleCitationCount":161,"googleAuthor":"","doi":"10.1038/leu.2017.265","elsevierAuthor":"Toft N.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"114"},{"title":"Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond","googleId":"ZLqK5NJ8WuQJ","googleLink":"https://www.nature.com/articles/leu2017329","googleCitationCount":153,"googleAuthor":"SK Kumar","doi":"10.1038/leu.2017.329","elsevierAuthor":"Lv M.","publicationName":"Oncology Reports","elsevierCoverDate":"2021-03-01","elsevierCoverDisplayDate":"March 2021","elsevierCitationCount":"0"},{"title":"Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL","googleId":"wNUNmh3X8jwJ","googleLink":"https://www.nature.com/articles/leu2017175","googleCitationCount":156,"googleAuthor":"P Hillmen","doi":"10.1038/leu.2017.175","elsevierAuthor":"Brown J.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"118"},{"title":"Isocitrate dehydrogenase mutations in myeloid malignancies","googleId":"1VedVQXGK8UJ","googleLink":"https://www.nature.com/articles/leu2016275?source=content_type%3Areact%7Cfirst_level_url%3Aarticle%7Csection%3Amain_content%7Cbutton%3Abody_link","googleCitationCount":207,"googleAuthor":"AT Fathi","doi":"10.1038/leu.2016.275","elsevierAuthor":"Medeiros B.C.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"149"},{"title":"Gemtuzumab ozogamicin in acute myeloid leukemia","googleId":"_oMrOL1VctMJ","googleLink":"https://www.nature.com/articles/leu2017187","googleCitationCount":135,"googleAuthor":"RP Gale","doi":"10.1038/leu.2017.187","elsevierAuthor":"Godwin C.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"100"},{"title":"A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis","googleId":"1byBNqdPS1YJ","googleLink":"https://www.nature.com/articles/leu2017169","googleCitationCount":134,"googleAuthor":"F Passamonti","doi":"10.1038/leu.2017.169","elsevierAuthor":"Passamonti F.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"105"},{"title":"An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies","googleId":"4jKGtvRL1gwJ","googleLink":"https://www.nature.com/articles/s41375-018-0065-5","googleCitationCount":114,"googleAuthor":"","doi":"10.1038/s41375-018-0065-5","elsevierAuthor":"Cooper M.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"92"},{"title":"Trends in overall survival and costs of multiple myeloma, 2000–2014","googleId":"yD5wCsAD9-gJ","googleLink":"https://www.nature.com/articles/leu2016380","googleCitationCount":180,"googleAuthor":"R Fonseca","doi":"10.1038/leu.2016.380","elsevierAuthor":"Fonseca R.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"143"},{"title":"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity","googleId":"tTvgj7ym_1EJ","googleLink":"https://www.nature.com/articles/s41375-018-0067-3","googleCitationCount":88,"googleAuthor":"N Amodio","doi":"10.1038/s41375-018-0067-3","elsevierAuthor":"Amodio N.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"76"},{"title":"Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia","googleId":"Uza33I0dn2wJ","googleLink":"https://www.nature.com/articles/s41375-018-0210-1","googleCitationCount":112,"googleAuthor":"PL Zinzani","doi":"10.1038/s41375-018-0210-1","elsevierAuthor":"Kreitman R.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"81"},{"title":"GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis","googleId":"ZH5e7cgRruEJ","googleLink":"https://www.nature.com/articles/s41375-018-0107-z","googleCitationCount":96,"googleAuthor":"P Guglielmelli","doi":"10.1038/s41375-018-0107-z","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"72"},{"title":"Fully human CD19-specific chimeric antigen receptors for T-cell therapy","googleId":"02aIA7ONIiUJ","googleLink":"https://www.nature.com/articles/leu201757","googleCitationCount":123,"googleAuthor":"AI Salter","doi":"10.1038/leu.2017.57","elsevierAuthor":"Sommermeyer D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"85"},{"title":"Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer","googleId":"vfS4kT3ZIioJ","googleLink":"https://www.nature.com/articles/s41375-018-0117-x","googleCitationCount":76,"googleAuthor":"B Wingelhofer","doi":"10.1038/s41375-018-0117-x","elsevierAuthor":"Wingelhofer B.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"57"},{"title":"ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation","googleId":"ouly619J3acJ","googleLink":"https://www.nature.com/articles/s41375-017-0007-7","googleCitationCount":81,"googleAuthor":"D Rossi","doi":"10.1038/s41375-017-0007-7","elsevierAuthor":"Malcikova J.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"58"},{"title":"Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial","googleId":"Wx5A0T5izigJ","googleLink":"https://www.nature.com/articles/leu2017211","googleCitationCount":105,"googleAuthor":"EK Mai","doi":"10.1038/leu.2017.211","elsevierAuthor":"Goldschmidt H.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"70"},{"title":"Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study","googleId":"TxmKYa5oldwJ","googleLink":"https://www.nature.com/articles/leu2017138","googleCitationCount":146,"googleAuthor":"SK Kumar","doi":"10.1038/leu.2017.138","elsevierAuthor":"Kumar S.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"115"},{"title":"High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients","googleId":"NiKtceOKkjUJ","googleLink":"https://www.nature.com/articles/leu2017145","googleCitationCount":105,"googleAuthor":"","doi":"10.1038/leu.2017.145","elsevierAuthor":"Tat T.","publicationName":"Oncotarget","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"2018","elsevierCitationCount":"1"},{"title":"A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo","googleId":"_27yPjJvyJgJ","googleLink":"https://www.nature.com/articles/leu2016388","googleCitationCount":146,"googleAuthor":"","doi":"10.1038/leu.2016.388","elsevierAuthor":"Yang Y.","publicationName":"Journal of Hematology and Oncology","elsevierCoverDate":"2020-12-01","elsevierCoverDisplayDate":"December 2020","elsevierCitationCount":"0"},{"title":"Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL","googleId":"_u5KtvgJqG0J","googleLink":"https://www.nature.com/articles/leu201741","googleCitationCount":108,"googleAuthor":"T Mueller","doi":"10.1038/leu.2017.41","elsevierAuthor":"Duell J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"81"},{"title":"Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes","googleId":"2qe9yaKAYBkJ","googleLink":"https://www.nature.com/articles/s41375-018-0070-8","googleCitationCount":73,"googleAuthor":"G Garcia-Manero","doi":"10.1038/s41375-018-0070-8","elsevierAuthor":"Daver N.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"58"},{"title":"Biological and clinical consequences of NPM1 mutations in AML","googleId":"YJZ4C9KKa48J","googleLink":"https://www.nature.com/articles/leu201730","googleCitationCount":101,"googleAuthor":"SM Chan","doi":"10.1038/leu.2017.30","elsevierAuthor":"Heath E.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"68"},{"title":"The emerging roles of tumor-derived exosomes in hematological malignancies","googleId":"x7NCGvPGgg8J","googleLink":"https://www.nature.com/articles/leu201791","googleCitationCount":105,"googleAuthor":"","doi":"10.1038/leu.2017.91","elsevierAuthor":"Boyiadzis M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"87"},{"title":"CAR T-cells targeting FLT3 have potent activity against FLT3− ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib","googleId":"u0N5EBUwCVEJ","googleLink":"https://www.nature.com/articles/s41375-018-0009-0","googleCitationCount":73,"googleAuthor":"","doi":"10.1038/s41375-018-0009-0","elsevierAuthor":"Jetani H.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"53"},{"title":"Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia","googleId":"PgRtTBgaW0kJ","googleLink":"https://www.nature.com/articles/leu2016360","googleCitationCount":136,"googleAuthor":"","doi":"10.1038/leu.2016.360","elsevierAuthor":"Ilander M.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"101"},{"title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","googleId":"0UBuiV13zGEJ","googleLink":"https://www.nature.com/articles/s41375-017-0005-9","googleCitationCount":69,"googleAuthor":"B Wingelhofer","doi":"10.1038/s41375-017-0005-9","elsevierAuthor":"Wingelhofer B.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"56"},{"title":"Measurable residual disease testing in acute myeloid leukaemia","googleId":"1aEsTh9jhpwJ","googleLink":"https://www.nature.com/articles/leu2017113","googleCitationCount":140,"googleAuthor":"CS Hourigan","doi":"10.1038/leu.2017.113","elsevierAuthor":"Hourigan C.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"104"},{"title":"Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients","googleId":"LiRo5eMVyD8J","googleLink":"https://www.nature.com/articles/leu2017179","googleCitationCount":93,"googleAuthor":"AL Sherborne","doi":"10.1038/leu.2017.179","elsevierAuthor":"Shah V.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"60"},{"title":"Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors","googleId":"QmkS2KUBA7cJ","googleLink":"https://www.nature.com/articles/leu2016180","googleCitationCount":127,"googleAuthor":"","doi":"10.1038/leu.2016.180","elsevierAuthor":"Monjezi R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"83"},{"title":"Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML …","googleId":"pFn6oKCi4nUJ","googleLink":"https://www.nature.com/articles/leu2017253","googleCitationCount":141,"googleAuthor":"M Lauseker","doi":"10.1038/leu.2017.253","elsevierAuthor":"Hehlmann R.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"94"},{"title":"Targeting Bcl-2 for the treatment of multiple myeloma","googleId":"iEhnGQPMAtYJ","googleLink":"https://www.nature.com/articles/s41375-018-0223-9","googleCitationCount":51,"googleAuthor":"P Moreau","doi":"10.1038/s41375-018-0223-9","elsevierAuthor":"Touzeau C.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"43"},{"title":"Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets","googleId":"dF9EdfNcJU4J","googleLink":"https://www.nature.com/articles/leu2017251","googleCitationCount":82,"googleAuthor":"K Karube","doi":"10.1038/leu.2017.251","elsevierAuthor":"Karube K.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"56"},{"title":"Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia","googleId":"tQA1TTnumf8J","googleLink":"https://www.nature.com/articles/leu201732","googleCitationCount":93,"googleAuthor":"SM Fernandes","doi":"10.1038/leu.2017.32","elsevierAuthor":"Deng J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"67"},{"title":"Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1","googleId":"DWP4S1xzxCEJ","googleLink":"https://www.nature.com/articles/leu2017243","googleCitationCount":81,"googleAuthor":"DM Moujalled","doi":"10.1038/leu.2017.243","elsevierAuthor":"Teh T.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"66"},{"title":"Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD …","googleId":"mk7FKtmjpBEJ","googleLink":"https://www.nature.com/articles/leu2017304","googleCitationCount":79,"googleAuthor":"JA Burger","doi":"10.1038/leu.2017.304","elsevierAuthor":"Kondo K.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"51"},{"title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","googleId":"POxuqSJlRoYJ","googleLink":"https://www.nature.com/articles/s41375-018-0037-9","googleCitationCount":77,"googleAuthor":"N Bolli","doi":"10.1038/s41375-018-0037-9","elsevierAuthor":"Bolli N.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"50"},{"title":"BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells","googleId":"XU0iQpgTMuAJ","googleLink":"https://www.nature.com/articles/leu2017207","googleCitationCount":78,"googleAuthor":"Y Qian","doi":"10.1038/leu.2017.207","elsevierAuthor":"Sun B.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"62"},{"title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","googleId":"1CmVkqJucmEJ","googleLink":"https://www.nature.com/articles/leu201716","googleCitationCount":112,"googleAuthor":"","doi":"10.1038/leu.2017.16","elsevierAuthor":"Neuenhahn M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"81"},{"title":"Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis","googleId":"G_C_HGhOOYoJ","googleLink":"https://www.nature.com/articles/s41375-018-0047-7","googleCitationCount":61,"googleAuthor":"M Jäger","doi":"10.1038/s41375-018-0047-7","elsevierAuthor":"Arends C.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"46"},{"title":"The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases","googleId":"Fngo7HOx_kIJ","googleLink":"https://www.nature.com/articles/leu2016263","googleCitationCount":111,"googleAuthor":"","doi":"10.1038/leu.2016.263","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"75"},{"title":"Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia","googleId":"NJTZVi1EyX8J","googleLink":"https://www.nature.com/articles/s41375-018-0034-z","googleCitationCount":71,"googleAuthor":"D Goerlich","doi":"10.1038/s41375-018-0034-z","elsevierAuthor":"Rothenberg-Thurley M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"57"},{"title":"PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma","googleId":"YWts1y6hHcYJ","googleLink":"https://www.nature.com/articles/leu2017103","googleCitationCount":85,"googleAuthor":"","doi":"10.1038/leu.2017.103","elsevierAuthor":"Atsaves V.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"73"},{"title":"Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma","googleId":"wtDaD9MB1b0J","googleLink":"https://www.nature.com/articles/s41375-018-0104-2","googleCitationCount":59,"googleAuthor":"W Chen","doi":"10.1038/s41375-018-0104-2","elsevierAuthor":"Hu Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"47"},{"title":"Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care","googleId":"YGnustR0lnUJ","googleLink":"https://www.nature.com/articles/s41375-018-0257-z","googleCitationCount":46,"googleAuthor":"H Döhner","doi":"10.1038/s41375-018-0257-z","elsevierAuthor":"Döhner H.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"34"},{"title":"Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)","googleId":"mS_OIxSdM5kJ","googleLink":"https://www.nature.com/articles/s41375-018-0142-9","googleCitationCount":54,"googleAuthor":"E Terpos","doi":"10.1038/s41375-018-0142-9","elsevierAuthor":"Larocca A.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"40"},{"title":"Multiple myeloma clonal evolution in homogeneously treated patients","googleId":"7FvecPOtNscJ","googleLink":"https://www.nature.com/articles/s41375-018-0153-6","googleCitationCount":47,"googleAuthor":"N Bolli","doi":"10.1038/s41375-018-0153-6","elsevierAuthor":"Corre J.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"36"},{"title":"Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients","googleId":"lkrT_8z2t-IJ","googleLink":"https://www.nature.com/articles/s41375-018-0018-z","googleCitationCount":60,"googleAuthor":"M Nicolosi","doi":"10.1038/s41375-018-0018-z","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"46"},{"title":"Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia","googleId":"blwLQnQDGUAJ","googleLink":"https://www.nature.com/articles/s41375-018-0075-3","googleCitationCount":55,"googleAuthor":"KH Chen","doi":"10.1038/s41375-018-0075-3","elsevierAuthor":"Petrov J.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"38"},{"title":"Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent …","googleId":"maTROr3-LMkJ","googleLink":"https://www.nature.com/articles/leu2017120","googleCitationCount":74,"googleAuthor":"A Dispenzieri","doi":"10.1038/leu.2017.120","elsevierAuthor":"Dispenzieri A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"54"},{"title":"Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012","googleId":"752LsznI8xIJ","googleLink":"https://www.nature.com/articles/s41375-018-0071-7","googleCitationCount":53,"googleAuthor":"JP Bourquin","doi":"10.1038/s41375-018-0071-7","elsevierAuthor":"Rasche M.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"35"},{"title":"Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo","googleId":"B1sFaO91TC4J","googleLink":"https://www.nature.com/articles/leu201746","googleCitationCount":75,"googleAuthor":"S Pusch","doi":"10.1038/leu.2017.46","elsevierAuthor":"Chaturvedi A.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"57"},{"title":"PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells","googleId":"a2DWdnioVJoJ","googleLink":"https://www.nature.com/articles/s41375-017-0008-6","googleCitationCount":52,"googleAuthor":"W Zheng","doi":"10.1038/s41375-017-0008-6","elsevierAuthor":"Zheng W.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"38"},{"title":"Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary …","googleId":"L2H1CXccSmkJ","googleLink":"https://www.nature.com/articles/leu2016393","googleCitationCount":92,"googleAuthor":"Y Qian","doi":"10.1038/leu.2016.393","elsevierAuthor":"Saenz D.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"85"},{"title":"European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias","googleId":"RpziixaBx1oJ","googleLink":"https://www.nature.com/articles/s41375-018-0209-7","googleCitationCount":48,"googleAuthor":"M Gavriatopoulou","doi":"10.1038/s41375-018-0209-7","elsevierAuthor":"Gavriatopoulou M.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"27"},{"title":"Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts","googleId":"3q3PlEbENkcJ","googleLink":"https://www.nature.com/articles/s41375-018-0019-y","googleCitationCount":57,"googleAuthor":"","doi":"10.1038/s41375-018-0019-y","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"44"},{"title":"Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor","googleId":"S_G0ZkXyREsJ","googleLink":"https://www.nature.com/articles/leu20178","googleCitationCount":87,"googleAuthor":"KH Chen","doi":"10.1038/leu.2017.8","elsevierAuthor":"Chen K.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"69"},{"title":"A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)","googleId":"xiEgkjbCzvYJ","googleLink":"https://www.nature.com/articles/leu2016176","googleCitationCount":89,"googleAuthor":"A Palumbo","doi":"10.1038/leu.2016.176","elsevierAuthor":"Hájek R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"70"},{"title":"Antigen receptor stereotypy in chronic lymphocytic leukemia","googleId":"tHiHxW-zsO0J","googleLink":"https://www.nature.com/articles/leu2016322","googleCitationCount":90,"googleAuthor":"A Agathangelidis","doi":"10.1038/leu.2016.322","elsevierAuthor":"Stamatopoulos K.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"53"},{"title":"Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with response-adapted therapy","googleId":"X9dM4cqwchAJ","googleLink":"https://www.nature.com/articles/leu2016234","googleCitationCount":88,"googleAuthor":"","doi":"10.1038/leu.2016.234","elsevierAuthor":"Pui C.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"65"},{"title":"Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and-independent pathways","googleId":"HccgAgseW6AJ","googleLink":"https://www.nature.com/articles/leu2017116","googleCitationCount":65,"googleAuthor":"J Lou","doi":"10.1038/leu.2017.116","elsevierAuthor":"Vafadar A.","publicationName":"Current Pharmaceutical Design","elsevierCoverDate":"2019-01-01","elsevierCoverDisplayDate":"2019","elsevierCitationCount":"42"},{"title":"Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network","googleId":"2mkRmQCRZgQJ","googleLink":"https://www.nature.com/articles/s41375-018-0040-1","googleCitationCount":58,"googleAuthor":"M Delforge","doi":"10.1038/s41375-018-0040-1","elsevierAuthor":"Ludwig H.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28"},{"title":"Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial","googleId":"rhIkFsDSBAEJ","googleLink":"https://www.nature.com/articles/s41375-018-0129-6","googleCitationCount":45,"googleAuthor":"RF Schlenk","doi":"10.1038/s41375-018-0129-6","elsevierAuthor":"Estey E.","publicationName":"American Journal of Hematology","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"68"},{"title":"Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site","googleId":"7MYtf4GsAkgJ","googleLink":"https://www.nature.com/articles/leu2017245","googleCitationCount":62,"googleAuthor":"E Hadzijusufovic","doi":"10.1038/leu.2017.245","elsevierAuthor":"Hadzijusufovic E.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"45"},{"title":"Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma","googleId":"L4hQQcDTKMIJ","googleLink":"https://www.nature.com/articles/s41375-018-0044-x","googleCitationCount":44,"googleAuthor":"F Shirazi","doi":"10.1038/s41375-018-0044-x","elsevierAuthor":"Zhang X.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"38"},{"title":"Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen","googleId":"0rOjXWm410kJ","googleLink":"https://www.nature.com/articles/leu2016373","googleCitationCount":81,"googleAuthor":"S Rafiq","doi":"10.1038/leu.2016.373","elsevierAuthor":"Rafiq S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"51"},{"title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations","googleId":"1WSD9NJzelYJ","googleLink":"https://www.nature.com/articles/leu2017125","googleCitationCount":62,"googleAuthor":"","doi":"10.1038/leu.2017.125","elsevierAuthor":"Rosenquist R.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"49"},{"title":"Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma","googleId":"N0nX6-jHSvoJ","googleLink":"https://www.nature.com/articles/leu2017212","googleCitationCount":57,"googleAuthor":"L Rasche","doi":"10.1038/leu.2017.212","elsevierAuthor":"Besse A.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"47"},{"title":"Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial","googleId":"Ljf-iq7nQ0UJ","googleLink":"https://www.nature.com/articles/s41375-018-0179-9","googleCitationCount":41,"googleAuthor":"I Glauche","doi":"10.1038/s41375-018-0179-9","elsevierAuthor":"Suttorp M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28"},{"title":"Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling","googleId":"i_s-EG6Gh4kJ","googleLink":"https://www.nature.com/articles/leu2017252","googleCitationCount":58,"googleAuthor":"B Yadav","doi":"10.1038/leu.2017.252","elsevierAuthor":"Andersson E.I.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"42"},{"title":"CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells","googleId":"KwDSqspuWEcJ","googleLink":"https://www.nature.com/articles/s41375-018-0285-8","googleCitationCount":37,"googleAuthor":"","doi":"10.1038/s41375-018-0285-8","elsevierAuthor":"Alcantara M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"26"},{"title":"Management of patients with acute promyelocytic leukemia","googleId":"GSI90OSmthoJ","googleLink":"https://www.nature.com/articles/s41375-018-0139-4","googleCitationCount":41,"googleAuthor":"RF Schlenk","doi":"10.1038/s41375-018-0139-4","elsevierAuthor":"Kayser S.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"32"},{"title":"Genetic deletion or small-molecule inhibition of the arginine methyltransferase PRMT5 exhibit anti-tumoral activity in mouse models of MLL-rearranged AML","googleId":"GMpguTd3JFIJ","googleLink":"https://www.nature.com/articles/leu2017206","googleCitationCount":54,"googleAuthor":"S Kaushik","doi":"10.1038/leu.2017.206","elsevierAuthor":"Kaushik S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"39"},{"title":"Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?","googleId":"P06IYrzKJq4J","googleLink":"https://www.nature.com/articles/s41375-018-0061-9","googleCitationCount":46,"googleAuthor":"K Vanderkerken","doi":"10.1038/s41375-018-0061-9","elsevierAuthor":"Xu S.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28"},{"title":"Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts","googleId":"0jBLbWvTEQUJ","googleLink":"https://www.nature.com/articles/leu2016251","googleCitationCount":76,"googleAuthor":"A Mupo","doi":"10.1038/leu.2016.251","elsevierAuthor":"Mupo A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"60"},{"title":"A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes","googleId":"MaGb_Il-pkoJ","googleLink":"https://www.nature.com/articles/leu2017192","googleCitationCount":55,"googleAuthor":"A Symeonidis","doi":"10.1038/leu.2017.192","elsevierAuthor":"Platzbecker U.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"45"},{"title":"Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma …","googleId":"S87N4L9r8L8J","googleLink":"https://www.nature.com/articles/s41375-018-0062-8","googleCitationCount":41,"googleAuthor":"Y Song","doi":"10.1038/s41375-018-0062-8","elsevierAuthor":"Bae J.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"35"},{"title":"Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia","googleId":"0tddOeSZ8a8J","googleLink":"https://www.nature.com/articles/leu2017291","googleCitationCount":52,"googleAuthor":"F Nadeu","doi":"10.1038/leu.2017.291","elsevierAuthor":"Nadeu F.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"40"},{"title":"Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of …","googleId":"0F0VPpETe0MJ","googleLink":"https://www.nature.com/articles/s41375-018-0068-2","googleCitationCount":43,"googleAuthor":"K Mrózek","doi":"10.1038/s41375-018-0068-2","elsevierAuthor":"Eisfeld A.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"34"},{"title":"SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies","googleId":"dIKCZmy7d1cJ","googleLink":"https://www.nature.com/articles/s41375-018-0074-4","googleCitationCount":41,"googleAuthor":"J Davidsson","doi":"10.1038/s41375-018-0074-4","elsevierAuthor":"Davidsson J.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"32"},{"title":"Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma","googleId":"5jxUFxEdg-MJ","googleLink":"https://www.nature.com/articles/leu2016366","googleCitationCount":71,"googleAuthor":"S Mithraprabhu","doi":"10.1038/leu.2016.366","elsevierAuthor":"Mithraprabhu S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"48"},{"title":"A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS","googleId":"mquWwBHDZasJ","googleLink":"https://www.nature.com/articles/s41375-018-0118-9","googleCitationCount":44,"googleAuthor":"","doi":"10.1038/s41375-018-0118-9","elsevierAuthor":"Fenaux P.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"37"},{"title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","googleId":"wR_lgzgUV8kJ","googleLink":"https://www.nature.com/articles/s41375-018-0043-y","googleCitationCount":45,"googleAuthor":"J Wang","doi":"10.1038/s41375-018-0043-y","elsevierAuthor":"Araf S.","publicationName":"Leukemia","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"1 June 2019","elsevierCitationCount":"0"},{"title":"Molecular remission as a therapeutic objective in acute promyelocytic leukemia","googleId":"lFIXu8IatEkJ","googleLink":"https://www.nature.com/articles/s41375-018-0219-5","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/s41375-018-0219-5","elsevierAuthor":"Cicconi L.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"26"},{"title":"Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in …","googleId":"b_EphjSm3uwJ","googleLink":"https://www.nature.com/articles/leu201787","googleCitationCount":54,"googleAuthor":"DH Mak","doi":"10.1038/leu.2017.87","elsevierAuthor":"Zhou H.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"42"},{"title":"CHIP, ICUS, CCUS and other four-letter words","googleId":"3LK7Xss9R2YJ","googleLink":"https://www.nature.com/articles/leu2017181","googleCitationCount":52,"googleAuthor":"","doi":"10.1038/leu.2017.181","elsevierAuthor":"Bejar R.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"36"},{"title":"RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia","googleId":"edjvsJPb33sJ","googleLink":"https://www.nature.com/articles/leu2017303","googleCitationCount":50,"googleAuthor":"","doi":"10.1038/leu.2017.303","elsevierAuthor":"Jerchel I.S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"33"},{"title":"Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category","googleId":"vjqLNWkvGuMJ","googleLink":"https://www.nature.com/articles/leu2016369","googleCitationCount":69,"googleAuthor":"E Muchtar","doi":"10.1038/leu.2016.369","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"55"},{"title":"Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics","googleId":"avsG_PSYlFUJ","googleLink":"https://www.nature.com/articles/leu201736","googleCitationCount":56,"googleAuthor":"","doi":"10.1038/leu.2017.36","elsevierAuthor":"Reckel S.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"46"},{"title":"Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial","googleId":"ZP0b6E0AMx8J","googleLink":"https://www.nature.com/articles/leu2017234","googleCitationCount":50,"googleAuthor":"TI George","doi":"10.1038/leu.2017.234","elsevierAuthor":"DeAngelo D.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"38"},{"title":"Genomic determinants of chronic myelomonocytic leukemia","googleId":"4L3Kg1ANI4IJ","googleLink":"https://www.nature.com/articles/leu2017164","googleCitationCount":51,"googleAuthor":"S Thota","doi":"10.1038/leu.2017.164","elsevierAuthor":"Patel B.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"41"},{"title":"Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS","googleId":"UAyIyhkh9xMJ","googleLink":"https://www.nature.com/articles/s41375-018-0140-y","googleCitationCount":37,"googleAuthor":"J Abdi","doi":"10.1038/s41375-018-0140-y","elsevierAuthor":"Rastgoo N.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"26"},{"title":"Differentiation stage of myeloma plasma cells: biological and clinical significance","googleId":"pTpWhdlIMzgJ","googleLink":"https://www.nature.com/articles/leu2016211","googleCitationCount":67,"googleAuthor":"","doi":"10.1038/leu.2016.211","elsevierAuthor":"Paiva B.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"39"},{"title":"High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells","googleId":"qfnaKNz1dacJ","googleLink":"https://www.nature.com/articles/leu201781","googleCitationCount":49,"googleAuthor":"P Sujobert","doi":"10.1038/leu.2017.81","elsevierAuthor":"Poulain L.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"31"},{"title":"A compound chimeric antigen receptor strategy for targeting multiple myeloma","googleId":"jjEIYYOt7n8J","googleLink":"https://www.nature.com/articles/leu2017302","googleCitationCount":47,"googleAuthor":"KH Chen","doi":"10.1038/leu.2017.302","elsevierAuthor":"Chen K.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"40"},{"title":"A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers","googleId":"VDy5AquqUy8J","googleLink":"https://www.nature.com/articles/leu201759","googleCitationCount":51,"googleAuthor":"G Tatsumi","doi":"10.1038/leu.2017.59","elsevierAuthor":"Sugino N.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"42"},{"title":"Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy","googleId":"bY0r451pUjAJ","googleLink":"https://www.nature.com/articles/leu2016282","googleCitationCount":65,"googleAuthor":"GL Uy","doi":"10.1038/leu.2016.282","elsevierAuthor":"Uy G.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"49"},{"title":"High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)","googleId":"BXi5Iei7L5IJ","googleLink":"https://www.nature.com/articles/leu2016334","googleCitationCount":66,"googleAuthor":"B Kasenda","doi":"10.1038/leu.2016.334","elsevierAuthor":"Fritsch K.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"52"},{"title":"Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients","googleId":"9-wYQWhg7fgJ","googleLink":"https://www.nature.com/articles/s41375-018-0027-y","googleCitationCount":40,"googleAuthor":"TML Andersson","doi":"10.1038/s41375-018-0027-y","elsevierAuthor":"Landtblom A.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"29"},{"title":"Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms","googleId":"NNbYoGPFxD0J","googleLink":"https://www.nature.com/articles/s41375-018-0103-3","googleCitationCount":37,"googleAuthor":"AJ Cornish","doi":"10.1038/s41375-018-0103-3","elsevierAuthor":"Hoang P.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"30"},{"title":"Monoclonal antibody therapy in multiple myeloma","googleId":"joFSCV2pD5UJ","googleLink":"https://www.nature.com/articles/leu201760","googleCitationCount":49,"googleAuthor":"","doi":"10.1038/leu.2017.60","elsevierAuthor":"Touzeau C.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"38"},{"title":"Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug …","googleId":"x5AJwQS6eg4J","googleLink":"https://www.nature.com/articles/s41375-018-0154-5","googleCitationCount":32,"googleAuthor":"R Katayama","doi":"10.1038/s41375-018-0154-5","elsevierAuthor":"Sakamoto K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"25"},{"title":"Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines","googleId":"E9WXnszC5voJ","googleLink":"https://www.nature.com/articles/leu2017345","googleCitationCount":45,"googleAuthor":"M Petljak","doi":"10.1038/leu.2017.345","elsevierAuthor":"Maura F.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"28"},{"title":"The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy","googleId":"NFry1hj5gXcJ","googleLink":"https://www.nature.com/articles/leu2017214","googleCitationCount":48,"googleAuthor":"MO Holmström","doi":"10.1038/leu.2017.214","elsevierAuthor":"Holmström M.O.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"41"},{"title":"Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia","googleId":"6AW4KSG6wb8J","googleLink":"https://www.nature.com/articles/s41375-018-0127-8","googleCitationCount":35,"googleAuthor":"S Demeyer","doi":"10.1038/s41375-018-0127-8","elsevierAuthor":"De Bie J.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"26"},{"title":"Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study","googleId":"QTBbiyuWUK8J","googleLink":"https://www.nature.com/articles/s41375-018-0094-0","googleCitationCount":41,"googleAuthor":"","doi":"10.1038/s41375-018-0094-0","elsevierAuthor":"Sun W.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"27"},{"title":"Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients","googleId":"_hWDz3ECduYJ","googleLink":"https://www.nature.com/articles/leu2016324","googleCitationCount":62,"googleAuthor":"S Vosberg","doi":"10.1038/leu.2016.324","elsevierAuthor":"Von Der Heide E.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"45"},{"title":"Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth","googleId":"V5fv7olL2iAJ","googleLink":"https://www.nature.com/articles/leu2017152","googleCitationCount":50,"googleAuthor":"J Delgado-Calle","doi":"10.1038/leu.2017.152","elsevierAuthor":"Delgado-Calle J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"40"},{"title":"PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies","googleId":"Tt_8Vkm-xYAJ","googleLink":"https://www.nature.com/articles/leu2016254?amp%3Bcode=7a1e93ec-9600-4e8a-aafb-bebc9c92fa5b","googleCitationCount":62,"googleAuthor":"PF Thall","doi":"10.1038/leu.2016.254","elsevierAuthor":"Qazilbash M.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"46"},{"title":"Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?","googleId":"sPpVzQk2yWYJ","googleLink":"https://www.nature.com/articles/s41375-018-0051-y","googleCitationCount":38,"googleAuthor":"MW Drazer","doi":"10.1038/s41375-018-0051-y","elsevierAuthor":"Tawana K.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"24"},{"title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","googleId":"9BJHBokyLyUJ","googleLink":"https://www.nature.com/articles/s41375-018-0175-0","googleCitationCount":30,"googleAuthor":"O Dufva","doi":"10.1038/s41375-018-0175-0","elsevierAuthor":"Brück O.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"24"},{"title":"Selective inhibition of leukemia-associated SHP2 E69K mutant by the allosteric SHP2 inhibitor SHP099","googleId":"I_j9HPz5gvEJ","googleLink":"https://www.nature.com/articles/s41375-018-0020-5","googleCitationCount":35,"googleAuthor":"X Sun","doi":"10.1038/s41375-018-0020-5","elsevierAuthor":"Sun X.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"28"},{"title":"Subtype-specific patterns of molecular mutations in acute myeloid leukemia","googleId":"EilTcQyeuHUJ","googleLink":"https://www.nature.com/articles/leu2016163","googleCitationCount":62,"googleAuthor":"D Rose","doi":"10.1038/leu.2016.163","elsevierAuthor":"Rose D.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"33"},{"title":"Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia","googleId":"Fr3DIruozz0J","googleLink":"https://www.nature.com/articles/leu2017257","googleCitationCount":44,"googleAuthor":"C Krupka","doi":"10.1038/leu.2017.257","elsevierAuthor":"Reiter K.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"33"},{"title":"Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms","googleId":"Fpu_99cEDJYJ","googleLink":"https://www.nature.com/articles/leu2016262","googleCitationCount":61,"googleAuthor":"M Ruella","doi":"10.1038/leu.2016.262","elsevierAuthor":"Ruella M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"49"},{"title":"Therapeutic targeting of CK2 in acute and chronic leukemias","googleId":"IQJJ9mGSrPAJ","googleLink":"https://www.nature.com/articles/leu2017301","googleCitationCount":47,"googleAuthor":"M Ruzzene","doi":"10.1038/leu.2017.301","elsevierAuthor":"Daneshmanesh A.","publicationName":"PLoS ONE","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"10"},{"title":"Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial","googleId":"d7iNQmJCxlcJ","googleLink":"https://www.nature.com/articles/leu201735","googleCitationCount":47,"googleAuthor":"A Oriol","doi":"10.1038/leu.2017.35","elsevierAuthor":"Rosiñol L.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"30"},{"title":"Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria","googleId":"J8h1nOatuWoJ","googleLink":"https://www.nature.com/articles/s41375-018-0060-x","googleCitationCount":36,"googleAuthor":"E Muchtar","doi":"10.1038/s41375-018-0060-x","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"33"},{"title":"Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib","googleId":"bJdo7g5cNZ8J","googleLink":"https://www.nature.com/articles/leu2016368","googleCitationCount":60,"googleAuthor":"J Yu","doi":"10.1038/leu.2016.368","elsevierAuthor":"Yu J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"43"},{"title":"Treatment and outcome of 2904 CML patients from the EUTOS population-based registry","googleId":"BxkvzDlHk10J","googleLink":"https://www.nature.com/articles/leu2016246","googleCitationCount":61,"googleAuthor":"","doi":"10.1038/leu.2016.246","elsevierAuthor":"Hoffmann V.S.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"43"},{"title":"U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions","googleId":"ZQ9OMrqpKkUJ","googleLink":"https://www.nature.com/articles/s41375-018-0078-0","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/s41375-018-0078-0","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"33"},{"title":"The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression","googleId":"ebd9jxndC_EJ","googleLink":"https://www.nature.com/articles/leu201782","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2017.82","elsevierAuthor":"Abraham M.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"43"},{"title":"JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","googleId":"wpkzaXpOTJEJ","googleLink":"https://www.nature.com/articles/leu2017136","googleCitationCount":59,"googleAuthor":"","doi":"10.1038/leu.2017.136","elsevierAuthor":"Meyer L.K.","publicationName":"PLoS ONE","elsevierCoverDate":"2019-06-01","elsevierCoverDisplayDate":"1 June 2019","elsevierCitationCount":"4"},{"title":"MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation","googleId":"Lwxhu4C-pLoJ","googleLink":"https://www.nature.com/articles/leu2017137","googleCitationCount":45,"googleAuthor":"","doi":"10.1038/leu.2017.137","elsevierAuthor":"Timrott K.","publicationName":"PLoS ONE","elsevierCoverDate":"2020-05-01","elsevierCoverDisplayDate":"May 2020","elsevierCitationCount":"0"},{"title":"HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia","googleId":"ncEFb_eQmyMJ","googleLink":"https://www.nature.com/articles/leu2016222","googleCitationCount":59,"googleAuthor":"A Kumar","doi":"10.1038/leu.2016.222","elsevierAuthor":"Kontro M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"37"},{"title":"Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure","googleId":"X5oYm32fWIUJ","googleLink":"https://www.nature.com/articles/leu201723","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2017.23","elsevierAuthor":"Wattad M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"38"},{"title":"Chromothripsis in acute myeloid leukemia: biological features and impact on survival","googleId":"04Rgq_CSo84J","googleLink":"https://www.nature.com/articles/s41375-018-0035-y","googleCitationCount":35,"googleAuthor":"G Marconi","doi":"10.1038/s41375-018-0035-y","elsevierAuthor":"Fontana M.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"28"},{"title":"Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome","googleId":"f9XQ7lwSTYQJ","googleLink":"https://www.nature.com/articles/leu2017142","googleCitationCount":46,"googleAuthor":"M Walsh","doi":"10.1038/leu.2017.142","elsevierAuthor":"Schwartz J.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"32"},{"title":"Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma","googleId":"5kW_2oV9em8J","googleLink":"https://www.nature.com/articles/leu2017273","googleCitationCount":49,"googleAuthor":"M Fujisawa","doi":"10.1038/leu.2017.273","elsevierAuthor":"Fujisawa M.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"31"},{"title":"Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment—the involvement …","googleId":"XqKIxg-rINYJ","googleLink":"https://www.nature.com/articles/s41375-018-0087-z","googleCitationCount":31,"googleAuthor":"A Abdel-Latif","doi":"10.1038/s41375-018-0087-z","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"26"},{"title":"Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia","googleId":"-opwynA7KEoJ","googleLink":"https://www.nature.com/articles/leu201739","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2017.39","elsevierAuthor":"Rossig C.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"36"},{"title":"Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma","googleId":"fchLZxC8K2sJ","googleLink":"https://www.nature.com/articles/leu2016175","googleCitationCount":57,"googleAuthor":"Q Gong","doi":"10.1038/leu.2016.175","elsevierAuthor":"Bouska A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"45"},{"title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","googleId":"A4K6I3pXYFoJ","googleLink":"https://www.nature.com/articles/leu201711","googleCitationCount":58,"googleAuthor":"NS Saba","doi":"10.1038/leu.2017.11","elsevierAuthor":"Herndon T.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"44"},{"title":"High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the …","googleId":"SMyJKZVsgqoJ","googleLink":"https://www.nature.com/articles/leu2017170","googleCitationCount":41,"googleAuthor":"B Kasenda","doi":"10.1038/leu.2017.170","elsevierAuthor":"Kasenda B.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"31"},{"title":"Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia","googleId":"-vNVWaCtpxEJ","googleLink":"https://www.nature.com/articles/leu2017300","googleCitationCount":40,"googleAuthor":"","doi":"10.1038/leu.2017.300","elsevierAuthor":"Fujita S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"31"},{"title":"The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma","googleId":"Uop7IapGtcoJ","googleLink":"https://www.nature.com/articles/s41375-018-0045-9","googleCitationCount":30,"googleAuthor":"","doi":"10.1038/s41375-018-0045-9","elsevierAuthor":"Schleussner N.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"23"},{"title":"HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications","googleId":"RvXyGNhrHNsJ","googleLink":"https://www.nature.com/articles/leu2017144","googleCitationCount":41,"googleAuthor":"","doi":"10.1038/leu.2017.144","elsevierAuthor":"Iwasa M.","publicationName":"Oncotarget","elsevierCoverDate":"2019-03-01","elsevierCoverDisplayDate":"1 March 2019","elsevierCitationCount":"4"},{"title":"Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial","googleId":"Kj4xvF0JLvEJ","googleLink":"https://www.nature.com/articles/leu2016219","googleCitationCount":55,"googleAuthor":"DI Marks","doi":"10.1038/leu.2016.219","elsevierAuthor":"Patel B.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"45"},{"title":"ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition","googleId":"ShK0eIkpNucJ","googleLink":"https://www.nature.com/articles/leu201745","googleCitationCount":44,"googleAuthor":"J Yang","doi":"10.1038/leu.2017.45","elsevierAuthor":"Ju H.Q.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"29"},{"title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","googleId":"QjtkqMPK7N4J","googleLink":"https://www.nature.com/articles/s41375-018-0058-4","googleCitationCount":30,"googleAuthor":"MJ Oberley","doi":"10.1038/s41375-018-0058-4","elsevierAuthor":"Maruffi M.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"20"},{"title":"Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells","googleId":"RZAFevOBqOEJ","googleLink":"https://www.nature.com/articles/s41375-018-0264-0","googleCitationCount":27,"googleAuthor":"DM Ross","doi":"10.1038/s41375-018-0264-0","elsevierAuthor":"Ross D.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"21"},{"title":"Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open …","googleId":"d_M7QjTKo24J","googleLink":"https://www.nature.com/articles/s41375-018-0023-2","googleCitationCount":35,"googleAuthor":"W Jurczak","doi":"10.1038/s41375-018-0023-2","elsevierAuthor":"Rule S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"25"},{"title":"SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells","googleId":"Gvkbp0pKTUcJ","googleLink":"https://www.nature.com/articles/s41375-018-0152-7","googleCitationCount":29,"googleAuthor":"T Tebaldi","doi":"10.1038/s41375-018-0152-7","elsevierAuthor":"Liang Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"20"},{"title":"Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV mut and IgHV unmut …","googleId":"DKsXJpIF3SMJ","googleLink":"https://www.nature.com/articles/leu2017177","googleCitationCount":40,"googleAuthor":"R Alsolami","doi":"10.1038/leu.2017.177","elsevierAuthor":"Burns A.","publicationName":"Leukemia","elsevierCoverDate":"2019-09-01","elsevierCoverDisplayDate":"1 September 2019","elsevierCitationCount":"0"},{"title":"Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)","googleId":"Rid0bTfzZZ0J","googleLink":"https://www.nature.com/articles/leu2017242","googleCitationCount":41,"googleAuthor":"N Kröger","doi":"10.1038/leu.2017.242","elsevierAuthor":"Bug G.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"27"},{"title":"Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the …","googleId":"bS4gL8VLFgkJ","googleLink":"https://www.nature.com/articles/leu2016186","googleCitationCount":56,"googleAuthor":"D Joshua","doi":"10.1038/leu.2016.186","elsevierAuthor":"Moreau P.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"38"},{"title":"Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR","googleId":"4EycgOxstmwJ","googleLink":"https://www.nature.com/articles/leu2016390","googleCitationCount":56,"googleAuthor":"WJ Chng","doi":"10.1038/leu.2016.390","elsevierAuthor":"Chng W.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"37"},{"title":"miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding","googleId":"w-RR7LmQ2uUJ","googleLink":"https://www.nature.com/articles/s41375-018-0015-2","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/s41375-018-0015-2","elsevierAuthor":"Peng D.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"30"},{"title":"Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma","googleId":"jN2emo8K7FEJ","googleLink":"https://www.nature.com/articles/leu2017322","googleCitationCount":41,"googleAuthor":"DS Das","doi":"10.1038/leu.2017.322","elsevierAuthor":"Ray A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"29"},{"title":"KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells","googleId":"KBdVFfHV-XgJ","googleLink":"https://www.nature.com/articles/leu2016145","googleCitationCount":52,"googleAuthor":"","doi":"10.1038/leu.2016.145","elsevierAuthor":"Etchin J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"35"},{"title":"KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival","googleId":"rqkt12wmYz0J","googleLink":"https://www.nature.com/articles/leu2017141","googleCitationCount":40,"googleAuthor":"","doi":"10.1038/leu.2017.141","elsevierAuthor":"Ohguchi H.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"29"},{"title":"Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib","googleId":"B8zAhrFPvqgJ","googleLink":"https://www.nature.com/articles/leu2016308","googleCitationCount":53,"googleAuthor":"K Shide","doi":"10.1038/leu.2016.308","elsevierAuthor":"Shide K.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"40"},{"title":"MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs","googleId":"lTloFMPYffoJ","googleLink":"https://www.nature.com/articles/leu2017163","googleCitationCount":39,"googleAuthor":"AR Pyzer","doi":"10.1038/leu.2017.163","elsevierAuthor":"Pyzer A.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"36"},{"title":"Natural history of t (11; 14) multiple myeloma","googleId":"o5yR_dJs8bcJ","googleLink":"https://www.nature.com/articles/leu2017204","googleCitationCount":40,"googleAuthor":"A Lakshman","doi":"10.1038/leu.2017.204","elsevierAuthor":"Lakshman A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"32"},{"title":"Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants","googleId":"8J1TWjCQ6AQJ","googleLink":"https://www.nature.com/articles/leu2017199","googleCitationCount":39,"googleAuthor":"","doi":"10.1038/leu.2017.199","elsevierAuthor":"Wang Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"25"},{"title":"JAM-A as a prognostic factor and new therapeutic target in multiple myeloma","googleId":"fIGij7VQ6hMJ","googleLink":"https://www.nature.com/articles/leu2017287","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.287","elsevierAuthor":"Solimando A.G.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"25"},{"title":"p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status","googleId":"OSa2LjRajjUJ","googleLink":"https://www.nature.com/articles/leu2016350","googleCitationCount":51,"googleAuthor":"A Qutub","doi":"10.1038/leu.2016.350","elsevierAuthor":"Quintás-Cardama A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"39"},{"title":"MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences","googleId":"veXXdmUF3VYJ","googleLink":"https://www.nature.com/articles/s41375-018-0033-0","googleCitationCount":36,"googleAuthor":"I Cifola","doi":"10.1038/s41375-018-0033-0","elsevierAuthor":"L’Abbate A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0"},{"title":"Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma","googleId":"9VJa6btXU4AJ","googleLink":"https://www.nature.com/articles/leu2017334","googleCitationCount":35,"googleAuthor":"M Fulciniti","doi":"10.1038/leu.2017.334","elsevierAuthor":"Gullà A.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"23"},{"title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","googleId":"0EWSdOY1CP0J","googleLink":"https://www.nature.com/articles/leu201744","googleCitationCount":42,"googleAuthor":"","doi":"10.1038/leu.2017.44","elsevierAuthor":"Kobayashi S.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"24"},{"title":"Targeting acute myeloid leukemia by drug-induced c-MYB degradation","googleId":"1g3o_iOw60IJ","googleLink":"https://www.nature.com/articles/leu2017317","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.317","elsevierAuthor":"Walf-Vorderwülbecke V.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"30"},{"title":"Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors","googleId":"6Pd3PW9b7yAJ","googleLink":"https://www.nature.com/articles/leu2016391","googleCitationCount":49,"googleAuthor":"GR Friberg","doi":"10.1038/leu.2016.391","elsevierAuthor":"Aldoss I.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"35"},{"title":"The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma","googleId":"4i0lOdqssukJ","googleLink":"https://www.nature.com/articles/leu2016296","googleCitationCount":48,"googleAuthor":"JT Powers","doi":"10.1038/leu.2016.296","elsevierAuthor":"Manier S.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"36"},{"title":"Dysregulated iron metabolism in polycythemia vera: etiology and consequences","googleId":"WBd4gcpzjPIJ","googleLink":"https://www.nature.com/articles/s41375-018-0207-9","googleCitationCount":25,"googleAuthor":"J Varkonyi","doi":"10.1038/s41375-018-0207-9","elsevierAuthor":"Ginzburg Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"22"},{"title":"Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease","googleId":"epahABuYVAYJ","googleLink":"https://www.nature.com/articles/s41375-018-0123-z","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/s41375-018-0123-z","elsevierAuthor":"Choi J.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"23"},{"title":"BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells","googleId":"Qh46B9bvwrkJ","googleLink":"https://www.nature.com/articles/leu2016260","googleCitationCount":49,"googleAuthor":"K Rajapakshe","doi":"10.1038/leu.2016.260","elsevierAuthor":"Saenz D.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"41"},{"title":"Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML","googleId":"715ndTxlVzUJ","googleLink":"https://www.nature.com/articles/leu20179","googleCitationCount":48,"googleAuthor":"","doi":"10.1038/leu.2017.9","elsevierAuthor":"Schütz C.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"2"},{"title":"miR-194-5p/BCLAF1 deregulation in AML tumorigenesis","googleId":"LVMdaA17uOwJ","googleLink":"https://www.nature.com/articles/leu201764","googleCitationCount":38,"googleAuthor":"G Lania","doi":"10.1038/leu.2017.64","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0"},{"title":"Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia","googleId":"_XM4wX_EKdEJ","googleLink":"https://www.nature.com/articles/leu2016327","googleCitationCount":48,"googleAuthor":"","doi":"10.1038/leu.2016.327","elsevierAuthor":"Dafflon C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"40"},{"title":"The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders","googleId":"RWmQDOpjHcwJ","googleLink":"https://www.nature.com/articles/leu2017139","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.139","elsevierAuthor":"Maslah N.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"25"},{"title":"Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia","googleId":"6HiTGZcKTDIJ","googleLink":"https://www.nature.com/articles/leu2016309","googleCitationCount":48,"googleAuthor":"RK Hills","doi":"10.1038/leu.2016.309","elsevierAuthor":"Khan N.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"43"},{"title":"The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling","googleId":"vH86fOENQzAJ","googleLink":"https://www.nature.com/articles/leu2017225","googleCitationCount":36,"googleAuthor":"S Vereecke","doi":"10.1038/leu.2017.225","elsevierAuthor":"Girardi T.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"24"},{"title":"Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression","googleId":"_4qadwh8XTAJ","googleLink":"https://www.nature.com/articles/s41375-018-0013-4","googleCitationCount":29,"googleAuthor":"CF de Larrea","doi":"10.1038/s41375-018-0013-4","elsevierAuthor":"De Larrea C.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"22"},{"title":"Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation","googleId":"yZoVNJXabOMJ","googleLink":"https://www.nature.com/articles/leu2016310","googleCitationCount":48,"googleAuthor":"E van den Berg","doi":"10.1038/leu.2016.310","elsevierAuthor":"Berger G.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"28"},{"title":"DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia","googleId":"yxf9ObciBrsJ","googleLink":"https://www.nature.com/articles/leu2017200","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/leu.2017.200","elsevierAuthor":"Gaidzik V.I.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"28"},{"title":"Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias","googleId":"KDkv4e-NBRUJ","googleLink":"https://www.nature.com/articles/leu2016166","googleCitationCount":48,"googleAuthor":"M Sanchez-Martin","doi":"10.1038/leu.2016.166","elsevierAuthor":"Wang K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"31"},{"title":"Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T cells","googleId":"L66_B5BbDtgJ","googleLink":"https://www.nature.com/articles/leu2017249","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/leu.2017.249","elsevierAuthor":"Lai Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"30"},{"title":"Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic …","googleId":"HIkt2m2epSgJ","googleLink":"https://www.nature.com/articles/leu2017276","googleCitationCount":35,"googleAuthor":"S Demeyer","doi":"10.1038/leu.2017.276","elsevierAuthor":"Degryse S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0"},{"title":"Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains","googleId":"dvke3iL1IlkJ","googleLink":"https://www.nature.com/articles/leu2017286","googleCitationCount":34,"googleAuthor":"S Sidana","doi":"10.1038/leu.2017.286","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"35"},{"title":"Targeting MYC in multiple myeloma","googleId":"-yqAubH9bzAJ","googleLink":"https://www.nature.com/articles/s41375-018-0036-x","googleCitationCount":35,"googleAuthor":"KK Jovanović","doi":"10.1038/s41375-018-0036-x","elsevierAuthor":"Jovanović K.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"21"},{"title":"Preleukemia: one name, many meanings","googleId":"EVhCupysSYAJ","googleLink":"https://www.nature.com/articles/leu2016364","googleCitationCount":46,"googleAuthor":"","doi":"10.1038/leu.2016.364","elsevierAuthor":"Koeffler H.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"30"},{"title":"Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on …","googleId":"Q3b-5sBgr-sJ","googleLink":"https://www.nature.com/articles/leu201733","googleCitationCount":40,"googleAuthor":"AM Zeidan","doi":"10.1038/leu.2017.33","elsevierAuthor":"Zeidan A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"29"},{"title":"NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components","googleId":"oOno2Ws9yuIJ","googleLink":"https://www.nature.com/articles/leu201790","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2017.90","elsevierAuthor":"Pozzo F.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"25"},{"title":"A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26. 13 and 12q23. 1","googleId":"AormZh75kFUJ","googleLink":"https://www.nature.com/articles/leu2016271","googleCitationCount":47,"googleAuthor":"J Vijayakrishnan","doi":"10.1038/leu.2016.271","elsevierAuthor":"Vijayakrishnan J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"41"},{"title":"Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)","googleId":"DB473EzXuV8J","googleLink":"https://www.nature.com/articles/leu2016160","googleCitationCount":48,"googleAuthor":"QY Sun","doi":"10.1038/leu.2016.160","elsevierAuthor":"Sun Q.Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"37"},{"title":"Proteomic characterization of human multiple myeloma bone marrow extracellular matrix","googleId":"6hwMtyJtGgcJ","googleLink":"https://www.nature.com/articles/leu2017102","googleCitationCount":37,"googleAuthor":"SV Glavey","doi":"10.1038/leu.2017.102","elsevierAuthor":"Glavey S.V.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"31"},{"title":"PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia","googleId":"Gb1pLdK55JIJ","googleLink":"https://www.nature.com/articles/leu2016328","googleCitationCount":46,"googleAuthor":"","doi":"10.1038/leu.2016.328","elsevierAuthor":"Goltz D.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"35"},{"title":"High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL","googleId":"01hJJDno0m0J","googleLink":"https://www.nature.com/articles/leu2016375","googleCitationCount":45,"googleAuthor":"SK Tasian","doi":"10.1038/leu.2016.375","elsevierAuthor":"Tasian S.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"37"},{"title":"Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma","googleId":"pXqNcceq_A8J","googleLink":"https://www.nature.com/articles/s41375-018-0038-8","googleCitationCount":33,"googleAuthor":"A Krishnan","doi":"10.1038/s41375-018-0038-8","elsevierAuthor":"Krishnan A.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"16"},{"title":"Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time","googleId":"E6rMp9UwK54J","googleLink":"https://www.nature.com/articles/leu2017331","googleCitationCount":32,"googleAuthor":"SK Kumar","doi":"10.1038/leu.2017.331","elsevierAuthor":"Kumar S.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"21"},{"title":"Consequences of mutant TET2 on clonality and subclonal hierarchy","googleId":"3Xq9NSgpbUgJ","googleLink":"https://www.nature.com/articles/s41375-018-0150-9","googleCitationCount":24,"googleAuthor":"A Nazha","doi":"10.1038/s41375-018-0150-9","elsevierAuthor":"Hirsch C.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"18"},{"title":"A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence","googleId":"wWzJsNohsSMJ","googleLink":"https://www.nature.com/articles/leu2016300","googleCitationCount":47,"googleAuthor":"","doi":"10.1038/leu.2016.300","elsevierAuthor":"Chowdhury O.","publicationName":"Leukemia","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"1"},{"title":"A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with⩽ 30% blasts","googleId":"l1PTZ61EgAMJ","googleLink":"https://www.nature.com/articles/leu2017159","googleCitationCount":36,"googleAuthor":"G Garcia-Manero","doi":"10.1038/leu.2017.159","elsevierAuthor":"Garcia-Manero G.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"29"},{"title":"Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease","googleId":"0TlQkZCkXZsJ","googleLink":"https://www.nature.com/articles/s41375-018-0151-8","googleCitationCount":30,"googleAuthor":"","doi":"10.1038/s41375-018-0151-8","elsevierAuthor":"Kim Y.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"25"},{"title":"GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML","googleId":"MwR0L2syRmMJ","googleLink":"https://www.nature.com/articles/s41375-018-0134-9","googleCitationCount":27,"googleAuthor":"AF Al Seraihi","doi":"10.1038/s41375-018-0134-9","elsevierAuthor":"Al Seraihi A.F.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"21"},{"title":"The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia","googleId":"7c0NOG-XeesJ","googleLink":"https://www.nature.com/articles/leu201786","googleCitationCount":35,"googleAuthor":"K Mrózek","doi":"10.1038/leu.2017.86","elsevierAuthor":"Eisfeld A.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"26"},{"title":"Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials","googleId":"HG8In44iGiYJ","googleLink":"https://www.nature.com/articles/s41375-018-0163-4","googleCitationCount":23,"googleAuthor":"A Richter","doi":"10.1038/s41375-018-0163-4","elsevierAuthor":"Heaney J.L.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"13"},{"title":"Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT …","googleId":"idgsXTWlQ1oJ","googleLink":"https://www.nature.com/articles/leu2016382","googleCitationCount":43,"googleAuthor":"VM Patel","doi":"10.1038/leu.2016.382","elsevierAuthor":"Patel V.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"37"},{"title":"Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio","googleId":"T21e9BDKrN4J","googleLink":"https://www.nature.com/articles/leu2016183","googleCitationCount":45,"googleAuthor":"J Versluis","doi":"10.1038/leu.2016.183","elsevierAuthor":"Versluis J.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"35"},{"title":"Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 …","googleId":"V1FeboTSKgwJ","googleLink":"https://www.nature.com/articles/leu2017230","googleCitationCount":34,"googleAuthor":"","doi":"10.1038/leu.2017.230","elsevierAuthor":"Kubesova B.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"21"},{"title":"TanCAR T cells targeting CD19 and CD133 efficiently eliminate MLL leukemic cells","googleId":"Mopzuds15NEJ","googleLink":"https://www.nature.com/articles/s41375-018-0212-z","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-018-0212-z","elsevierAuthor":"Li D.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"20"},{"title":"Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia","googleId":"aeb3ElAqvBkJ","googleLink":"https://www.nature.com/articles/leu201710","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2017.10","elsevierAuthor":"Ruefli-Brasse A.","publicationName":"Biochemical Journal","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"35"},{"title":"Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis","googleId":"VSs1oR_ebQcJ","googleLink":"https://www.nature.com/articles/leu2016381","googleCitationCount":44,"googleAuthor":"V Montefusco","doi":"10.1038/leu.2016.381","elsevierAuthor":"Gay F.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"30"},{"title":"HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma","googleId":"dTf635YU9GsJ","googleLink":"https://www.nature.com/articles/leu2017299","googleCitationCount":30,"googleAuthor":"WG Wang","doi":"10.1038/leu.2017.299","elsevierAuthor":"Jia Y.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"24"},{"title":"Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells","googleId":"0Ov9Luswc3sJ","googleLink":"https://www.nature.com/articles/leu2017133","googleCitationCount":35,"googleAuthor":"MK Hasan","doi":"10.1038/leu.2017.133","elsevierAuthor":"Caras I.W.","publicationName":"Stem Cells Translational Medicine","elsevierCoverDate":"2020-08-01","elsevierCoverDisplayDate":"1 August 2020","elsevierCitationCount":"0"},{"title":"Decreased spermatogonial quantity in prepubertal boys with leukaemia treated with alkylating agents","googleId":"gf7fdJYQS_MJ","googleLink":"https://www.nature.com/articles/leu201776","googleCitationCount":37,"googleAuthor":"I Masliukaite","doi":"10.1038/leu.2017.76","elsevierAuthor":"Poganitsch-Korhonen M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"24"},{"title":"Ninety-minute daratumumab infusion is safe in multiple myeloma","googleId":"Rkl2lSJnIlgJ","googleLink":"https://www.nature.com/articles/s41375-018-0120-2","googleCitationCount":31,"googleAuthor":"","doi":"10.1038/s41375-018-0120-2","elsevierAuthor":"Barr H.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"24"},{"title":"C/EBPα deregulation as a paradigm for leukemogenesis","googleId":"PByNMbGKL_sJ","googleLink":"https://www.nature.com/articles/leu2017229","googleCitationCount":32,"googleAuthor":"JA Pulikkan","doi":"10.1038/leu.2017.229","elsevierAuthor":"Pulikkan J.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"23"},{"title":"Novel evidence that extracellular nucleotides and purinergic signaling induce innate immunity-mediated mobilization of hematopoietic stem/progenitor cells","googleId":"mXwjI0Fm-t8J","googleLink":"https://www.nature.com/articles/s41375-018-0122-0","googleCitationCount":22,"googleAuthor":"K Bujko","doi":"10.1038/s41375-018-0122-0","elsevierAuthor":"Adamiak M.","publicationName":"Leukemia","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"1 April 2019","elsevierCitationCount":"0"},{"title":"Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion","googleId":"l_2AShPQpaAJ","googleLink":"https://www.nature.com/articles/s41375-018-0131-z","googleCitationCount":23,"googleAuthor":"","doi":"10.1038/s41375-018-0131-z","elsevierAuthor":"Heaton W.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"21"},{"title":"Novel targets in the treatment of chronic graft-versus-host disease","googleId":"0ye7l4JUSVsJ","googleLink":"https://www.nature.com/articles/leu2016367","googleCitationCount":42,"googleAuthor":"","doi":"10.1038/leu.2016.367","elsevierAuthor":"Im A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"32"},{"title":"Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD","googleId":"YHI7O9PMeUMJ","googleLink":"https://www.nature.com/articles/leu201780","googleCitationCount":34,"googleAuthor":"Q Zhang","doi":"10.1038/leu.2017.80","elsevierAuthor":"Yuan T.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"26"},{"title":"Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes","googleId":"xBZTodsgvTkJ","googleLink":"https://www.nature.com/articles/leu2017266","googleCitationCount":31,"googleAuthor":"A Nazha","doi":"10.1038/leu.2017.266","elsevierAuthor":"Nazha A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"26"},{"title":"RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma","googleId":"F_mFY61she4J","googleLink":"https://www.nature.com/articles/leu201754","googleCitationCount":34,"googleAuthor":"YL Lin","doi":"10.1038/leu.2017.54","elsevierAuthor":"Viziteu E.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"26"},{"title":"Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: A Phase IIa Study","googleId":"1vPl6E1br_wJ","googleLink":"https://www.nature.com/articles/leu20175","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2017.5","elsevierAuthor":"Ludwig H.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"39"},{"title":"Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503 …","googleId":"fANCLm6Ul2wJ","googleLink":"https://www.nature.com/articles/leu2016252","googleCitationCount":42,"googleAuthor":"G Uy","doi":"10.1038/leu.2016.252","elsevierAuthor":"Blum W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"36"},{"title":"Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations","googleId":"cyD_5jBTsqoJ","googleLink":"https://www.nature.com/articles/leu2016283","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2016.283","elsevierAuthor":"Marchetti M.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"28"},{"title":"APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL","googleId":"wNe6yIlrD7oJ","googleLink":"https://www.nature.com/articles/leu201775","googleCitationCount":35,"googleAuthor":"Z Li","doi":"10.1038/leu.2017.75","elsevierAuthor":"Li Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"27"},{"title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis","googleId":"qYvv4k1MXi4J","googleLink":"https://www.nature.com/articles/leu2016267","googleCitationCount":43,"googleAuthor":"","doi":"10.1038/leu.2016.267","elsevierAuthor":"Struski S.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"33"},{"title":"Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma","googleId":"buc92JKwa9cJ","googleLink":"https://www.nature.com/articles/leu2017197","googleCitationCount":31,"googleAuthor":"A Laganà","doi":"10.1038/leu.2017.197","elsevierAuthor":"Laganà A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"20"},{"title":"Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells","googleId":"yUwguSxkF8UJ","googleLink":"https://www.nature.com/articles/leu2016349","googleCitationCount":43,"googleAuthor":"F Yan","doi":"10.1038/leu.2016.349","elsevierAuthor":"Yan F.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"37"},{"title":"Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell …","googleId":"LZYCgl4YwmoJ","googleLink":"https://www.nature.com/articles/s41375-017-0004-x","googleCitationCount":24,"googleAuthor":"ZM Li","doi":"10.1038/s41375-017-0004-x","elsevierAuthor":"Nairismägi M.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"20"},{"title":"Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia","googleId":"TCdgIx3uGqAJ","googleLink":"https://www.nature.com/articles/leu2016365","googleCitationCount":41,"googleAuthor":"C Frech","doi":"10.1038/leu.2016.365","elsevierAuthor":"Vesely C.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"30"},{"title":"The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation","googleId":"KLlAG4TrvewJ","googleLink":"https://www.nature.com/articles/leu201770","googleCitationCount":31,"googleAuthor":"F Li","doi":"10.1038/leu.2017.70","elsevierAuthor":"Ha V.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"17"},{"title":"A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia","googleId":"V4E-Wh-uLZcJ","googleLink":"https://www.nature.com/articles/leu2017186","googleCitationCount":32,"googleAuthor":"M Lunghi","doi":"10.1038/leu.2017.186","elsevierAuthor":"Santini V.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"20"},{"title":"Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration","googleId":"rHuOyzFFTUkJ","googleLink":"https://www.nature.com/articles/s41375-018-0012-5","googleCitationCount":24,"googleAuthor":"N Eissa","doi":"10.1038/s41375-018-0012-5","elsevierAuthor":"Ali A.Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"17"},{"title":"Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes","googleId":"0Euk653ZsCgJ","googleLink":"https://www.nature.com/articles/leu2017196","googleCitationCount":30,"googleAuthor":"P Venugopal","doi":"10.1038/leu.2017.196","elsevierAuthor":"Chong C.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"24"},{"title":"Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia","googleId":"-lia0OLjLzgJ","googleLink":"https://www.nature.com/articles/leu2017171","googleCitationCount":31,"googleAuthor":"M Mingay","doi":"10.1038/leu.2017.171","elsevierAuthor":"Mingay M.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"25"},{"title":"Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response","googleId":"l_9Pqrt2g9YJ","googleLink":"https://www.nature.com/articles/leu2017130","googleCitationCount":31,"googleAuthor":"","doi":"10.1038/leu.2017.130","elsevierAuthor":"Long J.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"24"},{"title":"Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia","googleId":"U-JbLbTzVmYJ","googleLink":"https://www.nature.com/articles/s41375-018-0097-x","googleCitationCount":29,"googleAuthor":"MA Burns","doi":"10.1038/s41375-018-0097-x","elsevierAuthor":"Burns M.A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"23"},{"title":"Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis","googleId":"_7zT0YOmDFEJ","googleLink":"https://www.nature.com/articles/leu2016345","googleCitationCount":39,"googleAuthor":"R Gabdoulline","doi":"10.1038/leu.2016.345","elsevierAuthor":"Thol F.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"31"},{"title":"RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia","googleId":"O12VQffCL2wJ","googleLink":"https://www.nature.com/articles/s41375-018-0102-4","googleCitationCount":21,"googleAuthor":"S Rudat","doi":"10.1038/s41375-018-0102-4","elsevierAuthor":"Rudat S.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"16"},{"title":"Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms","googleId":"5Ww4ACGwCfsJ","googleLink":"https://www.nature.com/articles/s41375-018-0294-7","googleCitationCount":20,"googleAuthor":"K Bujko","doi":"10.1038/s41375-018-0294-7","elsevierAuthor":"Ratajczak M.Z.","publicationName":"Leukemia","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"1 April 2019","elsevierCitationCount":"0"},{"title":"Epigenetic silencing of miR-137 induces drug resistance and chromosomal instability by targeting AURKA in multiple myeloma","googleId":"hxeZ-QfFlb0J","googleLink":"https://www.nature.com/articles/leu2016325","googleCitationCount":38,"googleAuthor":"","doi":"10.1038/leu.2016.325","elsevierAuthor":"Qin Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"36"},{"title":"Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis","googleId":"kGgBBjzqZ58J","googleLink":"https://www.nature.com/articles/leu201761","googleCitationCount":32,"googleAuthor":"JA Cutler","doi":"10.1038/leu.2017.61","elsevierAuthor":"Cutler J.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"23"},{"title":"Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling","googleId":"UFd6elPHV0EJ","googleLink":"https://www.nature.com/articles/leu201748","googleCitationCount":33,"googleAuthor":"M Wang","doi":"10.1038/leu.2017.48","elsevierAuthor":"Wang M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"26"},{"title":"Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International …","googleId":"pFeMgYawOJ4J","googleLink":"https://www.nature.com/articles/leu201788","googleCitationCount":32,"googleAuthor":"MG Della Porta","doi":"10.1038/leu.2017.88","elsevierAuthor":"Della Porta M.G.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"19"},{"title":"Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression","googleId":"brxdkDjOQN8J","googleLink":"https://www.nature.com/articles/leu2016205","googleCitationCount":40,"googleAuthor":"WI Gonsalves","doi":"10.1038/leu.2016.205","elsevierAuthor":"Gonsalves W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"29"},{"title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","googleId":"UeNkR69nxEoJ","googleLink":"https://www.nature.com/articles/s41375-018-0082-4","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/s41375-018-0082-4","elsevierAuthor":"Pillonel V.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"19"},{"title":"The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment","googleId":"ZA-mzV7gVf4J","googleLink":"https://www.nature.com/articles/leu2016179","googleCitationCount":41,"googleAuthor":"LN Eadie","doi":"10.1038/leu.2016.179","elsevierAuthor":"Eadie L.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"29"},{"title":"Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis","googleId":"n_W6PE9QUlIJ","googleLink":"https://www.nature.com/articles/leu2016229","googleCitationCount":39,"googleAuthor":"","doi":"10.1038/leu.2016.229","elsevierAuthor":"Landau H.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"38"},{"title":"A predictive model for risk of early grade≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial","googleId":"uqh2zPaCt-MJ","googleLink":"https://www.nature.com/articles/s41375-018-0133-x","googleCitationCount":21,"googleAuthor":"MA Dimopoulos","doi":"10.1038/s41375-018-0133-x","elsevierAuthor":"Dumontet C.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"13"},{"title":"Health-related quality of life in lower-risk MDS patients compared with age-and sex-matched reference populations: a European LeukemiaNet study","googleId":"MsO-TCqsSpQJ","googleLink":"https://www.nature.com/articles/s41375-018-0089-x","googleCitationCount":24,"googleAuthor":"G Yu","doi":"10.1038/s41375-018-0089-x","elsevierAuthor":"Stauder R.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"21"},{"title":"Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma","googleId":"jlYXy2i-tv0J","googleLink":"https://www.nature.com/articles/leu201758","googleCitationCount":34,"googleAuthor":"J Martinez-Lopez","doi":"10.1038/leu.2017.58","elsevierAuthor":"Martinez-Lopez J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"23"},{"title":"Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group","googleId":"BrkIEYCNUlgJ","googleLink":"https://www.nature.com/articles/leu2017246","googleCitationCount":31,"googleAuthor":"","doi":"10.1038/leu.2017.246","elsevierAuthor":"Hoechstetter M.A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"18"},{"title":"Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche","googleId":"_vuaMVAZ1tIJ","googleLink":"https://www.nature.com/articles/s41375-018-0161-6","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/s41375-018-0161-6","elsevierAuthor":"Tsukamoto S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"15"},{"title":"Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia","googleId":"4bjJMbBpaOQJ","googleLink":"https://www.nature.com/articles/leu2016307","googleCitationCount":38,"googleAuthor":"T Smith","doi":"10.1038/leu.2016.307","elsevierAuthor":"Stamatopoulos B.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"25"},{"title":"A novel ASXL1–OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies","googleId":"azaE1hRelTkJ","googleLink":"https://www.nature.com/articles/s41375-018-0083-3","googleCitationCount":22,"googleAuthor":"P Sheridan","doi":"10.1038/s41375-018-0083-3","elsevierAuthor":"Inoue D.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"18"},{"title":"Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies","googleId":"QcSwHocSjWQJ","googleLink":"https://www.nature.com/articles/s41375-018-0132-y","googleCitationCount":22,"googleAuthor":"CB Peterson","doi":"10.1038/s41375-018-0132-y","elsevierAuthor":"Thompson P.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"13"},{"title":"An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma","googleId":"wS2IVF_fNqcJ","googleLink":"https://www.nature.com/articles/leu2017203","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/leu.2017.203","elsevierAuthor":"Lollies A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"22"},{"title":"Genomic profiling of acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis","googleId":"0nNlQsgmNOwJ","googleLink":"https://www.nature.com/articles/leu201755","googleCitationCount":30,"googleAuthor":"T Kolb","doi":"10.1038/leu.2017.55","elsevierAuthor":"Ratnaparkhe M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"20"},{"title":"PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment","googleId":"zMjWHLzRdeIJ","googleLink":"https://www.nature.com/articles/leu2017110","googleCitationCount":30,"googleAuthor":"D Jones","doi":"10.1038/leu.2017.110","elsevierAuthor":"Jones D.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"24"},{"title":"Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy","googleId":"NkTmpxU8yzIJ","googleLink":"https://www.nature.com/articles/leu2017272","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.272","elsevierAuthor":"Kelly K.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"19"},{"title":"HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation","googleId":"aFc97QinIRwJ","googleLink":"https://www.nature.com/articles/leu2017202","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/leu.2017.202","elsevierAuthor":"Yabe T.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"22"},{"title":"Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma","googleId":"OjbhSVeXuwUJ","googleLink":"https://www.nature.com/articles/leu2017173","googleCitationCount":29,"googleAuthor":"CC Hofmeister","doi":"10.1038/leu.2017.173","elsevierAuthor":"Richardson P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0"},{"title":"The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia","googleId":"9msnqEkssPAJ","googleLink":"https://www.nature.com/articles/leu2016214","googleCitationCount":38,"googleAuthor":"","doi":"10.1038/leu.2016.214","elsevierAuthor":"Qorraj M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"27"},{"title":"Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies","googleId":"8p177PIBAHwJ","googleLink":"https://www.nature.com/articles/s41375-018-0197-7","googleCitationCount":19,"googleAuthor":"T Bagratuni","doi":"10.1038/s41375-018-0197-7","elsevierAuthor":"Bagratuni T.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"13"},{"title":"Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation","googleId":"_nUEac3LK6sJ","googleLink":"https://www.nature.com/articles/leu2016288","googleCitationCount":36,"googleAuthor":"J Kanda","doi":"10.1038/leu.2016.288","elsevierAuthor":"Kanda J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"30"},{"title":"Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia","googleId":"0MPDJeRp50oJ","googleLink":"https://www.nature.com/articles/s41375-018-0110-4","googleCitationCount":20,"googleAuthor":"AEJ Yeoh","doi":"10.1038/s41375-018-0110-4","elsevierAuthor":"Ngoc P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"16"},{"title":"CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D","googleId":"9dUtsjY681sJ","googleLink":"https://www.nature.com/articles/leu2016378","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2016.378","elsevierAuthor":"Bruns H.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"27"},{"title":"Flow-cytometric vs.-morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG)","googleId":"AbNAcJdVx5wJ","googleLink":"https://www.nature.com/articles/s41375-018-0039-7","googleCitationCount":25,"googleAuthor":"S Gupta","doi":"10.1038/s41375-018-0039-7","elsevierAuthor":"Gupta S.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"18"},{"title":"We skip to work: alternative splicing in normal and malignant myelopoiesis","googleId":"odYmgPzS0RcJ","googleLink":"https://www.nature.com/articles/s41375-018-0021-4","googleCitationCount":20,"googleAuthor":"JEJ Rasko","doi":"10.1038/s41375-018-0021-4","elsevierAuthor":"Wong A.C.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"17"},{"title":"Dnmt3a regulates T-cell development and suppresses T-ALL transformation","googleId":"nGkpQJ6_PP8J","googleLink":"https://www.nature.com/articles/leu201789","googleCitationCount":30,"googleAuthor":"AC Kramer","doi":"10.1038/leu.2017.89","elsevierAuthor":"Kramer A.C.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"17"},{"title":"Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells","googleId":"8bVNcCx_eYMJ","googleLink":"https://www.nature.com/articles/leu2017132","googleCitationCount":29,"googleAuthor":"J Yu","doi":"10.1038/leu.2017.132","elsevierAuthor":"Yu J.","publicationName":"Methods in Molecular Biology","elsevierCoverDate":"2020-01-01","elsevierCoverDisplayDate":"2020","elsevierCitationCount":"0"},{"title":"Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation","googleId":"XHuuw7k6F2MJ","googleLink":"https://www.nature.com/articles/s41375-018-0073-5","googleCitationCount":20,"googleAuthor":"A Hnízda","doi":"10.1038/s41375-018-0073-5","elsevierAuthor":"Hnízda A.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"18"},{"title":"An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia","googleId":"IfgvpewfIAoJ","googleLink":"https://www.nature.com/articles/leu2016194","googleCitationCount":35,"googleAuthor":"","doi":"10.1038/leu.2016.194","elsevierAuthor":"Koerner S.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"25"},{"title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome","googleId":"lU-rIrE7xdYJ","googleLink":"https://www.nature.com/articles/leu2016168","googleCitationCount":36,"googleAuthor":"C Wang","doi":"10.1038/leu.2016.168","elsevierAuthor":"Wang C.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"30"},{"title":"The JAK2 V617F mutation is a target for specific T cells in the JAK2 V617F-positive myeloproliferative neoplasms","googleId":"WyVrcmcySv8J","googleLink":"https://www.nature.com/articles/leu2016290","googleCitationCount":36,"googleAuthor":"MO Holmström","doi":"10.1038/leu.2016.290","elsevierAuthor":"Holmström M.O.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"29"},{"title":"Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia","googleId":"SGnTVgh1th0J","googleLink":"https://www.nature.com/articles/leu2016377","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2016.377","elsevierAuthor":"Fisher D.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"30"},{"title":"MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells","googleId":"_VHZ9kMD8GsJ","googleLink":"https://www.nature.com/articles/leu2017336","googleCitationCount":26,"googleAuthor":"C Botta","doi":"10.1038/leu.2017.336","elsevierAuthor":"Botta C.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"21"},{"title":"Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade …","googleId":"JmVJTY-05ooJ","googleLink":"https://www.nature.com/articles/leu2017165","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.165","elsevierAuthor":"Halpern A.B.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"23"},{"title":"Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm","googleId":"kchrZVlrOZEJ","googleLink":"https://www.nature.com/articles/leu2017101","googleCitationCount":29,"googleAuthor":"","doi":"10.1038/leu.2017.101","elsevierAuthor":"Suzuki K.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"21"},{"title":"Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma","googleId":"NJXZcXwHViQJ","googleLink":"https://www.nature.com/articles/leu2016355","googleCitationCount":37,"googleAuthor":"KT Siu","doi":"10.1038/leu.2016.355","elsevierAuthor":"Siu K.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"31"},{"title":"EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia","googleId":"mFpliuTaPpcJ","googleLink":"https://www.nature.com/articles/leu2016359","googleCitationCount":36,"googleAuthor":"","doi":"10.1038/leu.2016.359","elsevierAuthor":"Young E.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"24"},{"title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical …","googleId":"OnBqDND8ApUJ","googleLink":"https://www.nature.com/articles/leu2016172","googleCitationCount":35,"googleAuthor":"S Barrio","doi":"10.1038/leu.2016.172","elsevierAuthor":"Barrio S.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"23"},{"title":"Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858","googleId":"6n-nZDXVFCIJ","googleLink":"https://www.nature.com/articles/leu201721","googleCitationCount":33,"googleAuthor":"EA Eksioglu","doi":"10.1038/leu.2017.21","elsevierAuthor":"Eksioglu E.A.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"29"},{"title":"Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1","googleId":"cHdzy6NTKqAJ","googleLink":"https://www.nature.com/articles/leu2016198","googleCitationCount":35,"googleAuthor":"A Abdelbaset-Ismail","doi":"10.1038/leu.2016.198","elsevierAuthor":"Abdelbaset-Ismail A.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"30"},{"title":"Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials","googleId":"IplMGZg7d20J","googleLink":"https://www.nature.com/articles/leu2017320","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2017.320","elsevierAuthor":"Arana P.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"16"},{"title":"Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia","googleId":"MNwlm_gyTU8J","googleLink":"https://www.nature.com/articles/leu2017313","googleCitationCount":25,"googleAuthor":"L Lhermitte","doi":"10.1038/leu.2017.313","elsevierAuthor":"Lhermitte L.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"22"},{"title":"High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG","googleId":"8GLLt9vJMBYJ","googleLink":"https://www.nature.com/articles/leu2017283","googleCitationCount":24,"googleAuthor":"","doi":"10.1038/leu.2017.283","elsevierAuthor":"Sakura T.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"13"},{"title":"Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia","googleId":"jAZUVhcgE40J","googleLink":"https://www.nature.com/articles/leu201722","googleCitationCount":33,"googleAuthor":"RF Schlenk","doi":"10.1038/leu.2017.22","elsevierAuthor":"Schlenk R.F.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"27"},{"title":"Novel evidence that the mannan-binding lectin pathway of complement activation plays a pivotal role in triggering mobilization of hematopoietic stem …","googleId":"zUF4HFYhpuMJ","googleLink":"https://www.nature.com/articles/leu2016278","googleCitationCount":33,"googleAuthor":"A Abdelbaset-Ismail","doi":"10.1038/leu.2016.278","elsevierAuthor":"Adamiak M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"30"},{"title":"Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children","googleId":"r-bwmJ9A-HsJ","googleLink":"https://www.nature.com/articles/leu2016274","googleCitationCount":36,"googleAuthor":"K Yoshida","doi":"10.1038/leu.2016.274","elsevierAuthor":"Kato M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"21"},{"title":"Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma","googleId":"xcXTTiGogE8J","googleLink":"https://www.nature.com/articles/s41375-018-0116-y","googleCitationCount":20,"googleAuthor":"M Fulciniti","doi":"10.1038/s41375-018-0116-y","elsevierAuthor":"Samur M.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"18"},{"title":"HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells","googleId":"OpfRCLWpc8sJ","googleLink":"https://www.nature.com/articles/leu2017106","googleCitationCount":27,"googleAuthor":"","doi":"10.1038/leu.2017.106","elsevierAuthor":"Germini D.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"18"},{"title":"Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t (8; 21)(q22; q22) acute myeloid leukemia","googleId":"MAVTbMaESOIJ","googleLink":"https://www.nature.com/articles/leu2016332","googleCitationCount":32,"googleAuthor":"","doi":"10.1038/leu.2016.332","elsevierAuthor":"Eisfeld A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"24"},{"title":"Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del (5q) MDS","googleId":"zGvtW1wgToAJ","googleLink":"https://www.nature.com/articles/leu2017326","googleCitationCount":23,"googleAuthor":"Y Mei","doi":"10.1038/leu.2017.326","elsevierAuthor":"Mei Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"21"},{"title":"The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20 …","googleId":"E0gmcaM_Wx4J","googleLink":"https://repub.eur.nl/pub/111318/","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.216","elsevierAuthor":"Garrido Castro P.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"22"},{"title":"Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide","googleId":"ZZJVEQDa-ZgJ","googleLink":"https://www.nature.com/articles/leu201792","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2017.92","elsevierAuthor":"Kayser S.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"20"},{"title":"Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes","googleId":"CWzP4BMzNFsJ","googleLink":"https://www.nature.com/articles/leu201728","googleCitationCount":32,"googleAuthor":"AK Johnson","doi":"10.1038/leu.2017.28","elsevierAuthor":"Guidugli L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"23"},{"title":"The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9","googleId":"aqrCT7sGwmcJ","googleLink":"https://www.nature.com/articles/leu2016240","googleCitationCount":33,"googleAuthor":"J Peterson","doi":"10.1038/leu.2016.240","elsevierAuthor":"Fisher J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"22"},{"title":"Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma","googleId":"Urej8tstUa8J","googleLink":"https://www.nature.com/articles/leu2016187","googleCitationCount":32,"googleAuthor":"KL Eales","doi":"10.1038/leu.2016.187","elsevierAuthor":"McNee G.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"23"},{"title":"Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients","googleId":"aXRk9gSx4x8J","googleLink":"https://www.nature.com/articles/leu2016351","googleCitationCount":34,"googleAuthor":"F Passamonti","doi":"10.1038/leu.2016.351","elsevierAuthor":"Passamonti F.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"29"},{"title":"Detection of recurrent and of novel fusion transcripts in myeloid malignancies by targeted RNA sequencing","googleId":"2-kyzwQD9V4J","googleLink":"https://www.nature.com/articles/s41375-017-0002-z","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/s41375-017-0002-z","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"13"},{"title":"Identification of a novel PML-RARG fusion in acute promyelocytic leukemia","googleId":"5a8K93nbJMUJ","googleLink":"https://www.nature.com/articles/leu2017167","googleCitationCount":26,"googleAuthor":"CS Ki","doi":"10.1038/leu.2017.167","elsevierAuthor":"Ha J.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"17"},{"title":"Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study","googleId":"BKubYiqhVDAJ","googleLink":"https://www.nature.com/articles/s41375-018-0146-5","googleCitationCount":18,"googleAuthor":"S Stilgenbauer","doi":"10.1038/s41375-018-0146-5","elsevierAuthor":"Stilgenbauer S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"13"},{"title":"Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study","googleId":"0bxYFgbGQG8J","googleLink":"https://www.nature.com/articles/s41375-018-0024-1","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/s41375-018-0024-1","elsevierAuthor":"Bringhen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"22"},{"title":"Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation","googleId":"623UmfoGHn8J","googleLink":"https://www.nature.com/articles/s41375-018-0014-3","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/s41375-018-0014-3","elsevierAuthor":"Correnti C.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"20"},{"title":"Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children","googleId":"83lgBOB8HHoJ","googleLink":"https://www.nature.com/articles/leu2016321","googleCitationCount":32,"googleAuthor":"","doi":"10.1038/leu.2016.321","elsevierAuthor":"Zvyagin I.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"21"},{"title":"Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results","googleId":"kvYHSV2ZNLsJ","googleLink":"https://www.nature.com/articles/leu2017247","googleCitationCount":25,"googleAuthor":"TP Hughes","doi":"10.1038/leu.2017.247","elsevierAuthor":"Hughes T.P.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"24"},{"title":"UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response","googleId":"DxfeyClYs3EJ","googleLink":"https://www.nature.com/articles/s41375-018-0141-x","googleCitationCount":19,"googleAuthor":"GL Zhang","doi":"10.1038/s41375-018-0141-x","elsevierAuthor":"Huiting L.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"14"},{"title":"A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells","googleId":"MtaHXAa2Kk4J","googleLink":"https://www.nature.com/articles/leu2017135","googleCitationCount":26,"googleAuthor":"DS Das","doi":"10.1038/leu.2017.135","elsevierAuthor":"Ray A.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"22"},{"title":"Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1","googleId":"2rhOGPSF5oIJ","googleLink":"https://www.nature.com/articles/leu2017100","googleCitationCount":26,"googleAuthor":"A Cosson","doi":"10.1038/leu.2017.100","elsevierAuthor":"Cosson A.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"15"},{"title":"Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress","googleId":"RfCV9nI7Nz8J","googleLink":"https://www.nature.com/articles/leu2017231","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2017.231","elsevierAuthor":"Masciarelli S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"17"},{"title":"A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis","googleId":"Hf6BUGFknx4J","googleLink":"https://www.nature.com/articles/leu2016215","googleCitationCount":33,"googleAuthor":"","doi":"10.1038/leu.2016.215","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22"},{"title":"YAP and TAZ are dispensable for physiological and malignant haematopoiesis","googleId":"qAzY02BmBcAJ","googleLink":"https://www.nature.com/articles/s41375-018-0111-3","googleCitationCount":19,"googleAuthor":"E Donato","doi":"10.1038/s41375-018-0111-3","elsevierAuthor":"Donato E.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"13"},{"title":"RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC","googleId":"WOFVE2fHtekJ","googleLink":"https://www.nature.com/articles/leu201740","googleCitationCount":27,"googleAuthor":"V Selvarajan","doi":"10.1038/leu.2017.40","elsevierAuthor":"Selvarajan V.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"22"},{"title":"The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment","googleId":"qVYAM_xwB0YJ","googleLink":"https://www.nature.com/articles/leu2016358","googleCitationCount":30,"googleAuthor":"MH Bashari","doi":"10.1038/leu.2016.358","elsevierAuthor":"Fan F.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"23"},{"title":"Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy","googleId":"7InKg1wJYZcJ","googleLink":"https://www.nature.com/articles/leu2017222","googleCitationCount":24,"googleAuthor":"GC Manyam","doi":"10.1038/leu.2017.222","elsevierAuthor":"Yao Z.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"17"},{"title":"Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","googleId":"W_gVsY609RcJ","googleLink":"https://www.nature.com/articles/leu2016243","googleCitationCount":32,"googleAuthor":"A Tzankov","doi":"10.1038/leu.2016.243","elsevierAuthor":"Xia Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"23"},{"title":"Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape","googleId":"-D83yZbvB5sJ","googleLink":"https://www.nature.com/articles/leu2017109","googleCitationCount":27,"googleAuthor":"P Silva","doi":"10.1038/leu.2017.109","elsevierAuthor":"Silva P.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"18"},{"title":"RPL5 on 1p22. 1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response","googleId":"M6VhNzcjx3oJ","googleLink":"https://www.nature.com/articles/leu2016370","googleCitationCount":31,"googleAuthor":"L Fancello","doi":"10.1038/leu.2016.370","elsevierAuthor":"Hofman I.J.F.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"25"},{"title":"Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia","googleId":"iZmw7PSKfqQJ","googleLink":"https://www.nature.com/articles/leu2017147","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/leu.2017.147","elsevierAuthor":"Chen L.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"19"},{"title":"Nucleotide excision repair is a potential therapeutic target in multiple myeloma","googleId":"41kgzfhurLoJ","googleLink":"https://www.nature.com/articles/leu2017182","googleCitationCount":26,"googleAuthor":"M Fulciniti","doi":"10.1038/leu.2017.182","elsevierAuthor":"Szalat R.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"20"},{"title":"Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22","googleId":"7qi6oSVvHIgJ","googleLink":"https://www.nature.com/articles/leu2016383","googleCitationCount":32,"googleAuthor":"B Gizdic","doi":"10.1038/leu.2016.383","elsevierAuthor":"Arruga F.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"26"},{"title":"Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol","googleId":"siNTeCHANU8J","googleLink":"https://www.nature.com/articles/leu2016203","googleCitationCount":31,"googleAuthor":"BO Wolthers","doi":"10.1038/leu.2016.203","elsevierAuthor":"Wolthers B.O.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"24"},{"title":"Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML","googleId":"2MneLYdQ8uAJ","googleLink":"https://www.nature.com/articles/leu2017239","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.239","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"16"},{"title":"Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements","googleId":"x2aohf2UpkgJ","googleLink":"https://www.nature.com/articles/leu2016362","googleCitationCount":30,"googleAuthor":"E Stalika","doi":"10.1038/leu.2016.362","elsevierAuthor":"Vardi A.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"22"},{"title":"Why are hematopoietic stem cells so 'sexy'? On a search for developmental explanation","googleId":"6OTTW9OcTlcJ","googleLink":"https://www.nature.com/articles/leu2017148","googleCitationCount":24,"googleAuthor":"","doi":"10.1038/leu.2017.148","elsevierAuthor":"Ratajczak M.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"21"},{"title":"Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia","googleId":"OLXe6Il6vIgJ","googleLink":"https://www.nature.com/articles/leu2017281","googleCitationCount":21,"googleAuthor":"DC Lin","doi":"10.1038/leu.2017.281","elsevierAuthor":"Takao S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"17"},{"title":"New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment","googleId":"7nmkfHpujHoJ","googleLink":"https://www.nature.com/articles/s41375-018-0144-7","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0144-7","elsevierAuthor":"Cheung L.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"13"},{"title":"Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations","googleId":"2_j_N9l4rkcJ","googleLink":"https://www.nature.com/articles/leu2016326","googleCitationCount":29,"googleAuthor":"ML Loh","doi":"10.1038/leu.2016.326","elsevierAuthor":"Liu W.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"25"},{"title":"Extracellular vesicles as potential biomarkers of acute graft-vs-host disease","googleId":"ZbWpsea36PIJ","googleLink":"https://www.nature.com/articles/leu2017277","googleCitationCount":21,"googleAuthor":"S Bruno","doi":"10.1038/leu.2017.277","elsevierAuthor":"Lia G.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"20"},{"title":"Germline alterations in a consecutive series of acute myeloid leukemia","googleId":"X3TW4dAKZkIJ","googleLink":"https://www.nature.com/articles/s41375-018-0049-5","googleCitationCount":16,"googleAuthor":"E Pitkänen","doi":"10.1038/s41375-018-0049-5","elsevierAuthor":"Wartiovaara-Kautto U.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"7"},{"title":"Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML","googleId":"S6ixjnN27iIJ","googleLink":"https://www.nature.com/articles/leu2016314","googleCitationCount":29,"googleAuthor":"D Malani","doi":"10.1038/leu.2016.314","elsevierAuthor":"Malani D.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"25"},{"title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","googleId":"mzaCluWqCEMJ","googleLink":"https://www.nature.com/articles/leu2016342","googleCitationCount":31,"googleAuthor":"V Pastor","doi":"10.1038/leu.2016.342","elsevierAuthor":"Pastor V.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"19"},{"title":"IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the …","googleId":"WNkiJdqsun4J","googleLink":"https://www.nature.com/articles/leu2016384","googleCitationCount":30,"googleAuthor":"J Krönke","doi":"10.1038/leu.2016.384","elsevierAuthor":"Krönke J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"23"},{"title":"Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantation","googleId":"YIfvD0iElpQJ","googleLink":"https://www.nature.com/articles/leu2017256","googleCitationCount":20,"googleAuthor":"R Chakraborty","doi":"10.1038/leu.2017.256","elsevierAuthor":"Chakraborty R.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"15"},{"title":"Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma","googleId":"g56ve7jPsp0J","googleLink":"https://www.nature.com/articles/leu2017193","googleCitationCount":23,"googleAuthor":"Q Wang","doi":"10.1038/leu.2017.193","elsevierAuthor":"Wang Q.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"18"},{"title":"Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant","googleId":"GhIGmv59LA0J","googleLink":"https://www.nature.com/articles/leu2016153","googleCitationCount":33,"googleAuthor":"A Hamasy","doi":"10.1038/leu.2016.153","elsevierAuthor":"Hamasy A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"22"},{"title":"Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia","googleId":"E9ReEkoahRQJ","googleLink":"https://www.nature.com/articles/s41375-018-0095-z","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/s41375-018-0095-z","elsevierAuthor":"Qin Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"14"},{"title":"The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms","googleId":"HGHYMep5RNsJ","googleLink":"https://www.nature.com/articles/leu2017233","googleCitationCount":22,"googleAuthor":"H Zhan","doi":"10.1038/leu.2017.233","elsevierAuthor":"Zhan H.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"16"},{"title":"Alloreactivity: the Janus-face of hematopoietic stem cell transplantation","googleId":"iBJZnFmQGP8J","googleLink":"https://www.nature.com/articles/leu201779","googleCitationCount":24,"googleAuthor":"J Cornelissen","doi":"10.1038/leu.2017.79","elsevierAuthor":"Gratwohl A.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"12"},{"title":"Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib","googleId":"7sse_0UWu3cJ","googleLink":"https://www.nature.com/articles/leu2016316","googleCitationCount":31,"googleAuthor":"W Thomas","doi":"10.1038/leu.2016.316","elsevierAuthor":"Kazianka L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"24"},{"title":"Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatments","googleId":"a7CWmycdl8QJ","googleLink":"https://www.nature.com/articles/s41375-018-0109-x","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/s41375-018-0109-x","elsevierAuthor":"Ghia P.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"9"},{"title":"A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation","googleId":"4p1H9yWtDHYJ","googleLink":"https://www.nature.com/articles/leu2016280","googleCitationCount":29,"googleAuthor":"FL Nice","doi":"10.1038/leu.2016.280","elsevierAuthor":"Kollmann K.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"21"},{"title":"Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia","googleId":"RgAGUA3nj2AJ","googleLink":"https://www.nature.com/articles/leu2016209","googleCitationCount":32,"googleAuthor":"SC Nunes","doi":"10.1038/leu.2016.209","elsevierAuthor":"Quotti Tubi L.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"27"},{"title":"Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia","googleId":"fK_BG-9svEsJ","googleLink":"https://www.nature.com/articles/leu2016279","googleCitationCount":28,"googleAuthor":"B Phipson","doi":"10.1038/leu.2016.279","elsevierAuthor":"Narayan N.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"22"},{"title":"A decade of progress in myelodysplastic syndrome with chromosome 5q deletion","googleId":"YjZxDlUZp_IJ","googleLink":"https://www.nature.com/articles/s41375-018-0029-9","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/s41375-018-0029-9","elsevierAuthor":"List A.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"16"},{"title":"NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome","googleId":"tFZq4tYJZLYJ","googleLink":"https://www.nature.com/articles/s41375-018-0147-4","googleCitationCount":15,"googleAuthor":"K Mrózek","doi":"10.1038/s41375-018-0147-4","elsevierAuthor":"Eisfeld A.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"9"},{"title":"Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner","googleId":"wtFVkxwwOc0J","googleLink":"https://www.nature.com/articles/leu2017261","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.261","elsevierAuthor":"Peña-Martínez P.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"17"},{"title":"NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL","googleId":"G5vTJjye8q8J","googleLink":"https://www.nature.com/articles/leu2017294","googleCitationCount":19,"googleAuthor":"C Prieto","doi":"10.1038/leu.2017.294","elsevierAuthor":"Rauwolf K.K.","publicationName":"Cancer and Metastasis Reviews","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"0"},{"title":"Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy","googleId":"6vrOzy0UeAQJ","googleLink":"https://www.nature.com/articles/leu2017160","googleCitationCount":22,"googleAuthor":"M Swamy","doi":"10.1038/leu.2017.160","elsevierAuthor":"Grzes K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"18"},{"title":"Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile janus kinase inhibition","googleId":"M1DIPJMp9TwJ","googleLink":"https://www.nature.com/articles/leu201743","googleCitationCount":44,"googleAuthor":"E Leroy","doi":"10.1038/leu.2017.43","elsevierAuthor":"Leroy E.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"1"},{"title":"In vitro and in vivo assessment of direct effects of simulated solar and galactic cosmic radiation on human hematopoietic stem/progenitor cells","googleId":"qIuKbw4ILrkJ","googleLink":"https://www.nature.com/articles/leu2016344","googleCitationCount":27,"googleAuthor":"G Almeida-Porada","doi":"10.1038/leu.2016.344","elsevierAuthor":"Rodman C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"15"},{"title":"Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine","googleId":"t02AZ8-FWakJ","googleLink":"https://www.nature.com/articles/leu2017323","googleCitationCount":21,"googleAuthor":"RJ Molenaar","doi":"10.1038/leu.2017.323","elsevierAuthor":"Molenaar R.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"14"},{"title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","googleId":"PGV4jOe2frEJ","googleLink":"https://www.nature.com/articles/leu2016231","googleCitationCount":28,"googleAuthor":"Z Chen","doi":"10.1038/leu.2016.231","elsevierAuthor":"Chen Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"22"},{"title":"ANP32A regulates histone H3 acetylation and promotes leukemogenesis","googleId":"nCUhlh8I47QJ","googleLink":"https://www.nature.com/articles/s41375-018-0010-7","googleCitationCount":14,"googleAuthor":"B Lu","doi":"10.1038/s41375-018-0010-7","elsevierAuthor":"Yang X.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"5"},{"title":"Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients","googleId":"Q7oXnjvgUdMJ","googleLink":"https://www.nature.com/articles/leu2016195","googleCitationCount":31,"googleAuthor":"K El-Karoui","doi":"10.1038/leu.2016.195","elsevierAuthor":"Vignon M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"19"},{"title":"Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined …","googleId":"poHkoYGkyOcJ","googleLink":"https://www.nature.com/articles/leu2016385","googleCitationCount":29,"googleAuthor":"MJ Maurer","doi":"10.1038/leu.2016.385","elsevierAuthor":"Rossille D.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"26"},{"title":"First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells","googleId":"ZgRFs5tZN3YJ","googleLink":"https://www.nature.com/articles/s41375-018-0113-1","googleCitationCount":17,"googleAuthor":"M Hojjat-Farsangi","doi":"10.1038/s41375-018-0113-1","elsevierAuthor":"Hojjat-Farsangi M.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"13"},{"title":"Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival","googleId":"yFSh17-2xzEJ","googleLink":"https://www.nature.com/articles/leu2016140","googleCitationCount":30,"googleAuthor":"E Muchtar","doi":"10.1038/leu.2016.140","elsevierAuthor":"Muchtar E.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"21"},{"title":"Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma","googleId":"DUBQFw2MrwYJ","googleLink":"https://www.nature.com/articles/leu2017327","googleCitationCount":20,"googleAuthor":"M D'Agostino","doi":"10.1038/leu.2017.327","elsevierAuthor":"Bringhen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"15"},{"title":"Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia","googleId":"jrTv5zzHJmgJ","googleLink":"https://www.nature.com/articles/leu2017240","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2017.240","elsevierAuthor":"Jawhar M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"15"},{"title":"Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia","googleId":"JejmyVRibicJ","googleLink":"https://www.nature.com/articles/s41375-018-0130-0","googleCitationCount":15,"googleAuthor":"S Iyer","doi":"10.1038/s41375-018-0130-0","elsevierAuthor":"Garcia E.G.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"11"},{"title":"Structural basis of DUX4/IGH-driven transactivation","googleId":"1YzfHe4B9hwJ","googleLink":"https://www.nature.com/articles/s41375-018-0093-1","googleCitationCount":14,"googleAuthor":"J Huang","doi":"10.1038/s41375-018-0093-1","elsevierAuthor":"Schroeder M.P.","publicationName":"Scientific Reports","elsevierCoverDate":"2019-12-01","elsevierCoverDisplayDate":"1 December 2019","elsevierCitationCount":"6"},{"title":"The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia","googleId":"8l5hHC1jVG8J","googleLink":"https://www.nature.com/articles/leu2017194","googleCitationCount":20,"googleAuthor":"A Rio-Machin","doi":"10.1038/leu.2017.194","elsevierAuthor":"Rio-Machin A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"8"},{"title":"Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia","googleId":"eZ3x9mmFcFUJ","googleLink":"https://www.nature.com/articles/leu2017306","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.306","elsevierAuthor":"Topp M.S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"13"},{"title":"NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways","googleId":"vVr0MVM0BpEJ","googleLink":"https://www.nature.com/articles/leu2017296","googleCitationCount":18,"googleAuthor":"","doi":"10.1038/leu.2017.296","elsevierAuthor":"Benedetti D.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"10"},{"title":"Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy","googleId":"zWZYqOo1IL0J","googleLink":"https://www.nature.com/articles/leu2017321","googleCitationCount":18,"googleAuthor":"VK Patel","doi":"10.1038/leu.2017.321","elsevierAuthor":"Patel V.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"12"},{"title":"A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML","googleId":"A2i73F4gpEkJ","googleLink":"https://www.nature.com/articles/leu201784","googleCitationCount":24,"googleAuthor":"LM Kats","doi":"10.1038/leu.2017.84","elsevierAuthor":"Kats L.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"21"},{"title":"Mechanisms of resistance to the BCR-ABL1 allosteric inhibitor asciminib","googleId":"4L5SovRQhh0J","googleLink":"https://www.nature.com/articles/leu2017264","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/leu.2017.264","elsevierAuthor":"Qiang W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"19"},{"title":"The clonal origins of leukemic progression of myelodysplasia","googleId":"ygh7yvzlsxkJ","googleLink":"https://www.nature.com/articles/leu201717","googleCitationCount":24,"googleAuthor":"T Kim","doi":"10.1038/leu.2017.17","elsevierAuthor":"Kim T.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"20"},{"title":"Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia","googleId":"re9NbOH6MuIJ","googleLink":"https://www.nature.com/articles/s41375-018-0157-2","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0157-2","elsevierAuthor":"Ernst T.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"13"},{"title":"Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis","googleId":"GdbyuFdI5W4J","googleLink":"https://www.nature.com/articles/leu2017318","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.318","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"17"},{"title":"Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin","googleId":"UUZ8lnoP7PkJ","googleLink":"https://www.nature.com/articles/leu201738","googleCitationCount":24,"googleAuthor":"L Brunetti","doi":"10.1038/leu.2017.38","elsevierAuthor":"Brunetti L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"17"},{"title":"Evidence-and consensus-based recommendations for phlebotomy in polycythemia vera","googleId":"b9Fpm8ee8mcJ","googleLink":"https://www.nature.com/articles/s41375-018-0199-5","googleCitationCount":13,"googleAuthor":"T Barbui","doi":"10.1038/s41375-018-0199-5","elsevierAuthor":"Barbui T.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"11"},{"title":"Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era","googleId":"m5e9F2lIqIUJ","googleLink":"https://www.nature.com/articles/leu2017150","googleCitationCount":20,"googleAuthor":"L Falchi","doi":"10.1038/leu.2017.150","elsevierAuthor":"Falchi L.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"12"},{"title":"Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?","googleId":"6BIwzWFti8YJ","googleLink":"https://www.nature.com/articles/s41375-018-0017-0","googleCitationCount":17,"googleAuthor":"C Pawlyn","doi":"10.1038/s41375-018-0017-0","elsevierAuthor":"Pawlyn C.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"13"},{"title":"Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma","googleId":"gjUeLSduSlAJ","googleLink":"https://www.nature.com/articles/leu2016387","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/leu.2016.387","elsevierAuthor":"Da Silva Filho M.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"23"},{"title":"Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance","googleId":"Lx6I-kXDomwJ","googleLink":"https://www.nature.com/articles/s41375-018-0030-3","googleCitationCount":18,"googleAuthor":"A Lakshman","doi":"10.1038/s41375-018-0030-3","elsevierAuthor":"Lakshman A.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"10"},{"title":"Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)","googleId":"cVmGjvAQ_Y8J","googleLink":"https://www.nature.com/articles/leu201747","googleCitationCount":24,"googleAuthor":"","doi":"10.1038/leu.2017.47","elsevierAuthor":"Chanan-Khan A.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"21"},{"title":"Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system","googleId":"IpfmI4eMIRoJ","googleLink":"https://www.nature.com/articles/leu2017328","googleCitationCount":18,"googleAuthor":"S Demeyer","doi":"10.1038/leu.2017.328","elsevierAuthor":"Bornschein S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"12"},{"title":"E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271","googleId":"zbVf0B2XonYJ","googleLink":"https://www.nature.com/articles/leu2017123","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2017.123","elsevierAuthor":"Natoni A.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"13"},{"title":"Preclinical modeling of myelodysplastic syndromes","googleId":"BSVEkeM0yOoJ","googleLink":"https://www.nature.com/articles/leu2017172","googleCitationCount":20,"googleAuthor":"K Rouault-Pierre","doi":"10.1038/leu.2017.172","elsevierAuthor":"Rouault-Pierre K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"16"},{"title":"Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia","googleId":"ZqXXmUFv35sJ","googleLink":"https://www.nature.com/articles/leu2016162","googleCitationCount":28,"googleAuthor":"","doi":"10.1038/leu.2016.162","elsevierAuthor":"Ping N.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"21"},{"title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","googleId":"G6IXwFrfFokJ","googleLink":"https://www.nature.com/articles/s41375-018-0069-1","googleCitationCount":14,"googleAuthor":"VP Lavallée","doi":"10.1038/s41375-018-0069-1","elsevierAuthor":"Lavallée V.P.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"13"},{"title":"Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels","googleId":"b14f_C-CwnkJ","googleLink":"https://www.nature.com/articles/s41375-018-0211-0","googleCitationCount":13,"googleAuthor":"V Svobodova","doi":"10.1038/s41375-018-0211-0","elsevierAuthor":"Pavlasova G.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"10"},{"title":"SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia","googleId":"ymZokqkbVw8J","googleLink":"https://www.nature.com/articles/leu2017339","googleCitationCount":17,"googleAuthor":"F He","doi":"10.1038/leu.2017.339","elsevierAuthor":"Bu J.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"14"},{"title":"O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies","googleId":"BUlG66RHm80J","googleLink":"https://www.nature.com/articles/leu20174","googleCitationCount":26,"googleAuthor":"","doi":"10.1038/leu.2017.4","elsevierAuthor":"Freund P.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"21"},{"title":"HDAC1, 2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome …","googleId":"hhrTRFLRLzAJ","googleLink":"https://www.nature.com/articles/leu2017174","googleCitationCount":21,"googleAuthor":"DP Johnson","doi":"10.1038/leu.2017.174","elsevierAuthor":"Tharkar-Promod S.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"13"},{"title":"Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases","googleId":"Ky7sU6U_nC8J","googleLink":"https://www.nature.com/articles/s41375-018-0143-8","googleCitationCount":15,"googleAuthor":"MM Patnaik","doi":"10.1038/s41375-018-0143-8","elsevierAuthor":"Patnaik M.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"13"},{"title":"Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing","googleId":"3evsD49CCSkJ","googleLink":"https://www.nature.com/articles/s41375-018-0115-z","googleCitationCount":16,"googleAuthor":"G Guo","doi":"10.1038/s41375-018-0115-z","elsevierAuthor":"Guo G.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"13"},{"title":"Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche","googleId":"uWU7Wmhqi8IJ","googleLink":"https://www.nature.com/articles/leu2017117","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.117","elsevierAuthor":"De Rooij B.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"12"},{"title":"A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target","googleId":"TopDOzrsppQJ","googleLink":"https://www.nature.com/articles/leu2017307","googleCitationCount":20,"googleAuthor":"F Yan","doi":"10.1038/leu.2017.307","elsevierAuthor":"Yan F.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"13"},{"title":"Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita","googleId":"nZs625K5zSEJ","googleLink":"https://www.nature.com/articles/s41375-018-0125-x","googleCitationCount":13,"googleAuthor":"MW Wlodarski","doi":"10.1038/s41375-018-0125-x","elsevierAuthor":"Kirschner M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"12"},{"title":"A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells","googleId":"ByFSRBGqryMJ","googleLink":"https://www.nature.com/articles/leu2016352","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2016.352","elsevierAuthor":"Hasnat S.","publicationName":"International Journal of Molecular Sciences","elsevierCoverDate":"2020-10-01","elsevierCoverDisplayDate":"1 October 2020","elsevierCitationCount":"0"},{"title":"The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL","googleId":"EIME0zeoobEJ","googleLink":"https://www.nature.com/articles/leu201793","googleCitationCount":20,"googleAuthor":"AM Savino","doi":"10.1038/leu.2017.93","elsevierAuthor":"Savino A.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"14"},{"title":"Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome","googleId":"NHuw9TLjRiEJ","googleLink":"https://www.nature.com/articles/leu2016268","googleCitationCount":24,"googleAuthor":"S Koide","doi":"10.1038/leu.2016.268","elsevierAuthor":"Hasegawa N.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"16"},{"title":"JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia","googleId":"Vte9ySqSpq8J","googleLink":"https://www.nature.com/articles/leu2016329?report=reader","googleCitationCount":24,"googleAuthor":"E Martinez","doi":"10.1038/leu.2016.329","elsevierAuthor":"Zhou C.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"22"},{"title":"Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm","googleId":"h4p7fdB-ae4J","googleLink":"https://www.nature.com/articles/leu20171","googleCitationCount":23,"googleAuthor":"H Yao","doi":"10.1038/leu.2017.1","elsevierAuthor":"Yao H.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"19"},{"title":"Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis","googleId":"MABX6RCg7JMJ","googleLink":"https://www.nature.com/articles/leu201778","googleCitationCount":20,"googleAuthor":"","doi":"10.1038/leu.2017.78","elsevierAuthor":"Mosoyan G.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"17"},{"title":"Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma","googleId":"_A5BOHBST8kJ","googleLink":"https://www.nature.com/articles/leu2016232","googleCitationCount":24,"googleAuthor":"MM Nietert","doi":"10.1038/leu.2016.232","elsevierAuthor":"Linke F.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"20"},{"title":"Validation of the EUTOS long-term survival score in a recent independent cohort of “real world” CML patients","googleId":"jOhEJTx5UfIJ","googleLink":"https://www.nature.com/articles/s41375-018-0136-7","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/s41375-018-0136-7","elsevierAuthor":"Geelen I.G.P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"11"},{"title":"Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial","googleId":"flOC6KFXFeUJ","googleLink":"https://www.nature.com/articles/leu2017111","googleCitationCount":20,"googleAuthor":"NJ Bahlis","doi":"10.1038/leu.2017.111","elsevierAuthor":"Bahlis N.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"13"},{"title":"Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy","googleId":"3kmgGxeTNDsJ","googleLink":"https://www.nature.com/articles/leu2016394","googleCitationCount":25,"googleAuthor":"G Cutrona","doi":"10.1038/leu.2016.394","elsevierAuthor":"Cutrona G.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"19"},{"title":"Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia","googleId":"WOHlRvJBkvMJ","googleLink":"https://www.nature.com/articles/leu201725","googleCitationCount":22,"googleAuthor":"Y Okuno","doi":"10.1038/leu.2017.25","elsevierAuthor":"Yoshida N.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"18"},{"title":"AMKL chimeric transcription factors are potent inducers of leukemia","googleId":"7_3XCwxrr3oJ","googleLink":"https://www.nature.com/articles/leu201751","googleCitationCount":22,"googleAuthor":"P Vogel","doi":"10.1038/leu.2017.51","elsevierAuthor":"Dang J.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"19"},{"title":"Genotoxic stresses promote clonal expansion of hematopoietic stem cells expressing mutant p53","googleId":"h5o9hyKBseIJ","googleLink":"https://www.nature.com/articles/leu2017325","googleCitationCount":18,"googleAuthor":"S Chen","doi":"10.1038/leu.2017.325","elsevierAuthor":"Chen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"11"},{"title":"Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis","googleId":"AEc0qg7Wx1cJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609269/","googleCitationCount":25,"googleAuthor":"AM Vannucchi","doi":"10.1038/leu.2016.323","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"6"},{"title":"SHP2 is required for BCR-ABL1-induced hematologic neoplasia","googleId":"62NhdcaftMIJ","googleLink":"https://www.nature.com/articles/leu2017250","googleCitationCount":16,"googleAuthor":"S Gu","doi":"10.1038/leu.2017.250","elsevierAuthor":"Gu S.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"13"},{"title":"AZA-MS: a novel multiparameter mass spectrometry method to determine the intracellular dynamics of azacitidine therapy in vivo","googleId":"5-CP_yOIzhEJ","googleLink":"https://www.nature.com/articles/leu2017340","googleCitationCount":15,"googleAuthor":"A Unnikrishnan","doi":"10.1038/leu.2017.340","elsevierAuthor":"Unnikrishnan A.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"15"},{"title":"Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors","googleId":"6Ksk-7yQRxkJ","googleLink":"https://www.nature.com/articles/leu2016182","googleCitationCount":24,"googleAuthor":"E Donato","doi":"10.1038/leu.2016.182","elsevierAuthor":"Donato E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"20"},{"title":"Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression","googleId":"FXMdnplD0w8J","googleLink":"https://www.nature.com/articles/leu2016217","googleCitationCount":23,"googleAuthor":"GP Maiti","doi":"10.1038/leu.2016.217","elsevierAuthor":"Boysen J.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"20"},{"title":"Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms","googleId":"BqYQYXJIH9oJ","googleLink":"https://www.nature.com/articles/s41375-018-0135-8","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0135-8","elsevierAuthor":"Halpern A.B.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"12"},{"title":"Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013","googleId":"H8_0TMwpNSoJ","googleLink":"https://www.nature.com/articles/leu201771","googleCitationCount":23,"googleAuthor":"","doi":"10.1038/leu.2017.71","elsevierAuthor":"Lehmann S.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"15"},{"title":"Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV","googleId":"v8tHgKW0BisJ","googleLink":"https://www.nature.com/articles/s41375-018-0055-7","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/s41375-018-0055-7","elsevierAuthor":"Saussele S.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"11"},{"title":"The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20 …","googleId":"_pIrMQ3yddEJ","googleLink":"https://www.nature.com/articles/leu2017216","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.216","elsevierAuthor":"Garrido Castro P.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"22"},{"title":"Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis","googleId":"IU48o4kmR2gJ","googleLink":"https://www.nature.com/articles/leu2017297","googleCitationCount":19,"googleAuthor":"JG Correa","doi":"10.1038/leu.2017.297","elsevierAuthor":"Hernández-Boluda J.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"13"},{"title":"PGC-1α driven mitochondrial biogenesis in stromal cells underpins mitochondrial trafficking to leukemic blasts","googleId":"__fu5Hq60V0J","googleLink":"https://www.nature.com/articles/s41375-018-0221-y","googleCitationCount":11,"googleAuthor":"","doi":"10.1038/s41375-018-0221-y","elsevierAuthor":"Marlein C.R.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"6"},{"title":"A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials","googleId":"KDYRUm4IpiQJ","googleLink":"https://www.nature.com/articles/leu2016303","googleCitationCount":24,"googleAuthor":"X Huang","doi":"10.1038/leu.2016.303","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0"},{"title":"A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients","googleId":"_E6s1c9-nYgJ","googleLink":"https://www.nature.com/articles/leu2017210","googleCitationCount":18,"googleAuthor":"JAI Thoms","doi":"10.1038/leu.2017.210","elsevierAuthor":"Beck D.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"16"},{"title":"Pharmacogenomics and chemical library screens reveal a novel SCF SKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma","googleId":"aepABNtP7icJ","googleLink":"https://www.nature.com/articles/leu2016258","googleCitationCount":24,"googleAuthor":"E Malek","doi":"10.1038/leu.2016.258","elsevierAuthor":"Malek E.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"22"},{"title":"The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation","googleId":"aLRWOGz0CboJ","googleLink":"https://www.nature.com/articles/s41375-018-0185-y","googleCitationCount":11,"googleAuthor":"JA Fein","doi":"10.1038/s41375-018-0185-y","elsevierAuthor":"Fein J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"7"},{"title":"Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia","googleId":"CMu6lhFWkZgJ","googleLink":"https://www.nature.com/articles/leu2017282","googleCitationCount":18,"googleAuthor":"SJ Vervoort","doi":"10.1038/leu.2017.282","elsevierAuthor":"Waibel M.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"12"},{"title":"A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone","googleId":"VA8RxIpsKuwJ","googleLink":"https://www.nature.com/articles/s41375-018-0121-1","googleCitationCount":13,"googleAuthor":"MM Patnaik","doi":"10.1038/s41375-018-0121-1","elsevierAuthor":"Patnaik M.M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"12"},{"title":"Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the …","googleId":"uXWPNnk4LTcJ","googleLink":"https://www.nature.com/articles/leu2017128","googleCitationCount":21,"googleAuthor":"M Van der Meulen","doi":"10.1038/leu.2017.128","elsevierAuthor":"Van Der Meulen M.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"14"},{"title":"Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition","googleId":"z0yCbk8iwG0J","googleLink":"https://www.nature.com/articles/leu2017129","googleCitationCount":17,"googleAuthor":"R Thijssen","doi":"10.1038/leu.2017.129","elsevierAuthor":"Slinger E.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"10"},{"title":"Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia","googleId":"FEu4pFjcvbcJ","googleLink":"https://www.nature.com/articles/leu2016202","googleCitationCount":24,"googleAuthor":"S Eldfors","doi":"10.1038/leu.2016.202","elsevierAuthor":"Eldfors S.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"16"},{"title":"Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia","googleId":"oZ96OdPnXxQJ","googleLink":"https://www.nature.com/articles/leu201724","googleCitationCount":22,"googleAuthor":"SE Karol","doi":"10.1038/leu.2017.24","elsevierAuthor":"Karol S.E.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14"},{"title":"ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma","googleId":"GOZ7oGisAZgJ","googleLink":"https://www.nature.com/articles/leu201794","googleCitationCount":21,"googleAuthor":"A Dzikiewicz-Krawczyk","doi":"10.1038/leu.2017.94","elsevierAuthor":"Dzikiewicz-Krawczyk A.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"16"},{"title":"Copy-number analysis identified new prognostic marker in acute myeloid leukemia","googleId":"Ac6lWJRXDDAJ","googleLink":"https://www.nature.com/articles/leu2016265","googleCitationCount":22,"googleAuthor":"N Pottier","doi":"10.1038/leu.2016.265","elsevierAuthor":"Nibourel O.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"19"},{"title":"Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis","googleId":"anbixTwdY-8J","googleLink":"https://www.nature.com/articles/leu2017330","googleCitationCount":16,"googleAuthor":"AW Roberts","doi":"10.1038/leu.2017.330","elsevierAuthor":"Pardanani A.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"13"},{"title":"MLL is essential for NUP98-HOXA9-induced leukemia","googleId":"rJIhGIfuLlQJ","googleLink":"https://www.nature.com/articles/leu201762","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2017.62","elsevierAuthor":"Shima Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"16"},{"title":"The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia","googleId":"3ef960by7m8J","googleLink":"https://www.nature.com/articles/leu2017342","googleCitationCount":16,"googleAuthor":"AG Sanarico","doi":"10.1038/leu.2017.342","elsevierAuthor":"Sanarico A.G.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"12"},{"title":"S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells","googleId":"9Un8KA5-jR8J","googleLink":"https://www.nature.com/articles/leu2017275","googleCitationCount":17,"googleAuthor":"M Ibrahim","doi":"10.1038/leu.2017.275","elsevierAuthor":"Vrzalikova K.","publicationName":"Leukemia","elsevierCoverDate":"2019-08-01","elsevierCoverDisplayDate":"1 August 2019","elsevierCitationCount":"0"},{"title":"Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial","googleId":"N556-ZjSmfgJ","googleLink":"https://www.nature.com/articles/leu2016298","googleCitationCount":23,"googleAuthor":"MJJ Rose-Zerilli","doi":"10.1038/leu.2016.298","elsevierAuthor":"Larrayoz M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"16"},{"title":"Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms","googleId":"zMjJhD_eXEgJ","googleLink":"https://www.nature.com/articles/leu2017190","googleCitationCount":16,"googleAuthor":"A Chase","doi":"10.1038/leu.2017.190","elsevierAuthor":"Rinke J.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"10"},{"title":"TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome","googleId":"gZehssIxDBUJ","googleLink":"https://www.nature.com/articles/leu2017176","googleCitationCount":17,"googleAuthor":"P Villarese","doi":"10.1038/leu.2017.176","elsevierAuthor":"Villarese P.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"14"},{"title":"Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agents","googleId":"1sFGbdEO1GUJ","googleLink":"https://www.nature.com/articles/s41375-018-0098-9","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/s41375-018-0098-9","elsevierAuthor":"Avet-Loiseau H.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"10"},{"title":"Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse","googleId":"kNWGjpAZyhQJ","googleLink":"https://www.nature.com/articles/leu2017285","googleCitationCount":21,"googleAuthor":"","doi":"10.1038/leu.2017.285","elsevierAuthor":"Boddu P.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"16"},{"title":"Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia","googleId":"Jk4UWJMNpGAJ","googleLink":"https://www.nature.com/articles/leu2016392","googleCitationCount":21,"googleAuthor":"WS Liau","doi":"10.1038/leu.2016.392","elsevierAuthor":"Liau W.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"16"},{"title":"The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response","googleId":"lgsJ_pSjy8sJ","googleLink":"https://www.nature.com/articles/s41375-018-0022-3","googleCitationCount":14,"googleAuthor":"S Sidana","doi":"10.1038/s41375-018-0022-3","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"12"},{"title":"Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma","googleId":"jAssFoqdYIYJ","googleLink":"https://www.nature.com/articles/leu201783","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.83","elsevierAuthor":"Einsele H.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"16"},{"title":"Loss of p300 accelerates MDS-associated leukemogenesis","googleId":"LHLX7pfA0pEJ","googleLink":"https://www.nature.com/articles/leu2016347","googleCitationCount":23,"googleAuthor":"T Asai","doi":"10.1038/leu.2016.347","elsevierAuthor":"Cheng G.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"16"},{"title":"Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia","googleId":"6_R9sMoHu1AJ","googleLink":"https://www.nature.com/articles/leu2017157","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.157","elsevierAuthor":"Tesio M.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"14"},{"title":"Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients","googleId":"RTTtyEs8JxQJ","googleLink":"https://www.nature.com/articles/s41375-018-0028-x","googleCitationCount":16,"googleAuthor":"M Nicolosi","doi":"10.1038/s41375-018-0028-x","elsevierAuthor":"Nicolosi M.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"14"},{"title":"Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia","googleId":"hkFaHOewjd8J","googleLink":"https://www.nature.com/articles/leu2017151","googleCitationCount":16,"googleAuthor":"E Bernson","doi":"10.1038/leu.2017.151","elsevierAuthor":"Bernson E.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"10"},{"title":"Targeting nucleolin for better survival in diffuse large B-cell lymphoma","googleId":"b3fMuxhAAzUJ","googleLink":"https://www.nature.com/articles/leu2017215","googleCitationCount":16,"googleAuthor":"R Mathur","doi":"10.1038/leu.2017.215","elsevierAuthor":"Jain N.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"11"},{"title":"Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient","googleId":"ASPDdP7AWeMJ","googleLink":"https://www.nature.com/articles/leu2017104","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2017.104","elsevierAuthor":"Herold S.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"14"},{"title":"Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes","googleId":"N3wKl_9S0foJ","googleLink":"https://www.nature.com/articles/s41375-018-0112-2","googleCitationCount":14,"googleAuthor":"S Abdelhamed","doi":"10.1038/s41375-018-0112-2","elsevierAuthor":"Hosseini M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"11"},{"title":"Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute …","googleId":"tys_6wM1degJ","googleLink":"https://www.nature.com/articles/leu2016341","googleCitationCount":21,"googleAuthor":"C Cerella","doi":"10.1038/leu.2016.341","elsevierAuthor":"Cerella C.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14"},{"title":"Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells","googleId":"3l_YxCN02kEJ","googleLink":"https://www.nature.com/articles/s41375-018-0032-1","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0032-1","elsevierAuthor":"Casado P.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"11"},{"title":"Proposed diagnostic criteria and classification of basophilic leukemias and related disorders","googleId":"xHZDl_mvQpIJ","googleLink":"https://www.nature.com/articles/leu201715","googleCitationCount":21,"googleAuthor":"K Hartmann","doi":"10.1038/leu.2017.15","elsevierAuthor":"Valent P.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"13"},{"title":"Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach","googleId":"EyA5InbjMqAJ","googleLink":"https://www.nature.com/articles/leu201749","googleCitationCount":20,"googleAuthor":"A Coppe","doi":"10.1038/leu.2017.49","elsevierAuthor":"Coppe A.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"15"},{"title":"Histone deacetylase inhibitors interrupt HSP90• RASGRP1 and HSP90• CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells","googleId":"BhSQDpQf0IUJ","googleLink":"https://www.nature.com/articles/leu2016357","googleCitationCount":19,"googleAuthor":"H Ding","doi":"10.1038/leu.2016.357","elsevierAuthor":"Ding H.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"14"},{"title":"Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis","googleId":"adAotowuBp0J","googleLink":"https://www.nature.com/articles/s41375-018-0085-1","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0085-1","elsevierAuthor":"Verbiest T.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"8"},{"title":"Kinase domain activation through gene rearrangement in multiple myeloma","googleId":"NBh0NIG-I8UJ","googleLink":"https://www.nature.com/articles/s41375-018-0108-y","googleCitationCount":11,"googleAuthor":"GJ Morgan","doi":"10.1038/s41375-018-0108-y","elsevierAuthor":"Morgan G.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"6"},{"title":"NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia","googleId":"1LM5OH8PDucJ","googleLink":"https://www.nature.com/articles/s41375-018-0245-3","googleCitationCount":8,"googleAuthor":"M Tulstrup","doi":"10.1038/s41375-018-0245-3","elsevierAuthor":"Tulstrup M.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"6"},{"title":"Diplotype analysis of NUDT15 variants and 6-mercaptopurine sensitivity in pediatric lymphoid neoplasms","googleId":"UzrfNvcFoY4J","googleLink":"https://www.nature.com/articles/s41375-018-0190-1","googleCitationCount":12,"googleAuthor":"T Osumi","doi":"10.1038/s41375-018-0190-1","elsevierAuthor":"Tsujimoto S.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"7"},{"title":"Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway","googleId":"bLp_rJyYonoJ","googleLink":"https://www.nature.com/articles/leu2016287","googleCitationCount":24,"googleAuthor":"J Xin","doi":"10.1038/leu.2016.287","elsevierAuthor":"Xin J.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"17"},{"title":"A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma","googleId":"tEMlLl81BLAJ","googleLink":"https://www.nature.com/articles/leu2016239","googleCitationCount":22,"googleAuthor":"","doi":"10.1038/leu.2016.239","elsevierAuthor":"Bonsignore L.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"17"},{"title":"Heavy+ light chain monitoring correlates with clinical outcome in multiple myeloma patients","googleId":"MZodUHfd5ecJ","googleLink":"https://www.nature.com/articles/leu2017209","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.209","elsevierAuthor":"Michallet M.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"12"},{"title":"Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin","googleId":"lRLslndOmEwJ","googleLink":"https://www.nature.com/articles/leu2016165","googleCitationCount":20,"googleAuthor":"MN Cruickshank","doi":"10.1038/leu.2016.165","elsevierAuthor":"Cruickshank M.N.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"11"},{"title":"Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing","googleId":"QDhtY-CxCYQJ","googleLink":"https://www.nature.com/articles/leu2017270","googleCitationCount":14,"googleAuthor":"A Zamò","doi":"10.1038/leu.2017.270","elsevierAuthor":"Zamò A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"14"},{"title":"Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2","googleId":"cu9JEjN93CEJ","googleLink":"https://www.nature.com/articles/leu2017298","googleCitationCount":14,"googleAuthor":"M Faisal","doi":"10.1038/leu.2017.298","elsevierAuthor":"Bartels S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"10"},{"title":"Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden","googleId":"QX3YrabFOJIJ","googleLink":"https://www.nature.com/articles/leu2016312","googleCitationCount":20,"googleAuthor":"V Lazarevic","doi":"10.1038/leu.2016.312","elsevierAuthor":"Juliusson G.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"10"},{"title":"FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome","googleId":"qEdITKXg5tQJ","googleLink":"https://www.nature.com/articles/s41375-018-0124-y","googleCitationCount":9,"googleAuthor":"T Hu","doi":"10.1038/s41375-018-0124-y","elsevierAuthor":"Hu T.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"9"},{"title":"PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions","googleId":"kd1gCx3KtMsJ","googleLink":"https://www.nature.com/articles/leu2016395","googleCitationCount":18,"googleAuthor":"SE Dunn","doi":"10.1038/leu.2016.395","elsevierAuthor":"Li Y.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"12"},{"title":"Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality","googleId":"EP9oKOwTUW4J","googleLink":"https://www.nature.com/articles/leu2017260","googleCitationCount":14,"googleAuthor":"K Durkin","doi":"10.1038/leu.2017.260","elsevierAuthor":"Artesi M.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"9"},{"title":"Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes","googleId":"cf7Wf1IyNyUJ","googleLink":"https://www.nature.com/articles/leu2017122","googleCitationCount":16,"googleAuthor":"MV Mateos","doi":"10.1038/leu.2017.122","elsevierAuthor":"Tangen J.","publicationName":"BMC Cancer","elsevierCoverDate":"2018-08-08","elsevierCoverDisplayDate":"8 August 2018","elsevierCitationCount":"3"},{"title":"Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms","googleId":"9FbxpyV-77sJ","googleLink":"https://www.nature.com/articles/leu2016295","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2016.295","elsevierAuthor":"Visconte V.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"15"},{"title":"HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression","googleId":"ZYmA2NsQufkJ","googleLink":"https://www.nature.com/articles/leu201774","googleCitationCount":15,"googleAuthor":"H Gazon","doi":"10.1038/leu.2017.74","elsevierAuthor":"Terol M.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"11"},{"title":"Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia","googleId":"J89g_lgodsAJ","googleLink":"https://www.nature.com/articles/leu2017140","googleCitationCount":16,"googleAuthor":"I Wilson","doi":"10.1038/leu.2017.140","elsevierAuthor":"Abarrategi A.","publicationName":"Journal of Experimental Medicine","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"36"},{"title":"Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab","googleId":"jOdOsVrhpJoJ","googleLink":"https://www.nature.com/articles/s41375-018-0100-6","googleCitationCount":10,"googleAuthor":"TD Shanafelt","doi":"10.1038/s41375-018-0100-6","elsevierAuthor":"Gentile M.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"7"},{"title":"High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t (6; 7)(p21; q34)/TRB@-PIM1 rearrangement","googleId":"7hm6e1bgN4wJ","googleLink":"https://www.nature.com/articles/s41375-018-0031-2","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0031-2","elsevierAuthor":"La Starza R.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"6"},{"title":"Utx loss causes myeloid transformation","googleId":"XrVFVEBtZ30J","googleLink":"https://www.nature.com/articles/s41375-018-0011-6","googleCitationCount":8,"googleAuthor":"L Xu","doi":"10.1038/s41375-018-0011-6","elsevierAuthor":"Zheng L.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"6"},{"title":"Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis","googleId":"6mcdxZd9TFAJ","googleLink":"https://www.nature.com/articles/s41375-018-0042-z","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0042-z","elsevierAuthor":"Suárez-González J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"7"},{"title":"Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences","googleId":"p9uhacAg_QEJ","googleLink":"https://www.nature.com/articles/leu2016277","googleCitationCount":21,"googleAuthor":"B Scheijen","doi":"10.1038/leu.2016.277","elsevierAuthor":"Waanders E.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"15"},{"title":"Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease","googleId":"A3j95k-mKTUJ","googleLink":"https://www.nature.com/articles/leu2016281","googleCitationCount":25,"googleAuthor":"","doi":"10.1038/leu.2016.281","elsevierAuthor":"Rubio M.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"18"},{"title":"Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target","googleId":"SHKIxxCSTKMJ","googleLink":"https://www.nature.com/articles/leu201752","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.52","elsevierAuthor":"Etxabe A.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"9"},{"title":"Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia","googleId":"blN5PPkhco4J","googleLink":"https://www.nature.com/articles/leu201734","googleCitationCount":17,"googleAuthor":"EJ Murphy","doi":"10.1038/leu.2017.34","elsevierAuthor":"Murphy E.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14"},{"title":"Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy","googleId":"IDyMM-U184EJ","googleLink":"https://www.nature.com/articles/leu2017178","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.178","elsevierAuthor":"Martínez-Cuadrón D.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"12"},{"title":"Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL","googleId":"uNyYKNqORAMJ","googleLink":"https://www.nature.com/articles/leu201765","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.65","elsevierAuthor":"Munir T.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"16"},{"title":"Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia","googleId":"TNmoXkRdx9sJ","googleLink":"https://www.nature.com/articles/leu2016181","googleCitationCount":21,"googleAuthor":"LM Saleh","doi":"10.1038/leu.2016.181","elsevierAuthor":"Saleh L.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"17"},{"title":"Extended time-lapse in vivo imaging of tibia bone marrow to visualize dynamic hematopoietic stem cell engraftment","googleId":"Q_83eTd957UJ","googleLink":"https://www.nature.com/articles/leu2016354","googleCitationCount":19,"googleAuthor":"S Kim","doi":"10.1038/leu.2016.354","elsevierAuthor":"Kim S.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"11"},{"title":"Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo","googleId":"JcO9bU9epHIJ","googleLink":"https://www.nature.com/articles/s41375-018-0126-9","googleCitationCount":11,"googleAuthor":"Y Guo","doi":"10.1038/s41375-018-0126-9","elsevierAuthor":"Guo Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"9"},{"title":"Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells","googleId":"s9XjuepzfL8J","googleLink":"https://www.nature.com/articles/leu2017338","googleCitationCount":11,"googleAuthor":"B Wingelhofer","doi":"10.1038/leu.2017.338","elsevierAuthor":"Peter B.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"9"},{"title":"Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL","googleId":"FoWA9budcAgJ","googleLink":"https://www.nature.com/articles/leu201796","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.96","elsevierAuthor":"Howard D.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"15"},{"title":"HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation","googleId":"jDwmPQpy670J","googleLink":"https://www.nature.com/articles/leu2016210","googleCitationCount":18,"googleAuthor":"","doi":"10.1038/leu.2016.210","elsevierAuthor":"Herr W.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"14"},{"title":"A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high …","googleId":"sZYcpQU6DjQJ","googleLink":"https://www.nature.com/articles/leu2016255","googleCitationCount":20,"googleAuthor":"H Chen","doi":"10.1038/leu.2016.255","elsevierAuthor":"Reddy N.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"15"},{"title":"Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome","googleId":"FiNXp4w8R0oJ","googleLink":"https://www.nature.com/articles/leu201727","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/leu.2017.27","elsevierAuthor":"Li J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"10"},{"title":"Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients","googleId":"3YFb-atpHIEJ","googleLink":"https://www.nature.com/articles/s41375-018-0086-0","googleCitationCount":11,"googleAuthor":"","doi":"10.1038/s41375-018-0086-0","elsevierAuthor":"Höllein A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"11"},{"title":"A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome","googleId":"MOqPW0qInYsJ","googleLink":"https://www.nature.com/articles/leu201712","googleCitationCount":18,"googleAuthor":"AD Kelly","doi":"10.1038/leu.2017.12","elsevierAuthor":"Kelly A.D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"18"},{"title":"The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies","googleId":"_fmKvNdJz9gJ","googleLink":"https://www.nature.com/articles/leu2016374","googleCitationCount":17,"googleAuthor":"T Radivoyevitch","doi":"10.1038/leu.2016.374","elsevierAuthor":"Statler A.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"15"},{"title":"Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway","googleId":"DQR7sqbSdL4J","googleLink":"https://www.nature.com/articles/leu2016339","googleCitationCount":16,"googleAuthor":"Y Shen","doi":"10.1038/leu.2016.339","elsevierAuthor":"Shen Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"11"},{"title":"The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia","googleId":"LgvYWILtNE4J","googleLink":"https://www.nature.com/articles/s41375-018-0046-8","googleCitationCount":11,"googleAuthor":"L Ermini","doi":"10.1038/s41375-018-0046-8","elsevierAuthor":"Furness C.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"7"},{"title":"Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis","googleId":"ROSSvb6DGHsJ","googleLink":"https://www.nature.com/articles/leu2017268","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2017.268","elsevierAuthor":"Tefferi A.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"14"},{"title":"Enhanced MAPK signaling is essential for CSF3R-induced leukemia","googleId":"pVOp1JdHMjwJ","googleLink":"https://www.nature.com/articles/leu2016376","googleCitationCount":18,"googleAuthor":"","doi":"10.1038/leu.2016.376","elsevierAuthor":"Rohrabaugh S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"16"},{"title":"RNA editing signature during myeloid leukemia cell differentiation","googleId":"09EChaVm_m8J","googleLink":"https://www.nature.com/articles/leu2017134","googleCitationCount":14,"googleAuthor":"E Picardi","doi":"10.1038/leu.2017.134","elsevierAuthor":"Riddy D.M.","publicationName":"PLoS ONE","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"8"},{"title":"Chromothripsis in acute myeloid leukemia: Biological features and impact on survival","googleId":"LD-3lb3BBg4J","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892717/","googleCitationCount":12,"googleAuthor":"G Marconi","doi":"10.1038/leu.2017.351","elsevierCitationCount":0},{"title":"EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia","googleId":"yxpAdAM4dAIJ","googleLink":"https://www.nature.com/articles/leu2016371","googleCitationCount":17,"googleAuthor":"S Charmsaz","doi":"10.1038/leu.2016.371","elsevierAuthor":"Charmsaz S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"15"},{"title":"The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia","googleId":"FRmE-IrGPHYJ","googleLink":"https://www.nature.com/articles/leu2016338","googleCitationCount":16,"googleAuthor":"R Dillon","doi":"10.1038/leu.2016.338","elsevierAuthor":"Jovanovic J.V.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"13"},{"title":"Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation","googleId":"tny1cnptb7EJ","googleLink":"https://www.nature.com/articles/s41375-018-0208-8","googleCitationCount":8,"googleAuthor":"F Stölzel","doi":"10.1038/s41375-018-0208-8","elsevierAuthor":"Chitre S.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"7"},{"title":"Influence of IDH on FLT3-ITD status in newly diagnosed AML","googleId":"AAd94Jg0_ckJ","googleLink":"https://www.nature.com/articles/leu2017244","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2017.244","elsevierAuthor":"Boddu P.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"10"},{"title":"Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis","googleId":"HwiGdHByhKAJ","googleLink":"https://www.nature.com/articles/leu2017166","googleCitationCount":11,"googleAuthor":"CG Mullighan","doi":"10.1038/leu.2017.166","elsevierAuthor":"Welsh S.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"5"},{"title":"Epigenetic heterogeneity affects the risk of relapse in children with t (8; 21) RUNX1-RUNX1T1-rearranged AML","googleId":"9o85KkXCTxYJ","googleLink":"https://www.nature.com/articles/s41375-017-0003-y","googleCitationCount":9,"googleAuthor":"M Zampini","doi":"10.1038/s41375-017-0003-y","elsevierAuthor":"Zampini M.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"6"},{"title":"Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation","googleId":"ZmbykQRJ1I8J","googleLink":"https://www.nature.com/articles/leu2016244","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2016.244","elsevierAuthor":"McCracken A.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14"},{"title":"The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell function","googleId":"bX6wKfsmXcAJ","googleLink":"https://www.nature.com/articles/s41375-018-0025-0","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/s41375-018-0025-0","elsevierAuthor":"Mohr J.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"8"},{"title":"Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014","googleId":"odpCjJGcZIMJ","googleLink":"https://www.nature.com/articles/s41375-018-0149-2","googleCitationCount":7,"googleAuthor":"AB de Gonzalez","doi":"10.1038/s41375-018-0149-2","elsevierAuthor":"Teepen J.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"5"},{"title":"Identification of immune-activated hematopoietic stem cells","googleId":"LsBG47aeWTwJ","googleLink":"https://www.nature.com/articles/s41375-018-0220-z","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-018-0220-z","elsevierAuthor":"Bujanover N.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"6"},{"title":"Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis","googleId":"3jikv3EoxjkJ","googleLink":"https://www.nature.com/articles/leu2017112","googleCitationCount":12,"googleAuthor":"T Maekawa","doi":"10.1038/leu.2017.112","elsevierAuthor":"Maekawa T.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0"},{"title":"Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling","googleId":"3UCauPTFppgJ","googleLink":"https://www.nature.com/articles/leu2017168","googleCitationCount":13,"googleAuthor":"JP Bürckert","doi":"10.1038/leu.2017.168","elsevierAuthor":"Hahn M.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8"},{"title":"Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group","googleId":"P062YXNy4CsJ","googleLink":"https://www.nature.com/articles/leu2016177","googleCitationCount":17,"googleAuthor":"E Manara","doi":"10.1038/leu.2016.177","elsevierAuthor":"Manara E.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"12"},{"title":"Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T …","googleId":"VdNut9Ki0dgJ","googleLink":"https://www.nature.com/articles/leu2017316","googleCitationCount":12,"googleAuthor":"GL Zhang","doi":"10.1038/leu.2017.316","elsevierAuthor":"Bae J.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"10"},{"title":"Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis","googleId":"KAxFg0jE88EJ","googleLink":"https://www.nature.com/articles/leu201742","googleCitationCount":15,"googleAuthor":"HL Wang","doi":"10.1038/leu.2017.42","elsevierAuthor":"Ustun C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14"},{"title":"MicroRNA-155 promotes G-CSF-induced mobilization of murine hematopoietic stem and progenitor cells via propagation of CXCL12 signaling","googleId":"WkDmBZpBkVsJ","googleLink":"https://www.nature.com/articles/leu201750","googleCitationCount":15,"googleAuthor":"T Itkin","doi":"10.1038/leu.2017.50","elsevierAuthor":"Itkin T.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"13"},{"title":"HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemia","googleId":"FR_65Ao-P8IJ","googleLink":"https://www.nature.com/articles/leu20173","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/leu.2017.3","elsevierAuthor":"Mehdipour P.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10"},{"title":"Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial","googleId":"QPYo94vT8kAJ","googleLink":"https://www.nature.com/articles/leu2017258","googleCitationCount":12,"googleAuthor":"JR Mikhael","doi":"10.1038/leu.2017.258","elsevierAuthor":"Ailawadhi S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"11"},{"title":"Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1","googleId":"a90fLshaM08J","googleLink":"https://www.nature.com/articles/leu2016285","googleCitationCount":19,"googleAuthor":"","doi":"10.1038/leu.2016.285","elsevierAuthor":"Du C.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"19"},{"title":"Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32","googleId":"PTQvKkJ8f4sJ","googleLink":"https://www.nature.com/articles/s41375-018-0231-9","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/s41375-018-0231-9","elsevierAuthor":"Babushok D.V.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4"},{"title":"New drugs in AML: uses and abuses","googleId":"x43znXD8KgwJ","googleLink":"https://www.nature.com/articles/s41375-018-0168-z","googleCitationCount":8,"googleAuthor":"RP Gale","doi":"10.1038/s41375-018-0168-z","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"7"},{"title":"Irf8 regulates the progression of myeloproliferative neoplasm-like syndrome via Mertk signaling in zebrafish","googleId":"Sx_AHMFWIU0J","googleLink":"https://www.nature.com/articles/leu2017189","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.189","elsevierAuthor":"Zhao F.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"5"},{"title":"PKM2 and other key regulators of Warburg effect positively correlate with CD147 (EMMPRIN) gene expression and predict survival in multiple myeloma","googleId":"qF2FmPNe114J","googleLink":"https://www.nature.com/articles/leu2016389","googleCitationCount":18,"googleAuthor":"I Schlam","doi":"10.1038/leu.2016.389","elsevierAuthor":"Panchabhai S.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"14"},{"title":"Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic …","googleId":"DeYiVmvUXdMJ","googleLink":"https://www.nature.com/articles/leu2017154","googleCitationCount":17,"googleAuthor":"","doi":"10.1038/leu.2017.154","elsevierAuthor":"Hinze L.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"11"},{"title":"Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML","googleId":"Du0PMCAeoiIJ","googleLink":"https://www.nature.com/articles/leu2017217","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2017.217","elsevierAuthor":"Herold S.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"9"},{"title":"A novel AHI-1–BCR-ABL–DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated …","googleId":"Z6jkZ6gDnUYJ","googleLink":"https://www.nature.com/articles/leu2017108","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2017.108","elsevierAuthor":"Liu X.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"10"},{"title":"A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal","googleId":"kLp_VpNfdG0J","googleLink":"https://www.nature.com/articles/leu2016201","googleCitationCount":16,"googleAuthor":"Z Zhang","doi":"10.1038/leu.2016.201","elsevierAuthor":"Zhang Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"13"},{"title":"Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm—a comparison of 756 cases","googleId":"u5ElUAN6AkQJ","googleLink":"https://www.nature.com/articles/s41375-018-0119-8","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/s41375-018-0119-8","elsevierAuthor":"Baer C.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4"},{"title":"Trends in pre-and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004 …","googleId":"Uc2LcOgvLq0J","googleLink":"https://www.nature.com/articles/leu2017185","googleCitationCount":12,"googleAuthor":"A D'Souza","doi":"10.1038/leu.2017.185","elsevierAuthor":"D'Souza A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"12"},{"title":"Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses","googleId":"TGu73rzjMUEJ","googleLink":"https://www.nature.com/articles/s41375-018-0080-6","googleCitationCount":9,"googleAuthor":"T Tashi","doi":"10.1038/s41375-018-0080-6","elsevierAuthor":"Hasselbalch H.C.","publicationName":"Seminars in Immunopathology","elsevierCoverDate":"2019-01-11","elsevierCoverDisplayDate":"11 January 2019","elsevierCitationCount":"20"},{"title":"c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish","googleId":"fAP5onTjpVUJ","googleLink":"https://www.nature.com/articles/leu2016170","googleCitationCount":16,"googleAuthor":"Z Huang","doi":"10.1038/leu.2016.170","elsevierAuthor":"Liu W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"19"},{"title":"Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis","googleId":"8sN_H0HnSCgJ","googleLink":"https://www.nature.com/articles/s41375-018-0063-7","googleCitationCount":8,"googleAuthor":"S Sidana","doi":"10.1038/s41375-018-0063-7","elsevierAuthor":"Sidana S.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"7"},{"title":"Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation","googleId":"POEnwFToc-EJ","googleLink":"https://www.nature.com/articles/leu2017105","googleCitationCount":12,"googleAuthor":"V Vas","doi":"10.1038/leu.2017.105","elsevierAuthor":"Thiel V.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"8"},{"title":"The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation","googleId":"wHjqVsURC94J","googleLink":"https://www.nature.com/articles/leu2016259","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/leu.2016.259","elsevierAuthor":"Weissinger E.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14"},{"title":"IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus","googleId":"IR3Arbiy-cMJ","googleLink":"https://www.nature.com/articles/leu2016356","googleCitationCount":16,"googleAuthor":"","doi":"10.1038/leu.2016.356","elsevierAuthor":"Drennan S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"12"},{"title":"Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma","googleId":"G_mMy0lMfD8J","googleLink":"https://www.nature.com/articles/s41375-018-0066-4","googleCitationCount":6,"googleAuthor":"J Bertran","doi":"10.1038/s41375-018-0066-4","elsevierAuthor":"Gallardo F.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"5"},{"title":"Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target","googleId":"Pd-_lywXtukJ","googleLink":"https://www.nature.com/articles/leu2016302","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/leu.2016.302","elsevierAuthor":"Barabé F.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11"},{"title":"Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia","googleId":"BjqHC5MiFQsJ","googleLink":"https://www.nature.com/articles/leu201772","googleCitationCount":13,"googleAuthor":"SH Kim","doi":"10.1038/leu.2017.72","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0"},{"title":"Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency","googleId":"2JuxvHbRgdEJ","googleLink":"https://www.nature.com/articles/leu2016256","googleCitationCount":15,"googleAuthor":"LW Ding","doi":"10.1038/leu.2016.256","elsevierAuthor":"Ding L.W.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"11"},{"title":"Rare germline variants in ATM are associated with chronic lymphocytic leukemia","googleId":"5UybE7OlEPcJ","googleLink":"https://www.nature.com/articles/leu2017201","googleCitationCount":13,"googleAuthor":"W Poh","doi":"10.1038/leu.2017.201","elsevierAuthor":"Tiao G.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"8"},{"title":"Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t (8; 21)(q22; q22): a study of the German-Austrian AML Study …","googleId":"0OF5Infv03IJ","googleLink":"https://www.nature.com/articles/leu201718","googleCitationCount":14,"googleAuthor":"M Agrawal","doi":"10.1038/leu.2017.18","elsevierAuthor":"Jahn N.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"11"},{"title":"Identification and characterization of activating ABL1 1b kinase mutations: impact on sensitivity to ATP-competitive and allosteric ABL1 inhibitors","googleId":"0nJWrTECTpkJ","googleLink":"https://www.nature.com/articles/leu2016353","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/leu.2016.353","elsevierAuthor":"Lee B.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"13"},{"title":"Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia","googleId":"SoDTlMUVbJgJ","googleLink":"https://www.nature.com/articles/s41375-018-0225-7","googleCitationCount":7,"googleAuthor":"CE Tognon","doi":"10.1038/s41375-018-0225-7","elsevierAuthor":"Kurtz S.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"5"},{"title":"A novel t (3; 13)(q13; q12) translocation fusing FLT3 with GOLGB1: toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3?","googleId":"eRdtEa_0JjgJ","googleLink":"https://www.nature.com/articles/leu2016304","googleCitationCount":14,"googleAuthor":"","doi":"10.1038/leu.2016.304","elsevierAuthor":"Troadec E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"13"},{"title":"Epigenetic loss of the RNA decapping enzyme NUDT16 mediates C-MYC activation in T-cell acute lymphoblastic leukemia","googleId":"zvcFIowimY8J","googleLink":"https://www.nature.com/articles/leu201799","googleCitationCount":12,"googleAuthor":"C Moutinho","doi":"10.1038/leu.2017.99","elsevierAuthor":"Anadón C.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"8"},{"title":"DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells","googleId":"jXSAsl-WfncJ","googleLink":"https://www.nature.com/articles/leu2016284","googleCitationCount":15,"googleAuthor":"M Wu","doi":"10.1038/leu.2016.284","elsevierAuthor":"Wu M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"11"},{"title":"Do we need to distinguish exosomes from microvesicles in hematological malignancies?","googleId":"l0Td6X5aYZUJ","googleLink":"https://www.nature.com/articles/leu2017205","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2017.205","elsevierAuthor":"Caivano A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"10"},{"title":"Diagnostic algorithm for lower-risk myelodysplastic syndromes","googleId":"EgRuybOsukoJ","googleLink":"https://www.nature.com/articles/s41375-018-0173-2","googleCitationCount":5,"googleAuthor":"GJ Mufti","doi":"10.1038/s41375-018-0173-2","elsevierAuthor":"Mufti G.J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"2"},{"title":"A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia","googleId":"7nV6Q-v2DLQJ","googleLink":"https://www.nature.com/articles/leu2016225","googleCitationCount":17,"googleAuthor":"NH Russell","doi":"10.1038/leu.2016.225","elsevierAuthor":"Burnett A.K.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"13"},{"title":"Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL","googleId":"eUMr5WvZv-4J","googleLink":"https://www.nature.com/articles/leu2017274","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/leu.2017.274","elsevierAuthor":"Brazdilova K.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8"},{"title":"Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma","googleId":"dNuoPeu5A84J","googleLink":"https://www.nature.com/articles/leu2017309","googleCitationCount":11,"googleAuthor":"G Hu","doi":"10.1038/leu.2017.309","elsevierAuthor":"Hu G.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"9"},{"title":"Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset","googleId":"Qs70BWd8CB0J","googleLink":"https://www.nature.com/articles/s41375-018-0099-8","googleCitationCount":10,"googleAuthor":"G Goyal","doi":"10.1038/s41375-018-0099-8","elsevierAuthor":"Goyal G.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"7"},{"title":"NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group","googleId":"4FNkWjiGTLsJ","googleLink":"https://www.nature.com/articles/leu2016361","googleCitationCount":15,"googleAuthor":"M Zampini","doi":"10.1038/leu.2016.361","elsevierAuthor":"Bisio V.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10"},{"title":"SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis","googleId":"plznjgF_yOEJ","googleLink":"https://www.nature.com/articles/leu2017183","googleCitationCount":11,"googleAuthor":"G Martinelli","doi":"10.1038/leu.2017.183","elsevierAuthor":"Martinelli G.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"11"},{"title":"Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used","googleId":"B4UT7rCHFqIJ","googleLink":"https://www.nature.com/articles/s41375-018-0041-0","googleCitationCount":9,"googleAuthor":"M Delforge","doi":"10.1038/s41375-018-0041-0","elsevierAuthor":"Bossuyt X.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"9"},{"title":"Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR","googleId":"nOYgGRx0ui8J","googleLink":"https://www.nature.com/articles/s41375-018-0052-x","googleCitationCount":9,"googleAuthor":"","doi":"10.1038/s41375-018-0052-x","elsevierAuthor":"Notario L.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"5"},{"title":"14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors","googleId":"WUGSdpqonk4J","googleLink":"https://www.nature.com/articles/leu2017288","googleCitationCount":9,"googleAuthor":"BG Barwick","doi":"10.1038/leu.2017.288","elsevierAuthor":"Gu Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"8"},{"title":"Saracatinib impairs maintenance of human T-ALL by targeting the LCK tyrosine kinase in cells displaying high level of lipid rafts","googleId":"JCYF5v9XMuMJ","googleLink":"https://www.nature.com/articles/s41375-018-0081-5","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0081-5","elsevierAuthor":"Buffière A.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"3"},{"title":"Novel PDGFRB fusions in childhood B-and T-acute lymphoblastic leukemia","googleId":"ITXPZlaoVg4J","googleLink":"https://www.nature.com/articles/leu2017161","googleCitationCount":10,"googleAuthor":"AB Schrock","doi":"10.1038/leu.2017.161","elsevierAuthor":"Heilmann A.M.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"10"},{"title":"A critical role of periostin in B-cell acute lymphoblastic leukemia","googleId":"mL6s1eZy8d4J","googleLink":"https://www.nature.com/articles/leu2017149","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.149","elsevierAuthor":"Ma Z.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"7"},{"title":"Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy","googleId":"QuoK_ZUWAdgJ","googleLink":"https://www.nature.com/articles/s41375-018-0101-5","googleCitationCount":6,"googleAuthor":"LN Eadie","doi":"10.1038/s41375-018-0101-5","elsevierAuthor":"Eadie L.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"6"},{"title":"IDH1 R132, IDH2 R140 and IDH2 R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies","googleId":"7dHGBA6IXz4J","googleLink":"https://www.nature.com/articles/s41375-018-0026-z","googleCitationCount":7,"googleAuthor":"W Walter","doi":"10.1038/s41375-018-0026-z","elsevierAuthor":"Meggendorfer M.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"6"},{"title":"Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS","googleId":"HY89xWGJ8n4J","googleLink":"https://www.nature.com/articles/leu2016264","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2016.264","elsevierAuthor":"Müller E.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10"},{"title":"PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis","googleId":"PMSDXGxA5d8J","googleLink":"https://www.nature.com/articles/leu2016333","googleCitationCount":14,"googleAuthor":"MJ Carter","doi":"10.1038/leu.2016.333","elsevierAuthor":"Carter M.J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"9"},{"title":"Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients","googleId":"Lemp3CE8SRIJ","googleLink":"https://www.nature.com/articles/leu2017220","googleCitationCount":10,"googleAuthor":"P Guglielmelli","doi":"10.1038/leu.2017.220","elsevierAuthor":"Ruberti S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"9"},{"title":"Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations","googleId":"QiuhxlL88BcJ","googleLink":"https://www.nature.com/articles/s41375-018-0056-6","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0056-6","elsevierAuthor":"Willekens C.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"7"},{"title":"Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target","googleId":"BMuFmJrb5qIJ","googleLink":"https://www.nature.com/articles/leu2016249","googleCitationCount":13,"googleAuthor":"","doi":"10.1038/leu.2016.249","elsevierAuthor":"Alatrash G.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"8"},{"title":"Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma","googleId":"E_oUnAVAlvcJ","googleLink":"https://www.nature.com/articles/leu2016253","googleCitationCount":16,"googleAuthor":"JD Shaughnessy Jr","doi":"10.1038/leu.2016.253","elsevierAuthor":"Sawyer J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"15"},{"title":"Lamin B1 regulates somatic mutations and progression of B-cell malignancies","googleId":"TJiA6Aqt26oJ","googleLink":"https://www.nature.com/articles/leu2017255","googleCitationCount":9,"googleAuthor":"T Klymenko","doi":"10.1038/leu.2017.255","elsevierAuthor":"Klymenko T.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"6"},{"title":"Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway","googleId":"Chzpx8IokEkJ","googleLink":"https://www.nature.com/articles/s41375-018-0114-0","googleCitationCount":15,"googleAuthor":"","doi":"10.1038/s41375-018-0114-0","elsevierAuthor":"Busch L.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"10"},{"title":"Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma","googleId":"DqsZhxEXIr0J","googleLink":"https://www.nature.com/articles/leu2016379","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2016.379","elsevierAuthor":"Nair J.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"10"},{"title":"Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone …","googleId":"7Ovgiv3WTMkJ","googleLink":"https://www.nature.com/articles/leu201773","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.73","elsevierAuthor":"Hussein K.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"8"},{"title":"Nuclear FOXM1 drives chemoresistance in AML","googleId":"FeqoVGilTXwJ","googleLink":"https://www.nature.com/articles/leu2016270","googleCitationCount":12,"googleAuthor":"P Gann","doi":"10.1038/leu.2016.270","elsevierAuthor":"Khan I.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"10"},{"title":"A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD","googleId":"R_NRMOQG7igJ","googleLink":"https://www.nature.com/articles/s41375-018-0183-0","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-018-0183-0","elsevierAuthor":"Sauer S.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4"},{"title":"An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS","googleId":"Y4sk8owKtTEJ","googleLink":"https://www.nature.com/articles/s41375-018-0189-7","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0189-7","elsevierAuthor":"Kida J.i.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"3"},{"title":"Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group","googleId":"SGAQMqrrSQwJ","googleLink":"https://www.nature.com/articles/leu2017221","googleCitationCount":8,"googleAuthor":"O Al-Sawaf","doi":"10.1038/leu.2017.221","elsevierAuthor":"Al-Sawaf O.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"3"},{"title":"Mutation, methylation, and gene expression profiles in dup (1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia","googleId":"P0TEvWThJfcJ","googleLink":"https://www.nature.com/articles/s41375-018-0092-2","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-018-0092-2","elsevierAuthor":"Gunnarsson R.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4"},{"title":"Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex","googleId":"TbeOYzgUJ3kJ","googleLink":"https://www.nature.com/articles/leu2016331","googleCitationCount":12,"googleAuthor":"TI Shaw","doi":"10.1038/leu.2016.331","elsevierAuthor":"Palacios G.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"12"},{"title":"NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma","googleId":"9lA9b9ndPMsJ","googleLink":"https://www.nature.com/articles/leu2017115","googleCitationCount":11,"googleAuthor":"J Shaughnessy","doi":"10.1038/leu.2017.115","elsevierAuthor":"Hao M.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"11"},{"title":"Frequent evolution of copy number alterations in CLL following first-line treatment with FC (R) is enriched with TP53 alterations: results from the CLL8 trial","googleId":"deqpenSpGxYJ","googleLink":"https://www.nature.com/articles/leu2016317","googleCitationCount":13,"googleAuthor":"DA Landau","doi":"10.1038/leu.2016.317","elsevierAuthor":"Edelmann J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"7"},{"title":"Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1","googleId":"_Zf-3Q3hCE4J","googleLink":"https://www.nature.com/articles/s41375-018-0091-3","googleCitationCount":7,"googleAuthor":"M Cavo","doi":"10.1038/s41375-018-0091-3","elsevierAuthor":"Garderet L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"4"},{"title":"RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo","googleId":"YFfpP0B1PAcJ","googleLink":"https://www.nature.com/articles/leu2017269","googleCitationCount":10,"googleAuthor":"N Jyotsana","doi":"10.1038/leu.2017.269","elsevierAuthor":"Jyotsana N.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8"},{"title":"Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia","googleId":"ebNBho1dNoMJ","googleLink":"https://www.nature.com/articles/s41375-018-0164-3","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/s41375-018-0164-3","elsevierAuthor":"Criado I.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"5"},{"title":"Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations","googleId":"eaVlxJIfZVEJ","googleLink":"https://www.nature.com/articles/leu2017126","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2017.126","elsevierAuthor":"Zhang H.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"10"},{"title":"Nucleolin promotes execution of the hematopoietic stem cell gene expression program","googleId":"wzlWBB3kjmMJ","googleLink":"https://www.nature.com/articles/s41375-018-0090-4","googleCitationCount":6,"googleAuthor":"S Bhatia","doi":"10.1038/s41375-018-0090-4","elsevierAuthor":"Mahotka C.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"5"},{"title":"How good are we at predicting the fate of someone with acute myeloid leukaemia?","googleId":"DBJW7IESnR0J","googleLink":"https://www.nature.com/articles/leu201756","googleCitationCount":19,"googleAuthor":"RP Gale","doi":"10.1038/leu.2017.56","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"17"},{"title":"The immune receptor Trem1 cooperates with diminished DNA damage response to induce preleukemic stem cell expansion","googleId":"cxGbr6y5dbIJ","googleLink":"https://www.nature.com/articles/leu2016242","googleCitationCount":11,"googleAuthor":"S Amarachintha","doi":"10.1038/leu.2016.242","elsevierAuthor":"Du W.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7"},{"title":"Epistasis between TIFAB and miR-146a: neighboring genes in del (5q) myelodysplastic syndrome","googleId":"vgKTv5WnTykJ","googleLink":"https://www.nature.com/articles/leu2016276","googleCitationCount":11,"googleAuthor":"ME Varney","doi":"10.1038/leu.2016.276","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0"},{"title":"Impact of treatment site on disparities in outcome among adolescent and young adults with Hodgkin lymphoma","googleId":"2TrwS3jcvcoJ","googleLink":"https://www.nature.com/articles/leu201766","googleCitationCount":9,"googleAuthor":"S Bhatia","doi":"10.1038/leu.2017.66","elsevierAuthor":"Wolfson J.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"6"},{"title":"Constitutive activation of nuclear factor kappa B-inducing kinase counteracts apoptosis in cells with rearranged mixed lineage leukemia gene","googleId":"WwLkayTCs_QJ","googleLink":"https://www.nature.com/articles/s41375-018-0128-7","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/s41375-018-0128-7","elsevierAuthor":"Studencka-Turski M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"4"},{"title":"Transforming growth factor-β1 regulates the nascent hematopoietic stem cell niche by promoting gluconeogenesis","googleId":"9AsVBcvGwJUJ","googleLink":"https://www.nature.com/articles/leu2017198","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/leu.2017.198","elsevierAuthor":"Zhang C.Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"7"},{"title":"Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis","googleId":"cryWBBjFtWgJ","googleLink":"https://www.nature.com/articles/leu2016299","googleCitationCount":12,"googleAuthor":"RF Schlenk","doi":"10.1038/leu.2016.299","elsevierAuthor":"Schlenk R.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10"},{"title":"Myelodysplastic syndromes and bone loss in mice and men","googleId":"b7IS3O1JVvUJ","googleLink":"https://www.nature.com/articles/leu20177","googleCitationCount":12,"googleAuthor":"J Schmitt","doi":"10.1038/leu.2017.7","elsevierAuthor":"Weidner H.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"7"},{"title":"Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL","googleId":"TdiUwYq5XaUJ","googleLink":"https://www.nature.com/articles/leu201713","googleCitationCount":11,"googleAuthor":"","doi":"10.1038/leu.2017.13","elsevierAuthor":"Serafin V.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"9"},{"title":"DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms","googleId":"vTA9kNtruZUJ","googleLink":"https://www.nature.com/articles/leu201798","googleCitationCount":9,"googleAuthor":"HA O'Leary","doi":"10.1038/leu.2017.98","elsevierAuthor":"O'Leary H.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"10"},{"title":"Casein kinase 2 controls the survival of normal thymic and leukemic γδ T cells via promotion of AKT signaling","googleId":"GeKB79hJlRQJ","googleLink":"https://www.nature.com/articles/leu2016363","googleCitationCount":12,"googleAuthor":"ST Ribeiro","doi":"10.1038/leu.2016.363","elsevierAuthor":"Ribeiro S.T.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"9"},{"title":"PPAR-delta modulates membrane cholesterol and cytokine signaling in malignant B cells","googleId":"zUqZ9nI4SyEJ","googleLink":"https://www.nature.com/articles/leu2017162","googleCitationCount":9,"googleAuthor":"SE Dunn","doi":"10.1038/leu.2017.162","elsevierAuthor":"Sun L.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"6"},{"title":"A human bone marrow mesodermal-derived cell population with hemogenic potential","googleId":"LktpJE_lwGEJ","googleLink":"https://www.nature.com/articles/s41375-018-0016-1","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0016-1","elsevierAuthor":"Mokhtari S.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"0"},{"title":"Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity","googleId":"zDH2IdbRr2IJ","googleLink":"https://www.nature.com/articles/leu2017343","googleCitationCount":8,"googleAuthor":"H Khiabanian","doi":"10.1038/leu.2017.343","elsevierAuthor":"Marsilio S.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"6"},{"title":"Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort","googleId":"ywLZPslrICcJ","googleLink":"https://www.nature.com/articles/leu201768","googleCitationCount":9,"googleAuthor":"TV Kourelis","doi":"10.1038/leu.2017.68","elsevierAuthor":"Kourelis T.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"5"},{"title":"Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia","googleId":"96R9dw_vPXcJ","googleLink":"https://www.nature.com/articles/leu2016286","googleCitationCount":12,"googleAuthor":"","doi":"10.1038/leu.2016.286","elsevierAuthor":"Ojamies P.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"6"},{"title":"A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies","googleId":"WYQSPx0oMY8J","googleLink":"https://www.nature.com/articles/leu2017293","googleCitationCount":7,"googleAuthor":"S Bournazos","doi":"10.1038/leu.2017.293","elsevierAuthor":"Casey E.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4"},{"title":"Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role","googleId":"I4dP78rU754J","googleLink":"https://www.nature.com/articles/s41375-018-0072-6","googleCitationCount":5,"googleAuthor":"MV Mateos","doi":"10.1038/s41375-018-0072-6","elsevierAuthor":"Rodríguez-Otero P.","publicationName":"Leukemia","elsevierCoverDate":"2019-04-01","elsevierCoverDisplayDate":"1 April 2019","elsevierCitationCount":"0"},{"title":"Response kinetics and factors predicting survival in core-binding factor leukemia","googleId":"pu818wUrypsJ","googleLink":"https://www.nature.com/articles/s41375-018-0158-1","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0158-1","elsevierAuthor":"Boddu P.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"5"},{"title":"Demethylator phenotypes in acute myeloid leukemia","googleId":"6dvQnCgUvWkJ","googleLink":"https://www.nature.com/articles/s41375-018-0084-2","googleCitationCount":5,"googleAuthor":"AD Kelly","doi":"10.1038/s41375-018-0084-2","elsevierAuthor":"Kelly A.D.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4"},{"title":"Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?","googleId":"tkdZOZo75QQJ","googleLink":"https://www.nature.com/articles/leu2017263","googleCitationCount":9,"googleAuthor":"PS Becker","doi":"10.1038/leu.2017.263","elsevierAuthor":"Zhou Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"9"},{"title":"Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma","googleId":"Vooai9__TXcJ","googleLink":"https://www.nature.com/articles/leu2017146","googleCitationCount":17,"googleAuthor":"E Menu","doi":"10.1038/leu.2017.146","elsevierAuthor":"Favreau M.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"13"},{"title":"Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster","googleId":"vndPZHz8BoUJ","googleLink":"https://www.nature.com/articles/leu2017127","googleCitationCount":8,"googleAuthor":"G Cazzaniga","doi":"10.1038/leu.2017.127","elsevierAuthor":"Cazzaniga G.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"4"},{"title":"Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance","googleId":"g87505vxWFoJ","googleLink":"https://www.nature.com/articles/s41375-018-0202-1","googleCitationCount":4,"googleAuthor":"M Merz","doi":"10.1038/s41375-018-0202-1","elsevierAuthor":"Merz M.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1"},{"title":"Establishment of a congenital amegakaryocytic thrombocytopenia model and a thrombocyte–specific reporter line in zebrafish","googleId":"gk4cp8K1_YMJ","googleLink":"https://www.nature.com/articles/leu2016320","googleCitationCount":11,"googleAuthor":"Y Zhang","doi":"10.1038/leu.2016.320","elsevierAuthor":"Lin Q.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"7"},{"title":"JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1","googleId":"vpgZqlWpr5EJ","googleLink":"https://www.nature.com/articles/leu201726","googleCitationCount":11,"googleAuthor":"N Gupta","doi":"10.1038/leu.2017.26","elsevierAuthor":"Gupta N.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"7"},{"title":"No evidence for microsatellite instability in acute myeloid leukemia","googleId":"Pw8nPI1skIcJ","googleLink":"https://www.nature.com/articles/leu201797","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.97","elsevierAuthor":"Walker C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"6"},{"title":"Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches","googleId":"aoRGJq9Ko4AJ","googleLink":"https://www.nature.com/articles/leu2017143","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.143","elsevierAuthor":"Pearson S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0"},{"title":"RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia","googleId":"4bbXaG3WPnoJ","googleLink":"https://www.nature.com/articles/leu2017284","googleCitationCount":6,"googleAuthor":"A Jacquel","doi":"10.1038/leu.2017.284","elsevierAuthor":"Hospital M.A.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"10"},{"title":"The-2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and …","googleId":"zhLf8f9A2xEJ","googleLink":"https://www.nature.com/articles/s41375-018-0088-y","googleCitationCount":5,"googleAuthor":"G Gobbi","doi":"10.1038/s41375-018-0088-y","elsevierAuthor":"Masselli E.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"4"},{"title":"Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90 Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499","googleId":"tOYsMFEIQpYJ","googleLink":"https://www.nature.com/articles/leu2016305","googleCitationCount":11,"googleAuthor":"F Hong","doi":"10.1038/leu.2016.305","elsevierAuthor":"Smith M.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7"},{"title":"Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?","googleId":"8cu1LajWnIwJ","googleLink":"https://www.nature.com/articles/s41375-018-0247-1","googleCitationCount":4,"googleAuthor":"N Aghel","doi":"10.1038/s41375-018-0247-1","elsevierAuthor":"Aghel N.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"2"},{"title":"Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms","googleId":"WCeMC2t2ggYJ","googleLink":"https://www.nature.com/articles/leu2017295","googleCitationCount":6,"googleAuthor":"SK Balasubramanian","doi":"10.1038/leu.2017.295","elsevierAuthor":"Balasubramanian S.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"5"},{"title":"Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia","googleId":"Az9cdw8tvdsJ","googleLink":"https://www.nature.com/articles/s41375-018-0187-9","googleCitationCount":4,"googleAuthor":"J Bond","doi":"10.1038/s41375-018-0187-9","elsevierAuthor":"Bond J.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"2"},{"title":"Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma","googleId":"wNWKZFihpPcJ","googleLink":"https://www.nature.com/articles/leu2016238","googleCitationCount":9,"googleAuthor":"J Richter","doi":"10.1038/leu.2016.238","elsevierAuthor":"Wurster K.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"7"},{"title":"Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma","googleId":"AYNx4epSm-IJ","googleLink":"https://www.nature.com/articles/leu2017124","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.124","elsevierAuthor":"Knop S.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"6"},{"title":"Recurrent cyclin D2 mutations in myeloid neoplasms","googleId":"byRm2jRMdJ0J","googleLink":"https://www.nature.com/articles/leu2017195","googleCitationCount":7,"googleAuthor":"V Khanna","doi":"10.1038/leu.2017.195","elsevierAuthor":"Khanna V.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"4"},{"title":"Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity","googleId":"td-EB3rz_KkJ","googleLink":"https://www.nature.com/articles/leu2016167","googleCitationCount":10,"googleAuthor":"S Weng","doi":"10.1038/leu.2016.167","elsevierAuthor":"Weng S.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"9"},{"title":"A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial","googleId":"LqgxMR-miDEJ","googleLink":"https://www.nature.com/articles/s41375-018-0148-3","googleCitationCount":5,"googleAuthor":"RK Hills","doi":"10.1038/s41375-018-0148-3","elsevierAuthor":"Burnett A.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4"},{"title":"Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib","googleId":"QIb66V5xGZwJ","googleLink":"https://www.nature.com/articles/leu2016174","googleCitationCount":10,"googleAuthor":"","doi":"10.1038/leu.2016.174","elsevierAuthor":"Ishiyama K.I.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"7"},{"title":"Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?","googleId":"5xx5-PmN8IIJ","googleLink":"https://www.nature.com/articles/leu2017238","googleCitationCount":7,"googleAuthor":"MA Sekeres","doi":"10.1038/leu.2017.238","elsevierAuthor":"Zeidan A.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"7"},{"title":"Mutant NRAS Q61K is responsible for MAPK pathway activation in the MARIMO cell line and renders these cells independent of the CALR–MPL–JAK2–STAT5 …","googleId":"6abA-jm9pT4J","googleLink":"https://www.nature.com/articles/s41375-018-0234-6","googleCitationCount":3,"googleAuthor":"TH Brümmendorf","doi":"10.1038/s41375-018-0234-6","elsevierAuthor":"Han L.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"3"},{"title":"Perspective on Diamond–Blackfan anemia: lessons from a rare congenital bone marrow failure syndrome","googleId":"58RWXOMXi7UJ","googleLink":"https://www.nature.com/articles/leu2017314","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2017.314","elsevierAuthor":"Sakamoto K.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4"},{"title":"B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN/AKT/RCOR2/RUNX1 pathways","googleId":"lLHAo8KBNnMJ","googleLink":"https://www.nature.com/articles/leu2017232","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2017.232","elsevierAuthor":"Xia F.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"5"},{"title":"PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias","googleId":"JyRgx8HVOfMJ","googleLink":"https://www.nature.com/articles/leu2016386","googleCitationCount":9,"googleAuthor":"L Riva","doi":"10.1038/leu.2016.386","elsevierAuthor":"Ronchini C.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"7"},{"title":"Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study","googleId":"XMe390H57e8J","googleLink":"https://www.nature.com/articles/s41375-018-0268-9","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0268-9","elsevierAuthor":"Braess J.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"4"},{"title":"MZH29 is a novel potent inhibitor that overcomes drug resistance FLT3 mutations in acute myeloid leukemia","googleId":"5Y8_cBE4x00J","googleLink":"https://www.nature.com/articles/leu2016297","googleCitationCount":9,"googleAuthor":"B Xu","doi":"10.1038/leu.2016.297","elsevierAuthor":"Xu B.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"8"},{"title":"Discriminating a common somatic ASXL1 mutation (c. 1934dup; p. G646Wfs* 12) from artifact in myeloid malignancies using NGS","googleId":"RsBuX4dvQgEJ","googleLink":"https://www.nature.com/articles/s41375-018-0193-y","googleCitationCount":3,"googleAuthor":"MO Alberti","doi":"10.1038/s41375-018-0193-y","elsevierAuthor":"Alberti M.O.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"3"},{"title":"Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis","googleId":"_4EzKgV9rGwJ","googleLink":"https://www.nature.com/articles/leu2017267","googleCitationCount":5,"googleAuthor":"FC Baltanas","doi":"10.1038/leu.2017.267","elsevierAuthor":"Gerboth S.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"5"},{"title":"Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions","googleId":"hOJ-2gdoQQ0J","googleLink":"https://www.nature.com/articles/s41375-018-0214-x","googleCitationCount":4,"googleAuthor":"FH Heidel","doi":"10.1038/s41375-018-0214-x","elsevierAuthor":"Heidel F.H.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"3"},{"title":"Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia","googleId":"VHcm9kuA0msJ","googleLink":"https://www.nature.com/articles/s41375-017-0001-0","googleCitationCount":6,"googleAuthor":"JA Hixon","doi":"10.1038/s41375-017-0001-0","elsevierAuthor":"Cramer S.D.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"5"},{"title":"Plastic CD34 and CD38 expression in adult B–cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations","googleId":"dSSOcBUAlWoJ","googleLink":"https://www.nature.com/articles/leu2016315","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/leu.2016.315","elsevierAuthor":"Lang F.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"6"},{"title":"Lenalidomide-mediated erythroid improvement in non-del (5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling","googleId":"-Dyb9GAJupcJ","googleLink":"https://www.nature.com/articles/leu2017305","googleCitationCount":6,"googleAuthor":"E Becht","doi":"10.1038/leu.2017.305","elsevierAuthor":"Kerdivel G.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4"},{"title":"C-terminal BRE overexpression in 11q23-rearranged and t (8; 16) acute myeloid leukemia is caused by intragenic transcription initiation","googleId":"QGGsGJdWLR8J","googleLink":"https://www.nature.com/articles/leu2017280","googleCitationCount":5,"googleAuthor":"KHM Prange","doi":"10.1038/leu.2017.280","elsevierAuthor":"Marneth A.E.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"4"},{"title":"Acute myeloid leukemia therapy and the chosen people","googleId":"NAogqIXtT9gJ","googleLink":"https://www.nature.com/articles/leu2016306","googleCitationCount":10,"googleAuthor":"RP Gale","doi":"10.1038/leu.2016.306","elsevierAuthor":"Estey E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"10"},{"title":"Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM","googleId":"MomFs8b8vykJ","googleLink":"https://www.nature.com/articles/leu2017271","googleCitationCount":5,"googleAuthor":"D Townsley","doi":"10.1038/leu.2017.271","elsevierAuthor":"Albitar A.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"2"},{"title":"Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective","googleId":"lUCB3TsWs9MJ","googleLink":"https://www.nature.com/articles/s41375-018-0050-z","googleCitationCount":3,"googleAuthor":"D Yan","doi":"10.1038/s41375-018-0050-z","elsevierAuthor":"Than H.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2"},{"title":"Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia","googleId":"i-BlhJrtHL0J","googleLink":"https://www.nature.com/articles/s41375-018-0059-3","googleCitationCount":4,"googleAuthor":"P Strati","doi":"10.1038/s41375-018-0059-3","elsevierAuthor":"Strati P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"3"},{"title":"Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria","googleId":"UFpvzDHuik0J","googleLink":"https://www.nature.com/articles/s41375-018-0138-5","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0138-5","elsevierAuthor":"Clemente M.","publicationName":"Leukemia","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"1 November 2018","elsevierCitationCount":"4"},{"title":"E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia","googleId":"CLhoDJfu1iwJ","googleLink":"https://www.nature.com/articles/leu2016293","googleCitationCount":8,"googleAuthor":"SD Baker","doi":"10.1038/leu.2016.293","elsevierAuthor":"Park I.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"8"},{"title":"A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells","googleId":"DfEJAKD6e4AJ","googleLink":"https://www.nature.com/articles/s41375-018-0200-3","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-018-0200-3","elsevierAuthor":"Du W.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2"},{"title":"Erratum: Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells","googleId":"HABob9asBD0J","googleLink":"https://www.nature.com/articles/leu201777","googleCitationCount":8,"googleAuthor":"S Sharma","doi":"10.1038/leu.2017.77","elsevierAuthor":"Fiskus W.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"1"},{"title":"Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia","googleId":"EgLY337jmhQJ","googleLink":"https://www.nature.com/articles/leu2016330","googleCitationCount":8,"googleAuthor":"","doi":"10.1038/leu.2016.330","elsevierAuthor":"Baer C.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"7"},{"title":"P2X7 polymorphisms and stem cell mobilisation","googleId":"vS9ENcNl1pkJ","googleLink":"https://www.nature.com/articles/s41375-018-0232-8","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/s41375-018-0232-8","elsevierAuthor":"Koldej R.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"3"},{"title":"NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma","googleId":"4P2MJNx1Ew8J","googleLink":"https://www.nature.com/articles/leu2016292","googleCitationCount":7,"googleAuthor":"E Pomari","doi":"10.1038/leu.2016.292","elsevierAuthor":"Pomari E.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"5"},{"title":"Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD","googleId":"GoRIHWj92AYJ","googleLink":"https://www.nature.com/articles/leu2016343","googleCitationCount":7,"googleAuthor":"QY Sun","doi":"10.1038/leu.2016.343","elsevierAuthor":"Chien W.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"5"},{"title":"Inhibition of reactive oxygen species limits expansion of chronic lymphocytic leukemia cells","googleId":"OR5bvsFpXEkJ","googleLink":"https://www.nature.com/articles/leu2017241","googleCitationCount":5,"googleAuthor":"B Yigit","doi":"10.1038/leu.2017.241","elsevierAuthor":"Yigit B.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"2"},{"title":"NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors","googleId":"xxQ8FTjnO-wJ","googleLink":"https://www.nature.com/articles/leu2016250","googleCitationCount":8,"googleAuthor":"K Byrgazov","doi":"10.1038/leu.2016.250","elsevierAuthor":"Byrgazov K.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"8"},{"title":"Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia","googleId":"anRD_4jT9BAJ","googleLink":"https://www.nature.com/articles/leu2016294","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2016.294","elsevierAuthor":"Lohmann G.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"5"},{"title":"Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma","googleId":"IPYKE9gdaDsJ","googleLink":"https://www.nature.com/articles/leu2016311","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2016.311","elsevierAuthor":"Piao W.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"7"},{"title":"Base excision repair proteins couple activation-induced cytidine deaminase and endonuclease G during replication stress-induced MLL destabilization","googleId":"vH64iK7uTtwJ","googleLink":"https://www.nature.com/articles/leu2017191","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.191","elsevierAuthor":"Gole B.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"1"},{"title":"High frequency of RUNX1 mutation in myelodysplastic syndrome patients with whole-arm translocation of der (1; 7)(q10; p10)","googleId":"z7nJoe2W0QcJ","googleLink":"https://www.nature.com/articles/leu2017228","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/leu.2017.228","elsevierAuthor":"Zhang T.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"5"},{"title":"Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice","googleId":"APYPByKBCXUJ","googleLink":"https://www.nature.com/articles/leu201769","googleCitationCount":6,"googleAuthor":"Y Fløisand","doi":"10.1038/leu.2017.69","elsevierAuthor":"Wang D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"4"},{"title":"Towards 'off-the-shelf'genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells","googleId":"7aSG3GMsgSYJ","googleLink":"https://www.nature.com/articles/leu2017332","googleCitationCount":4,"googleAuthor":"N Or-Geva","doi":"10.1038/leu.2017.332","elsevierAuthor":"Or-Geva N.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"4"},{"title":"Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia","googleId":"YTNkN_eBbrQJ","googleLink":"https://www.nature.com/articles/s41375-018-0137-6","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/s41375-018-0137-6","elsevierAuthor":"Renneville A.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2"},{"title":"Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients","googleId":"r5l8NUdJqS4J","googleLink":"https://www.nature.com/articles/leu2017315","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/leu.2017.315","elsevierAuthor":"Bera T.K.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"4"},{"title":"Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML","googleId":"Jr4OR956He0J","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29381150/","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2017.9.","elsevierAuthor":"Schütz C.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"2"},{"title":"Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004","googleId":"mjeOHdvXzuUJ","googleLink":"https://www.nature.com/articles/leu2017121","googleCitationCount":4,"googleAuthor":"M Dworzak","doi":"10.1038/leu.2017.121","elsevierAuthor":"Rasche M.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"2"},{"title":"Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia","googleId":"P4WWAZXOUEkJ","googleLink":"https://www.nature.com/articles/s41375-018-0076-2","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0076-2","elsevierAuthor":"Ali A.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"1"},{"title":"Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia","googleId":"fknZKPO3E9gJ","googleLink":"https://www.nature.com/articles/s41375-018-0191-0","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0191-0","elsevierAuthor":"Lundin-Ström K.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2"},{"title":"An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia","googleId":"r6M6kAcMWrsJ","googleLink":"https://www.nature.com/articles/leu2017208","googleCitationCount":5,"googleAuthor":"D Kentrup","doi":"10.1038/leu.2017.208","elsevierAuthor":"Angenendt L.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"5"},{"title":"CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC","googleId":"HU8A1V6A0nUJ","googleLink":"https://www.nature.com/articles/leu2017346","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.346","elsevierAuthor":"Tirado-Gonzalez I.","publicationName":"Leukemia","elsevierCoverDate":"2021-01-01","elsevierCoverDisplayDate":"January 2021","elsevierCitationCount":"0"},{"title":"Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia","googleId":"sEnhMGOWrsUJ","googleLink":"https://www.nature.com/articles/leu2017324","googleCitationCount":5,"googleAuthor":"","doi":"10.1038/leu.2017.324","elsevierAuthor":"Nimmagadda S.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"3"},{"title":"Phosphatase PRL2 promotes oncogenic NOTCH1-Induced T-cell leukemia","googleId":"g6eRaR22DKcJ","googleLink":"https://www.nature.com/articles/leu2016340","googleCitationCount":7,"googleAuthor":"Y Bai","doi":"10.1038/leu.2016.340","elsevierAuthor":"Kobayashi M.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"5"},{"title":"A revisionist history of adult marrow stem cell biology or 'they forgot about the discard'","googleId":"pc_T_aK94pUJ","googleLink":"https://www.nature.com/articles/leu2017155","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.155","elsevierAuthor":"Quesenberry P.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"4"},{"title":"Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma","googleId":"r-Uc9E25ShoJ","googleLink":"https://www.nature.com/articles/leu2016346","googleCitationCount":7,"googleAuthor":"J Bordini","doi":"10.1038/leu.2016.346","elsevierAuthor":"Bordini J.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"5"},{"title":"Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia","googleId":"b6JBXhQnZigJ","googleLink":"https://www.nature.com/articles/leu2016223","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2016.223","elsevierAuthor":"Fang Y.","publicationName":"Leukemia","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"6"},{"title":"Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells","googleId":"0F-RclkiSwMJ","googleLink":"https://www.nature.com/articles/leu2016154","googleCitationCount":7,"googleAuthor":"","doi":"10.1038/leu.2016.154","elsevierAuthor":"Charaf L.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"4"},{"title":"Response commentary: exosomes vs microvesicles in hematological malignancies","googleId":"rAzeD-zsELEJ","googleLink":"https://www.nature.com/articles/leu2017248","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.248","elsevierAuthor":"Whiteside T.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"4"},{"title":"Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?","googleId":"tXE2iWWkH1kJ","googleLink":"https://www.nature.com/articles/leu2016266","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2016.266","elsevierAuthor":"Némethová V.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"4"},{"title":"A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia","googleId":"YHm593d-4IoJ","googleLink":"https://www.nature.com/articles/leu2017319","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.319","elsevierAuthor":"Sakai H.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 March 2018","elsevierCitationCount":"3"},{"title":"Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid …","googleId":"jA95sV7IJFEJ","googleLink":"https://www.nature.com/articles/leu2017118","googleCitationCount":5,"googleAuthor":"P Kongtim","doi":"10.1038/leu.2017.118","elsevierAuthor":"Kongtim P.","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"4"},{"title":"Treatment-free remission in chronic myeloid leukemia: floating between expectation and evidence","googleId":"uf364V5PQYAJ","googleLink":"https://www.nature.com/articles/leu201720","googleCitationCount":6,"googleAuthor":"","doi":"10.1038/leu.2017.20","elsevierAuthor":"Baccarani M.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"6"},{"title":"CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS","googleId":"Qc2FvLwrKKwJ","googleLink":"https://www.nature.com/articles/leu2016272","googleCitationCount":5,"googleAuthor":"SR Oruganti","doi":"10.1038/leu.2016.272","elsevierAuthor":"Oruganti S.R.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"5"},{"title":"Managing myeloproliferative neoplasms evidence based on the ELN treatment recommendations 2018","googleId":"2L50e1cVYDMJ","googleLink":"https://www.nature.com/articles/s41375-018-0079-z","googleCitationCount":2,"googleAuthor":"FH Heidel","doi":"10.1038/s41375-018-0079-z","elsevierAuthor":"Heidel F.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"0"},{"title":"Revisiting thrombocytopenia in acute promyelocytic leukemia","googleId":"DLqLgP_dijIJ","googleLink":"https://www.nature.com/articles/s41375-018-0105-1","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0105-1","elsevierAuthor":"Kuchenbauer F.","publicationName":"Leukemia","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"1 June 2018","elsevierCitationCount":"2"},{"title":"Deletion of Ptpn1 induces myeloproliferative neoplasm","googleId":"dGuPGcogP44J","googleLink":"https://www.nature.com/articles/leu201731","googleCitationCount":5,"googleAuthor":"Y Yang","doi":"10.1038/leu.2017.31","elsevierAuthor":"Jobe F.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"3"},{"title":"Equivalence of BCSH and WHO diagnostic criteria for ET","googleId":"HC_3Son7daIJ","googleLink":"https://www.nature.com/articles/leu2016318","googleCitationCount":5,"googleAuthor":"MF McMullin","doi":"10.1038/leu.2016.318","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"0"},{"title":"JAK/MAP kinase pathway activation and TP53 mutations in acute leukemia with megakaryocytic and erythroid differentiation","googleId":"jVcW7YjY50YJ","googleLink":"https://www.nature.com/articles/s41375-018-0145-6","googleCitationCount":1,"googleAuthor":"W Xiao","doi":"10.1038/s41375-018-0145-6","elsevierAuthor":"Xiao W.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"0"},{"title":"Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low-and very-low-risk genetic profile","googleId":"DDUYOh-k59oJ","googleLink":"https://www.nature.com/articles/leu2017292","googleCitationCount":4,"googleAuthor":"GM Rigolin","doi":"10.1038/leu.2017.292","elsevierAuthor":"Del Giudice I.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"3"},{"title":"Gain of function in Jak2 V617F-positive T-cells","googleId":"WXJ6luudrbMJ","googleLink":"https://www.nature.com/articles/leu20176","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2017.6","elsevierAuthor":"Nishanth G.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"3"},{"title":"Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3","googleId":"ocgAT4hQTckJ","googleLink":"https://www.nature.com/articles/leu2016289","googleCitationCount":6,"googleAuthor":"M Clarke","doi":"10.1038/leu.2016.289","elsevierAuthor":"Clarke M.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"4"},{"title":"Prognostic implication of appendicular skeleton bone marrow abnormalities detected using low-dose multidetector computed tomography in patients with …","googleId":"TMorQueLJ0cJ","googleLink":"https://www.nature.com/articles/s41375-018-0048-6","googleCitationCount":2,"googleAuthor":"M Fujisawa","doi":"10.1038/s41375-018-0048-6","elsevierAuthor":"Abe Y.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"2"},{"title":"Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?","googleId":"EdTCmauPY-oJ","googleLink":"https://www.nature.com/articles/leu2017237","googleCitationCount":3,"googleAuthor":"X Calvo","doi":"10.1038/leu.2017.237","elsevierAuthor":"Calvo X.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"2"},{"title":"Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and …","googleId":"qMPGSe3CpMwJ","googleLink":"https://www.nature.com/articles/leu2017289","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.289","elsevierAuthor":"Piette C.","publicationName":"Leukemia","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3"},{"title":"Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells","googleId":"Wn8X8G48zYYJ","googleLink":"https://www.nature.com/articles/leu2016372","googleCitationCount":4,"googleAuthor":"FL Cosset","doi":"10.1038/leu.2016.372","elsevierAuthor":"Costa C.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"4"},{"title":"Response to'Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression'","googleId":"Lh83vhg8wCYJ","googleLink":"https://www.nature.com/articles/s41375-018-0155-4","googleCitationCount":1,"googleAuthor":"A Lakshman","doi":"10.1038/s41375-018-0155-4","elsevierAuthor":"Lakshman A.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1"},{"title":"Do hematopoietic stem cells get old?","googleId":"Qc40_5YJVu8J","googleLink":"https://www.nature.com/articles/leu2016301","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2016.301","elsevierAuthor":"Jung J.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"4"},{"title":"Correction: MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences","googleId":"CbJVG-HeMkEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608236/","googleCitationCount":2,"googleAuthor":"I Cifola","doi":"10.1038/s41375-018-0177-y","elsevierAuthor":"L’Abbate A.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0"},{"title":"CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes","googleId":"cwWG-aV_Uw8J","googleLink":"https://www.nature.com/articles/leu2017223","googleCitationCount":4,"googleAuthor":"KS Tan","doi":"10.1038/leu.2017.223","elsevierAuthor":"Mathias M.D.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"4"},{"title":"Blast-phase chronic myelomonocytic leukemia: more than just semantics","googleId":"u7Eaup8gDsQJ","googleLink":"https://www.nature.com/articles/s41375-018-0228-4","googleCitationCount":1,"googleAuthor":"MM Patnaik","doi":"10.1038/s41375-018-0228-4","elsevierAuthor":"Patnaik M.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1"},{"title":"Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia","googleId":"rKkLBR5YqE0J","googleLink":"https://www.nature.com/articles/leu201737","googleCitationCount":3,"googleAuthor":"L Chilton","doi":"10.1038/leu.2017.37","elsevierAuthor":"Chilton L.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"3"},{"title":"Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014","googleId":"IyX162k9D3kJ","googleLink":"https://www.nature.com/articles/s41375-018-0057-5","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0057-5","elsevierAuthor":"Helm-Petersen S.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1"},{"title":"CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis","googleId":"metMaKN9qp4J","googleLink":"https://www.nature.com/articles/leu201753","googleCitationCount":3,"googleAuthor":"A Mandoli","doi":"10.1038/leu.2017.53","elsevierAuthor":"Cordonnier G.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"3"},{"title":"Mtss1 (CSC156) mutant mice fail to display efficient Mtss1 protein depletion","googleId":"IAAciMlcaFEJ","googleLink":"https://www.nature.com/articles/leu201719","googleCitationCount":3,"googleAuthor":"S Koschmieder","doi":"10.1038/leu.2017.19","elsevierAuthor":"Fahrenkamp D.","publicationName":"Leukemia","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"3"},{"title":"Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study","googleId":"5ls0ix4FF8MJ","googleLink":"https://www.nature.com/articles/s41375-018-0054-8","googleCitationCount":1,"googleAuthor":"JL Biccler","doi":"10.1038/s41375-018-0054-8","elsevierAuthor":"Biccler J.L.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"1"},{"title":"Spotlight on pomalidomide: could less be more?","googleId":"qeGmCaCoM6YJ","googleLink":"https://www.nature.com/articles/leu2017156","googleCitationCount":3,"googleAuthor":"T Zander","doi":"10.1038/leu.2017.156","elsevierAuthor":"Zander T.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"3"},{"title":"Comment on structural basis of DUX4/IGH-driven transactivation","googleId":"d5Cxw3gK-F8J","googleLink":"https://www.nature.com/articles/s41375-018-0217-7","googleCitationCount":1,"googleAuthor":"H Aihara","doi":"10.1038/s41375-018-0217-7","elsevierAuthor":"Aihara H.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1"},{"title":"The NF1 hotspot in acute myeloid leukemia: what's in a name?","googleId":"wo9h0WZ8RNoJ","googleLink":"https://www.nature.com/articles/s41375-018-0266-y","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-018-0266-y","elsevierAuthor":"Vandepoele K.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1"},{"title":"Phosphatase PRL2 promotes AML1-ETO-induced acute myeloid leukemia","googleId":"Juo6Ye1bduEJ","googleLink":"https://www.nature.com/articles/leu201767","googleCitationCount":4,"googleAuthor":"S Chen","doi":"10.1038/leu.2017.67","elsevierAuthor":"Kobayashi M.","publicationName":"Leukemia","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"4"},{"title":"MDS with deletions in the long arm of chromosome 11 are associated with a high frequency of SF3B1 mutations","googleId":"AWnIgNh9lBEJ","googleLink":"https://www.nature.com/articles/leu2017180","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.180","elsevierAuthor":"Stengel A.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"2"},{"title":"An unusual, activating insertion/deletion MPL mutant in primary myelofibrosis","googleId":"Bx2CaSENAlgJ","googleLink":"https://www.nature.com/articles/leu2017153","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/leu.2017.153","elsevierAuthor":"Defour J.P.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"3"},{"title":"The C-terminal multimerization domain is essential for leukemia development by CBFβ-SMMHC in a mouse knockin model","googleId":"iVie0ClkFKIJ","googleLink":"https://www.nature.com/articles/leu2017262","googleCitationCount":2,"googleAuthor":"H Alkadi","doi":"10.1038/leu.2017.262","elsevierAuthor":"Zhao L.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"2"},{"title":"High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis","googleId":"23OLack7RUUJ","googleLink":"https://www.nature.com/articles/leu2017227","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/leu.2017.227","elsevierAuthor":"Kawabata K.C.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"2"},{"title":"Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia","googleId":"jRvtCuMcaS4J","googleLink":"https://www.nature.com/articles/leu2017290","googleCitationCount":2,"googleAuthor":"P van den Elzen","doi":"10.1038/leu.2017.290","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0"},{"title":"New drugs in myeloma: beware of phase I trial results, beware of cost and demand for new trials","googleId":"MOQtwsitM0cJ","googleLink":"https://www.nature.com/articles/leu2017188","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/leu.2017.188","elsevierAuthor":"Moreau P.","publicationName":"Leukemia","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"1 September 2017","elsevierCitationCount":"0"},{"title":"Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin","googleId":"ui_c0Lcv_2MJ","googleLink":"https://www.nature.com/articles/leu2016313","googleCitationCount":3,"googleAuthor":"TH Liu","doi":"10.1038/leu.2016.313","elsevierAuthor":"Liu T.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"1"},{"title":"Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2","googleId":"SCLnqsfYFD0J","googleLink":"https://www.nature.com/articles/s41375-018-0171-4","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/s41375-018-0171-4","elsevierAuthor":"Holmqvist A.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1"},{"title":"Cardiologist's perspective to the European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid …","googleId":"Utc_nIczNGsJ","googleLink":"https://www.nature.com/articles/leu2016336","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2016.336","elsevierAuthor":"Constance C.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1"},{"title":"MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling","googleId":"y-r7YOCba-EJ","googleLink":"https://www.nature.com/articles/s41375-018-0053-9","googleCitationCount":0,"googleAuthor":"F Pagano","doi":"10.1038/s41375-018-0053-9","elsevierAuthor":"Pagano F.","publicationName":"Leukemia","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"1 August 2018","elsevierCitationCount":"0"},{"title":"No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden","googleId":"e_kMNbN67NgJ","googleLink":"https://www.nature.com/articles/leu2017131","googleCitationCount":1,"googleAuthor":"M Höglund","doi":"10.1038/leu.2017.131","elsevierAuthor":"Gunnarsson N.","publicationName":"Leukemia","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"1"},{"title":"Application of the Filter approach and the Clustering algorithm on Cancer datasets","googleId":"IbBRGaHeknAJ","googleLink":"https://www.researchgate.net/profile/Sara_Haddou_Bouazza/publication/347447334_Application_of_the_Filter_approach_and_the_Clustering_algorithm_on_Cancer_datasets/links/5fdc8aaa299bf140881d1852/Application-of-the-Filter-approach-and-the-Clustering-algorithm-on-Cancer-datasets.pdf","googleCitationCount":1,"googleAuthor":"A ZEROUAL"},{"title":"Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia","googleId":"vLQnEVVyyvkJ","googleLink":"https://www.nature.com/articles/leu2016159","googleCitationCount":3,"googleAuthor":"T Velasco-Hernandez","doi":"10.1038/leu.2016.159","elsevierAuthor":"Jaako P.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"2"},{"title":"Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria","googleId":"bIQ855IoswEJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608183/","googleCitationCount":4,"googleAuthor":"","doi":"10.1038/leu.2016.291","elsevierAuthor":"","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1"},{"title":"(In) convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes","googleId":"O_4ZZMCflIkJ","googleLink":"https://www.nature.com/articles/s41375-018-0064-6","googleCitationCount":0,"googleAuthor":"X Calvo","doi":"10.1038/s41375-018-0064-6","elsevierAuthor":"Calvo X.","publicationName":"Leukemia","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"1 May 2018","elsevierCitationCount":"0"},{"title":"Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL","googleId":"UPnzP04udpMJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608364/","googleCitationCount":2,"googleAuthor":"","doi":"10.1038/s41375-018-0236-4","elsevierAuthor":"Prieto C.","publicationName":"Leukemia","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"2"},{"title":"The pattern of the M-protein in smoldering myeloma over the time: an evolving risk factor","googleId":"sLh0VBBz9f0J","googleLink":"https://www.nature.com/articles/s41375-018-0156-3","googleCitationCount":1,"googleAuthor":"CF de Larrea","doi":"10.1038/s41375-018-0156-3","elsevierAuthor":"Fernández de Larrea C.","publicationName":"Leukemia","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"1 September 2018","elsevierCitationCount":"1"},{"title":"Response to “Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions” by …","googleId":"kV1OaXuq3dIJ","googleLink":"https://www.nature.com/articles/s41375-018-0259-x","googleCitationCount":0,"googleAuthor":"F Passamonti","doi":"10.1038/s41375-018-0259-x","elsevierAuthor":"Barosi G.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0"},{"title":"Response to 'Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?'","googleId":"3owjBUDA55AJ","googleLink":"https://www.nature.com/articles/leu2016335","googleCitationCount":0,"googleAuthor":"LN Eadie","doi":"10.1038/leu.2016.335","elsevierAuthor":"Eadie L.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"0"},{"title":"Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma","googleId":"mRDkC8duuI8J","googleLink":"https://www.nature.com/articles/s41375-018-0235-5","googleCitationCount":0,"googleAuthor":"CC Hofmeister","doi":"10.1038/s41375-018-0235-5","elsevierAuthor":"Richardson P.","publicationName":"Leukemia","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"1 October 2018","elsevierCitationCount":"0"},{"title":"The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib","googleId":"drqFKNc52LIJ","googleLink":"https://www.nature.com/articles/leu2016269","googleCitationCount":1,"googleAuthor":"CT Quang","doi":"10.1038/leu.2016.269","elsevierAuthor":"Rocchetti F.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"1"},{"title":"Reply to Goel et al.'TP53 mutation allele-burden and disease outcome in MDS/AML'","googleId":"HYR0NgpxyjYJ","googleLink":"https://www.nature.com/articles/leu2016257","googleCitationCount":2,"googleAuthor":"E Padron","doi":"10.1038/leu.2016.257","elsevierAuthor":"Sallman D.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1"},{"title":"Bone Marrow Study is Still Gold Standard In Evaluation Of Peripheral Pancytopenia","googleId":"dFi8OP_O4AoJ","googleLink":"https://www.academia.edu/download/56845654/F1701083342.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Reply to Constance et al.","googleId":"1czXTJI7bkcJ","googleLink":"https://www.nature.com/articles/leu2016337","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/leu.2016.337","elsevierAuthor":"Steegmann J.L.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"0"},{"title":"So-called “blast phase” of chronic myelomonocytic leukemia: a plea for uniform terminology","googleId":"TF6oTmReRZoJ","googleLink":"https://www.nature.com/articles/s41375-018-0186-x","googleCitationCount":0,"googleAuthor":"E Margolskee","doi":"10.1038/s41375-018-0186-x","elsevierAuthor":"Margolskee E.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"1"},{"title":"NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib","googleId":"h8cCUzYYPNoJ","googleLink":"https://www.nature.com/articles/leu2017235","googleCitationCount":1,"googleAuthor":"S Mustjoki","doi":"10.1038/leu.2017.235","elsevierAuthor":"Sopper S.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"2"},{"title":"Role of absolute reticulocyte count (ARC) in assessment of pancytopenia in patients undergoing bone marrow biopsy","googleId":"zgQ-VUmJSmEJ","googleLink":"https://www.researchgate.net/profile/Shahzad_Ali_Jiskani/publication/342550543_Role_of_Absolute_Reticulocyte_Count_in_Pancytopenia_in_Patients_Undergoing_Bone_Marrow_Biopsy/links/5efafa42a6fdcc4ca43d9fcd/Role-of-Absolute-Reticulocyte-Count-in-Pancytopenia-in-Patients-Undergoing-Bone-Marrow-Biopsy.pdf","googleCitationCount":0,"googleAuthor":"SA Jiskani"},{"title":"The expression of P2Y14, a purinergic G-protein coupled receptor, defines functionally distinct subpopulations in placenta-derived hematopoietic stem progenitor cells","googleId":"LmAmWazIRlUJ","googleLink":"https://www.nature.com/articles/leu2017254","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/leu.2017.254","elsevierAuthor":"Kook S.H.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"2017","elsevierCitationCount":"1"},{"title":"Intrapatient functional clonality deconvoluted by coupling intracellular flow cytometry and next-generation sequencing in human leukemia","googleId":"BvhdZZrMpb8J","googleLink":"https://www.nature.com/articles/leu2017184","googleCitationCount":0,"googleAuthor":"Q Zhang","doi":"10.1038/leu.2017.184","elsevierAuthor":"Zhang Q.","publicationName":"Leukemia","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"1 February 2018","elsevierCitationCount":"0"},{"title":"A Pilot study of different doses of Ibrutinib in patients with Chronic Lymphocytic Leukemia 2016-0226","googleId":"tWuZckf-yMkJ","googleLink":"https://www.clinicaltrials.gov/ProvidedDocs/78/NCT02801578/Prot_SAP_000.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Correction: Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis","googleId":"KmhtdK93IqUJ","googleLink":"https://www.nature.com/articles/s41375-018-0237-3","googleCitationCount":0,"googleAuthor":"T Maekawa","doi":"10.1038/s41375-018-0237-3","elsevierAuthor":"Maekawa T.","publicationName":"Leukemia","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"1 December 2018","elsevierCitationCount":"0"},{"title":"Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo","googleId":"hfbJfE2HbYkJ","googleLink":"https://www.nature.com/articles/leu2017114","googleCitationCount":3,"googleAuthor":"","doi":"10.1038/leu.2017.114","elsevierAuthor":"Yokota A.","publicationName":"Leukemia","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"1 December 2017","elsevierCitationCount":"3"},{"title":"Response to Harrison et al.'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'","googleId":"ZzCDgsy0Hn4J","googleLink":"https://www.nature.com/articles/leu2016319","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/leu.2016.319","elsevierAuthor":"Gisslinger H.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"0"},{"title":"Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used (epub ahead of print)","googleId":"IyKlhdZYDEgJ","googleLink":"https://lirias.kuleuven.be/retrieve/485462","googleCitationCount":1,"googleAuthor":"M Delforge","doi":"10.1038/leu.2017.335","elsevierCitationCount":0},{"title":"Package 'plsgenomics'","googleId":"B3LjmTBKScwJ","googleLink":"https://pbil.univ-lyon1.fr/CRAN/web/packages/plsgenomics/plsgenomics.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"The assembly competence domain is essential for inv (16)-associated acute myeloid leukemia","googleId":"9gaEtVAxO6kJ","googleLink":"https://www.nature.com/articles/leu2017236","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/leu.2017.236","elsevierAuthor":"Kim H.G.","publicationName":"Leukemia","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"1 October 2017","elsevierCitationCount":"1"},{"title":"Microbiology of Acute Rhinosinusitis in Immunosuppressed Patients","googleId":"La3KvcQA6EAJ","googleLink":"https://www.researchgate.net/profile/John_Greene7/publication/317933996_Microbiology_of_Acute_Rhinosinusitis_in_Immunosuppressed_Patients/links/599ec363aca272dff134dc16/Microbiology-of-Acute-Rhinosinusitis-in-Immunosuppressed-Patients.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Practice Corner","googleId":"_WJpvrdOMgUJ","googleLink":"https://aphon.org/UPLOADS/Education/APHON_Counts/counts_ref_summer18.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION: EBMT DATA MANAGEMENT GROUP—POSTER SESSION (P739–P749)","googleId":"e3RXwdxjjj8J","googleLink":"https://www.nature.com/bmt/journal/v52/n1s/pdf/bmt2017137a.pdf?origin=ppub","googleCitationCount":0,"googleAuthor":""},{"title":"Gender differences in disease characteristics and biologic treatment outcomes in 1750","googleId":"Mcc-wnpoMVgJ","googleLink":"http://www.parkerinst.dk/sites/default/files/gender_differences_in_tnfi_outcomes_among_patients_with_psoriatic_arthritis_a_registry_study_protocol.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic …","googleId":"ZbrfzWkoSK0J","googleLink":"https://biblio.ugent.be/publication/8664266/file/8664268","googleCitationCount":0,"googleAuthor":"S Demeyer"},{"title":"International Journal of Medical and Health Sciences","googleId":"93s51WJd3zAJ","googleLink":"https://www.academia.edu/download/51985864/paper.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Nudges for Privacy and Security: Understanding and Assisting Users' Choices Online ACM Reference Format","googleId":"jMoK1yuvZOQJ","googleLink":"https://pennstate.pure.elsevier.com/en/publications/nudges-for-privacy-and-security-understanding-and-assisting-users","googleCitationCount":0,"googleAuthor":"A Acquisti","doi":"10.1145/3054926","elsevierAuthor":"Acquisti A.","publicationName":"ACM Computing Surveys","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"102"},{"title":"Quantum Chemical Insight into the Adsorption Mechanisms of Troxacitabine onto Functionalized Carbon Nanotubes","googleId":"Kms92TiK5FgJ","googleLink":"https://www.researchgate.net/profile/Ali_Morsali2/publication/328267941_Quantum_chemical_insight_into_the_adsorption_mechanisms_of_troxacitabine_onto_functionalized_carbon_nanotubes/links/5c3522c0458515a4c71771ff/Quantum-chemical-insight-into-the-adsorption-mechanisms-of-troxacitabine-onto-functionalized-carbon-nanotubes.pdf","googleCitationCount":0,"googleAuthor":""},{"title":"Johannes Joseph van Rood Pioneer in immuno-genetics (7 April 1926–21 July 2017)","googleId":"5oG74d9FtOsJ","googleLink":"https://www.nature.com/articles/leu2017278","googleCitationCount":0,"googleAuthor":"RP Gale","doi":"10.1038/leu.2017.278","elsevierAuthor":"Fibbe W.","publicationName":"Leukemia","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"1 November 2017","elsevierCitationCount":"0"},{"title":"Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential","googleId":"Jp2X5Yyj6yQJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/29891936/","googleCitationCount":0,"googleAuthor":"","doi":"10.1038/s41375-018-0172-3,","elsevierAuthor":"Mokhtari S.","publicationName":"Leukemia","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"1 July 2018","elsevierCitationCount":"0"},{"title":"Responses to pomalidomide and placebo in myelofibrosis-related anaemia","googleId":"0Azn7oe634oJ","googleLink":"https://www.nature.com/articles/leu2016348","googleCitationCount":1,"googleAuthor":"DM Ross","doi":"10.1038/leu.2016.348","elsevierAuthor":"Ross D.","publicationName":"Leukemia","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"1"},{"title":"The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia","googleId":"KegB8W6POe8J","googleLink":"https://www.nature.com/articles/leu2017308","googleCitationCount":0,"googleAuthor":"B Said","doi":"10.1038/leu.2017.308","elsevierAuthor":"Said B.","publicationName":"Leukemia","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"1 April 2018","elsevierCitationCount":"0"},{"title":"Expansion of Th 1-like Vγ 9 Vδ 2 T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid","googleId":"ZGwx8dHB7IkJ","googleLink":"https://www.nature.com/articles/leu2016273","googleCitationCount":1,"googleAuthor":"","doi":"10.1038/leu.2016.273","elsevierAuthor":"Harada T.","publicationName":"Leukemia","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"1"},{"title":"Recently approved therapies in acute myeloid leukemia: a complex treatment landscape","googleId":"m6aDAPti3SgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302078","googleCitationCount":39,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.001","elsevierAuthor":"Talati C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"28"},{"title":"Current approach to the treatment of chronic myeloid leukaemia","googleId":"_jfdROuauEoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730005X","googleCitationCount":55,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.005","elsevierAuthor":"Pasic I.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"32"},{"title":"The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia","googleId":"m8eJUv3QUsQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306185","googleCitationCount":34,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.009","elsevierAuthor":"Zhao H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"29"},{"title":"Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo","googleId":"19-1xp6IRw8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305222","googleCitationCount":36,"googleAuthor":"J Laloy","doi":"10.1016/j.leukres.2017.09.014","elsevierAuthor":"Bouvy C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"22"},{"title":"Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML","googleId":"nr3qCi7FQjwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304228","googleCitationCount":40,"googleAuthor":"E Hadzijusufovic","doi":"10.1016/j.leukres.2017.05.008","elsevierAuthor":"Valent P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"28"},{"title":"Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years","googleId":"RS6sZXgSulsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300462","googleCitationCount":38,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.033","elsevierAuthor":"Lyons R.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"22"},{"title":"Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia","googleId":"_DEcXrnG4McJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300383","googleCitationCount":37,"googleAuthor":"JL Patel","doi":"10.1016/j.leukres.2017.01.027","elsevierAuthor":"Patel J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"31"},{"title":"8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms","googleId":"XvIyFSXJheEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300195","googleCitationCount":25,"googleAuthor":"Z Tang","doi":"10.1016/j.leukres.2018.01.013","elsevierAuthor":"Boddu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"22"},{"title":"Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group …","googleId":"sbPZIT5_IBAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300067","googleCitationCount":26,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.008","elsevierAuthor":"Harada Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"21"},{"title":"Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis","googleId":"FSsQTcjr6IAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304460","googleCitationCount":33,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.001","elsevierAuthor":"Masarova L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"27"},{"title":"Extracellular vesicles in leukemia","googleId":"FxLhYVtkwGEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305970","googleCitationCount":23,"googleAuthor":"JL Reagan","doi":"10.1016/j.leukres.2017.11.011","elsevierAuthor":"Pando A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"17"},{"title":"Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome","googleId":"gFtHxRbiCa8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305684","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.015","elsevierAuthor":"Shirahata-Adachi M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"15"},{"title":"Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia","googleId":"AnDbsidSQpIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305209","googleCitationCount":22,"googleAuthor":"P Bhatia","doi":"10.1016/j.leukres.2017.09.012","elsevierAuthor":"Singh M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"15"},{"title":"Bortezomib in plasmablastic lymphoma: a glimpse of hope for a hard-to-treat disease","googleId":"hEOiH5_IqpAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305283","googleCitationCount":23,"googleAuthor":"JJ Castillo","doi":"10.1016/j.leukres.2017.09.020","elsevierAuthor":"Guerrero-Garcia T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"17"},{"title":"A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease","googleId":"Y9-LBHLJw5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302480","googleCitationCount":16,"googleAuthor":"L Hazlehurst","doi":"10.1016/j.leukres.2018.10.002","elsevierAuthor":"Sweet K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"15"},{"title":"PD-1/PD-L1 checkpoint in hematological malignancies","googleId":"1OZ9xp2cyRMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300201","googleCitationCount":21,"googleAuthor":"O Annibali","doi":"10.1016/j.leukres.2018.01.014","elsevierAuthor":"Annibali O.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"14"},{"title":"Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events","googleId":"gvVKbxKgX90J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302121","googleCitationCount":15,"googleAuthor":"Z Tang","doi":"10.1016/j.leukres.2018.09.006","elsevierAuthor":"Tang Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"13"},{"title":"Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic …","googleId":"ZPRpClES9jgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301000","googleCitationCount":21,"googleAuthor":"CK Kontos","doi":"10.1016/j.leukres.2018.04.014","elsevierAuthor":"Papageorgiou S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"14"},{"title":"Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic …","googleId":"FbJ80Qbod_wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301498","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.005","elsevierAuthor":"Sommer S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"12"},{"title":"High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features …","googleId":"YDMCy-BTfSwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304344","googleCitationCount":22,"googleAuthor":"L Magnano","doi":"10.1016/j.leukres.2017.05.014","elsevierAuthor":"Dlouhy I.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"19"},{"title":"Subcellular localization of the FLT3-ITD oncogene plays a significant role in the production of NOX-and p22phox-derived reactive oxygen species in acute myeloid …","googleId":"jse4zQT-ybcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302466","googleCitationCount":27,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.006","elsevierAuthor":"Moloney J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"14"},{"title":"High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation","googleId":"9URnf4Z9aJIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301024","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.016","elsevierAuthor":"Iovino L.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"17"},{"title":"Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey","googleId":"fMXWO6ssmRgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302661","googleCitationCount":26,"googleAuthor":"A Candoni","doi":"10.1016/j.leukres.2016.12.003","elsevierAuthor":"Lazzarotto D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22"},{"title":"Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia","googleId":"G0SmM0PT7nEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306148","googleCitationCount":22,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.010","elsevierAuthor":"Millan N.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"15"},{"title":"Pegylated interferon alpha–2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial","googleId":"kuVbZT8DrhcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300085","googleCitationCount":24,"googleAuthor":"T Jain","doi":"10.1016/j.leukres.2017.01.006","elsevierAuthor":"Gowin K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"14"},{"title":"Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy","googleId":"7h19MUaZIjAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304964","googleCitationCount":20,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.015","elsevierAuthor":"Comont T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"11"},{"title":"Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma","googleId":"hnhYJKvU58IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301607","googleCitationCount":16,"googleAuthor":"T Radivoyevitch","doi":"10.1016/j.leukres.2018.07.016","elsevierAuthor":"Radivoyevitch T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"9"},{"title":"Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts","googleId":"Z7jERiOXn4cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301541","googleCitationCount":16,"googleAuthor":"AA Mangaonkar","doi":"10.1016/j.leukres.2018.07.010","elsevierAuthor":"Mangaonkar A.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"8"},{"title":"A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)","googleId":"oBV04NTlxRkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302612","googleCitationCount":25,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.015","elsevierAuthor":"Mascarenhas J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"22"},{"title":"Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia","googleId":"JKWvtg6oiRgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305131","googleCitationCount":22,"googleAuthor":"JA Webster","doi":"10.1016/j.leukres.2017.09.005","elsevierAuthor":"Webster J.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"18"},{"title":"Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study","googleId":"U0v2224EeCgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830016X","googleCitationCount":18,"googleAuthor":"Y Najima","doi":"10.1016/j.leukres.2018.01.010","elsevierAuthor":"Najima Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"12"},{"title":"Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms","googleId":"ZDXZ0GqCEmQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301371","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2018.06.014","elsevierAuthor":"Berdeja J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"17"},{"title":"A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia","googleId":"4v7hWvaNVLEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305842","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.006","elsevierAuthor":"Navada S.C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"14"},{"title":"Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7+ 3) in newly …","googleId":"k6n3E-wkibAJ","googleLink":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7169946/","googleCitationCount":14,"googleAuthor":"JF Zeidner"},{"title":"A phase 1 study of the Janus kinase 2 (JAK2) V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential …","googleId":"MNs2Sk5_0BwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304915","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.010","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"16"},{"title":"Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study","googleId":"AZVRqVmgfIYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305866","googleCitationCount":29,"googleAuthor":"D Azzam","doi":"10.1016/j.leukres.2017.11.008","elsevierAuthor":"Swords R.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"23"},{"title":"Immunotherapy in adult acute leukemia","googleId":"oAG0_z5PzHgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304642","googleCitationCount":18,"googleAuthor":"S Blum","doi":"10.1016/j.leukres.2017.06.011","elsevierAuthor":"Blum S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"14"},{"title":"Iron overload in myelodysplastic syndromes: evidence based guidelines from the Canadian consortium on MDS","googleId":"P_yCbEB3QvgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830211X","googleCitationCount":10,"googleAuthor":"R Buckstein","doi":"10.1016/j.leukres.2018.09.005","elsevierAuthor":"Leitch H.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"8"},{"title":"An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function","googleId":"8Xhq4yKjXBEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302248","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.017","elsevierAuthor":"Maimaitili Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7"},{"title":"Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology","googleId":"Hspu98DLGEkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730111X","googleCitationCount":18,"googleAuthor":"P Guglielmelli","doi":"10.1016/j.leukres.2017.04.006","elsevierAuthor":"Guglielmelli P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"10"},{"title":"Telomerase and telomere biology in hematological diseases: A new therapeutic target","googleId":"fZD-VOncqGQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300486","googleCitationCount":18,"googleAuthor":"V Innao","doi":"10.1016/j.leukres.2017.02.002","elsevierAuthor":"Allegra A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11"},{"title":"Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections …","googleId":"N37qZMkQRLsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830033X","googleCitationCount":16,"googleAuthor":"CAC Wong","doi":"10.1016/j.leukres.2018.02.005","elsevierAuthor":"Wong C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"12"},{"title":"Interpretation of clinical endpoints in trials of acute myeloid leukemia","googleId":"OMnYbUDQdr8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300304","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.002","elsevierAuthor":"Medeiros B.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10"},{"title":"Living with the burden of relapse in multiple myeloma from the patient and physician perspective","googleId":"5JgBHFgQ01YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304411","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.019","elsevierAuthor":"Hulin C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"9"},{"title":"Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy","googleId":"VVhNRwfvAuQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302236","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.018","elsevierAuthor":"Bonifacio M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5"},{"title":"The rising prevalence of chronic myeloid leukemia in France","googleId":"hhaPUlAtBnEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300948","googleCitationCount":15,"googleAuthor":"M Delord","doi":"10.1016/j.leukres.2018.04.008","elsevierAuthor":"Delord M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7"},{"title":"Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma","googleId":"eKB6hbOycQsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301085","googleCitationCount":18,"googleAuthor":"M Ahmadvand","doi":"10.1016/j.leukres.2018.05.006","elsevierAuthor":"Ahmadvand M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"16"},{"title":"A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia","googleId":"bSjTMuPw-hsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304162","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.002","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"14"},{"title":"New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): characteristics of refined MDS types","googleId":"Z17P_goDpLQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300644","googleCitationCount":21,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.008","elsevierAuthor":"Strupp C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"15"},{"title":"Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome","googleId":"a3uN3BfsW6QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617301108","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.04.005","elsevierAuthor":"Zheng Q.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"17"},{"title":"Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: faster immune reconstitution using younger donors","googleId":"oFsz3G5YIgwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730070X","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.03.001","elsevierAuthor":"González-Vicent M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14"},{"title":"Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia","googleId":"Iz3QkUsdxVUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306173","googleCitationCount":13,"googleAuthor":"M Byrne","doi":"10.1016/j.leukres.2017.12.012","elsevierAuthor":"Strickland S.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"6"},{"title":"Incorporating newer agents in the treatment of acute myeloid leukemia","googleId":"6K4Dm5ifWLcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304429","googleCitationCount":8,"googleAuthor":"RV Raj","doi":"10.1016/j.leukres.2018.10.008","elsevierAuthor":"Raj R.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6"},{"title":"Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway","googleId":"yPtR8g_EZREJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300742","googleCitationCount":13,"googleAuthor":"CF Lam","doi":"10.1016/j.leukres.2018.03.012","elsevierAuthor":"Lam C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"10"},{"title":"5′-Triphosphate siRNA targeting MDR1 reverses multi-drug resistance and activates RIG-I-induced immune-stimulatory and apoptotic effects against human myeloid …","googleId":"7rO0ZzBX8wIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300863","googleCitationCount":19,"googleAuthor":"RP Gale","doi":"10.1016/j.leukres.2017.03.010","elsevierAuthor":"Li D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"16"},{"title":"Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells","googleId":"VKNyVeP9AGAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305234","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.015","elsevierAuthor":"Huang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12"},{"title":"The BCR/ABL tyrosine kinase inhibitor, nilotinib, stimulates expression of IL-1β in vascular endothelium in association with downregulation of miR-3p","googleId":"tlvAFXo4r5EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304198","googleCitationCount":19,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.005","elsevierAuthor":"Sukegawa M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"11"},{"title":"Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view","googleId":"wLqqWjusOJkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300316","googleCitationCount":13,"googleAuthor":"F Kouhkan","doi":"10.1016/j.leukres.2018.02.003","elsevierAuthor":"Shokri G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"11"},{"title":"Towards repositioning of quinacrine for treatment of acute myeloid leukemia–Promising synergies and in vivo effects","googleId":"2onQvm9PRx4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305659","googleCitationCount":13,"googleAuthor":"J Gullbo","doi":"10.1016/j.leukres.2017.10.012","elsevierAuthor":"Eriksson A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"10"},{"title":"Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells","googleId":"-b72QG0RzisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305374","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.022","elsevierAuthor":"Tan M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12"},{"title":"Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia","googleId":"xeVYNP1PeoEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300298","googleCitationCount":12,"googleAuthor":"N Tosic","doi":"10.1016/j.leukres.2018.02.001","elsevierAuthor":"Tosic N.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"8"},{"title":"Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells","googleId":"H0lh1G7Ih4EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304605","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.007","elsevierAuthor":"Chen L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"15"},{"title":"Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes","googleId":"R_kfM5otdm0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305386","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.001","elsevierAuthor":"Angelucci E.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"9"},{"title":"Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: a …","googleId":"1yb9uMLvPGsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304648","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2018.11.003","elsevierAuthor":"Itonaga H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"8"},{"title":"Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway","googleId":"JFh_0f3jlQ8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300821","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.004","elsevierAuthor":"Grohmann T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"8"},{"title":"Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary …","googleId":"v85h5vjnb_QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300371","googleCitationCount":16,"googleAuthor":"G Zhang","doi":"10.1016/j.leukres.2017.01.026","elsevierAuthor":"Yao J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"10"},{"title":"CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia","googleId":"ap67V_da1H0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301784","googleCitationCount":12,"googleAuthor":"G Garcia-Manero","doi":"10.1016/j.leukres.2018.08.001","elsevierAuthor":"Garcia-Manero G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8"},{"title":"Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study","googleId":"-Luuz8Vk_ukJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304314","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.10.006","elsevierAuthor":"Birgegård G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6"},{"title":"Management of melanoma in patients with chronic lymphocytic leukemia","googleId":"044hmuSwqwAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301474","googleCitationCount":11,"googleAuthor":"WJ Archibald","doi":"10.1016/j.leukres.2018.07.003","elsevierAuthor":"Archibald W.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"9"},{"title":"The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma","googleId":"y7JsFV0nc8QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300061","googleCitationCount":18,"googleAuthor":"N Burwick","doi":"10.1016/j.leukres.2017.01.007","elsevierAuthor":"Burwick N.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-04-01","elsevierCoverDisplayDate":"1 April 2017","elsevierCitationCount":"12"},{"title":"Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia","googleId":"V2i9k1GoTggJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301899","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.009","elsevierAuthor":"Chen X.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"7"},{"title":"Prognostic importance of Aurora Kinases and mitotic spindle genes transcript levels in Myelodysplastic syndrome","googleId":"kjNxK2VgXwYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305994","googleCitationCount":13,"googleAuthor":"CRK Paier","doi":"10.1016/j.leukres.2017.11.013","elsevierAuthor":"Borges D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7"},{"title":"The FOSSIL Study: FLAG or standard 7+ 3 induction therapy in secondary acute myeloid leukemia","googleId":"JlYPCLmD7OoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301139","googleCitationCount":13,"googleAuthor":"AJ Perissinotti","doi":"10.1016/j.leukres.2018.05.011","elsevierAuthor":"Vulaj V.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"9"},{"title":"Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosis","googleId":"smtwrOwJ-dgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304587","googleCitationCount":24,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.005","elsevierAuthor":"Gowin K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"18"},{"title":"Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia","googleId":"buc9DOODh3sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300225","googleCitationCount":11,"googleAuthor":"J Petiti","doi":"10.1016/j.leukres.2018.01.016","elsevierAuthor":"Petiti J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6"},{"title":"Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML","googleId":"Ml8_pEJYfb0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730601X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.002","elsevierAuthor":"Schuler E.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"7"},{"title":"Independent prognostic significance of monosomy 17 and impact of karyotype complexity in monosomal karyotype/complex karyotype acute myeloid leukemia: results …","googleId":"UgIMSNwBe8sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304241","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.010","elsevierAuthor":"Strickland S.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"12"},{"title":"IRF4 in multiple myeloma—biology, disease and therapeutic target","googleId":"WgIUJh6QHOgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301772","googleCitationCount":11,"googleAuthor":"EJ Mancini","doi":"10.1016/j.leukres.2018.07.025","elsevierAuthor":"Agnarelli A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"8"},{"title":"Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in myeloma","googleId":"9Mf0N2zwMdIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301590","googleCitationCount":11,"googleAuthor":"DA Salem","doi":"10.1016/j.leukres.2018.07.015","elsevierAuthor":"Salem D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"11"},{"title":"DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia","googleId":"FXYGmTmzz6EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304976","googleCitationCount":12,"googleAuthor":"S Younesian","doi":"10.1016/j.leukres.2017.08.016","elsevierAuthor":"Younesian S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"8"},{"title":"Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: a retrospective cohort study","googleId":"-8cJgnwwSHMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304897","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.008","elsevierAuthor":"Frairia C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"10"},{"title":"Pediatric acute lymphoblastic leukemia—Conquering the CNS across the choroid plexus","googleId":"iHgCFh_i_MMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301450","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.001","elsevierAuthor":"März M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"7"},{"title":"Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma","googleId":"HorG2W9kupgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730526X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.018","elsevierAuthor":"Guidetti A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"8"},{"title":"Recent advances in the genomics and therapy of BCR/ABL1-positive and-negative chronic myeloproliferative neoplasms","googleId":"KbvPTJDHvAkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300432","googleCitationCount":10,"googleAuthor":"S Koschmieder","doi":"10.1016/j.leukres.2018.02.008","elsevierAuthor":"Mughal T.I.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"5"},{"title":"Outcomes and predictors of survival in blast phase myeloproliferative neoplasms","googleId":"4VoTxDaCjxUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301061","googleCitationCount":13,"googleAuthor":"A Brunner","doi":"10.1016/j.leukres.2018.05.004","elsevierAuthor":"Lancman G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"11"},{"title":"Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia","googleId":"sEytDrjLXQ4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304216","googleCitationCount":15,"googleAuthor":"B Kumar","doi":"10.1016/j.leukres.2017.05.007","elsevierAuthor":"Kumar B.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"12"},{"title":"Global methylation patterns in primary plasma cell leukemia","googleId":"dukP8YkAI1oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302133","googleCitationCount":7,"googleAuthor":"V Simeon","doi":"10.1016/j.leukres.2018.09.007","elsevierAuthor":"Todoerti K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"6"},{"title":"Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-κB signaling","googleId":"MTQXCFIL8HUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304678","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.002","elsevierAuthor":"Yang H.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"12"},{"title":"Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias","googleId":"0M9QIZnLDuUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300942","googleCitationCount":16,"googleAuthor":"C Weiss","doi":"10.1016/j.leukres.2017.03.011","elsevierAuthor":"Popp H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"14"},{"title":"mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia","googleId":"2cgcg2wAk7oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302600","googleCitationCount":16,"googleAuthor":"CK Kontos","doi":"10.1016/j.leukres.2016.11.014","elsevierAuthor":"Kontos C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"11"},{"title":"Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years","googleId":"My3v_CscrtYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302636","googleCitationCount":17,"googleAuthor":"","doi":"10.1016/j.leukres.2016.12.001","elsevierAuthor":"Heini A.D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"11"},{"title":"Incidence and survival of therapy related myeloid neoplasm in United States","googleId":"B6WVANX_ZrkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301577","googleCitationCount":12,"googleAuthor":"GSG Murthy","doi":"10.1016/j.leukres.2018.07.013","elsevierAuthor":"Guru Murthy G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"9"},{"title":"Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell …","googleId":"6DJNsu1FedwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300262","googleCitationCount":12,"googleAuthor":"Y Imai","doi":"10.1016/j.leukres.2018.01.020","elsevierAuthor":"Wang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"8"},{"title":"Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","googleId":"AXKWsf8NwFwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617301005","googleCitationCount":15,"googleAuthor":"","doi":"10.1016/j.leukres.2017.04.003","elsevierAuthor":"Medinger M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"10"},{"title":"Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia","googleId":"tDOWCIk-2xMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304691","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.004","elsevierAuthor":"Mpakou V.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"7"},{"title":"Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by Multiplex Ligation-dependent Probe Amplification (MLPA)","googleId":"7OanHp8U3J8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304447","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.022","elsevierAuthor":"Vázquez-Reyes A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"8"},{"title":"CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation","googleId":"RvH5zrNQbecJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302648","googleCitationCount":16,"googleAuthor":"","doi":"10.1016/j.leukres.2016.12.002","elsevierAuthor":"Gordon M.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"16"},{"title":"Association between health literacy, communication and psychological distress among myelodysplastic syndromes patients","googleId":"Ug8xvJG29nYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301875","googleCitationCount":7,"googleAuthor":"PN Butow","doi":"10.1016/j.leukres.2018.08.020","elsevierAuthor":"Ousseine Y.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4"},{"title":"Targeting autophagy in multiple myeloma","googleId":"jSUBvcDN03MJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304472","googleCitationCount":17,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.002","elsevierAuthor":"Yun Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"11"},{"title":"Genomic analysis of adult B-ALL identifies potential markers of shorter survival","googleId":"m7yGv-Ypp2sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300450","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.034","elsevierAuthor":"Patel S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"6"},{"title":"Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia","googleId":"NM6UETkymFEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301930","googleCitationCount":7,"googleAuthor":"CA Hudson","doi":"10.1016/j.leukres.2018.08.015","elsevierAuthor":"Hudson C.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"7"},{"title":"Therapeutic drug monitoring of ponatinib using a simple high-performance liquid chromatography method in Japanese patients","googleId":"2X3fXy9JUsEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305982","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.012","elsevierAuthor":"Abumiya M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"9"},{"title":"Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemia","googleId":"7c63yzLiQRgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305362","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.021","elsevierAuthor":"Henkenius K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"8"},{"title":"Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms","googleId":"m_Rb-IiyVWMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306100","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.005","elsevierAuthor":"Gángó A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"5"},{"title":"Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous …","googleId":"fqcldGcroyIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300274","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.021","elsevierAuthor":"Advani A.S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6"},{"title":"Tetraploidy/near-tetraploidy acute myeloid leukemia","googleId":"tl1Cs33MopAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302624","googleCitationCount":14,"googleAuthor":"S Li","doi":"10.1016/j.leukres.2016.11.016","elsevierAuthor":"Huang L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"8"},{"title":"Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia","googleId":"O_MDs9amzRwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300997","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.013","elsevierAuthor":"Tan Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4"},{"title":"Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: a single-center experience","googleId":"cPJfhgN8sK4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300158","googleCitationCount":11,"googleAuthor":"BR Dholaria","doi":"10.1016/j.leukres.2018.01.009","elsevierAuthor":"Dholaria B.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"5"},{"title":"NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells","googleId":"4HkG_nbhdSUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302224","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.09.016","elsevierAuthor":"Hishiki K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"6"},{"title":"The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia","googleId":"RRBLaUGYbgUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305878","googleCitationCount":10,"googleAuthor":"H Jiang","doi":"10.1016/j.leukres.2017.11.009","elsevierAuthor":"Zhu H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"10"},{"title":"Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by …","googleId":"rsudcKEBT1EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304721","googleCitationCount":12,"googleAuthor":"K Tarte","doi":"10.1016/j.leukres.2017.07.007","elsevierAuthor":"Aggoune D.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"8"},{"title":"Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia","googleId":"JKO6sUR0P0oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730067X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.011","elsevierAuthor":"Mauro F.R.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"11"},{"title":"Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with …","googleId":"f4uGYzGuBKoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730615X","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.013","elsevierAuthor":"Burke P.W.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"7"},{"title":"Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute …","googleId":"R4-XAujtnq4J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300043","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.004","elsevierAuthor":"Wang S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"9"},{"title":"Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia","googleId":"84IMtgDdkssJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300663","googleCitationCount":10,"googleAuthor":"EJ Choi","doi":"10.1016/j.leukres.2018.03.006","elsevierAuthor":"Choi E.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"8"},{"title":"Primary plasma cell leukemia in the era of novel agents for myeloma–a multicenter retrospective analysis of outcome","googleId":"9qrPplk3Js8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300456","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.010","elsevierAuthor":"Ganzel C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"6"},{"title":"Comparative study of porcine anti-human lymphocyte immunoglobulin and rabbit anti-human thymocyte immunoglobulin as a first-line treatment of acquired severe …","googleId":"Z_3KcUlus7oJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300018","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.001","elsevierAuthor":"Chen M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"7"},{"title":"High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients","googleId":"zN2qI13wvdkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300991","googleCitationCount":13,"googleAuthor":"M Tiribelli","doi":"10.1016/j.leukres.2017.04.001","elsevierAuthor":"Tiribelli M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"7"},{"title":"Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line","googleId":"jYXEoDT7ZdMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302157","googleCitationCount":5,"googleAuthor":"K Podshivalova","doi":"10.1016/j.leukres.2018.09.009","elsevierAuthor":"Podshivalova K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4"},{"title":"Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy","googleId":"pwt4d6bPUUgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300449","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.032","elsevierAuthor":"Verstovsek S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"11"},{"title":"A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual …","googleId":"1kPqwtumtt8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730423X","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.009","elsevierAuthor":"Duan M.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"8"},{"title":"Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group","googleId":"aNS2CArliTMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300036","googleCitationCount":13,"googleAuthor":"M Ishikawa","doi":"10.1016/j.leukres.2017.01.003","elsevierAuthor":"Iriyama N.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"8"},{"title":"Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of …","googleId":"k8efu4bMqgQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304563","googleCitationCount":18,"googleAuthor":"","doi":"10.1016/j.leukres.2017.06.004","elsevierAuthor":"Barosi G.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"13"},{"title":"Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine","googleId":"n3xXI_TPWWoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305829","googleCitationCount":9,"googleAuthor":"CC Porter","doi":"10.1016/j.leukres.2017.11.004","elsevierAuthor":"Garcia T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"8"},{"title":"Synergistic antitumor effect of histone deacetylase inhibitor and Doxorubicin in peripheral T-cell lymphoma","googleId":"nczUR3nVOwsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730036X","googleCitationCount":12,"googleAuthor":"H Zhang","doi":"10.1016/j.leukres.2017.01.025","elsevierAuthor":"Zhang H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"10"},{"title":"Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk","googleId":"vmDrl9-Mc5AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300651","googleCitationCount":9,"googleAuthor":"MW Schoen","doi":"10.1016/j.leukres.2018.03.005","elsevierAuthor":"Schoen M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5"},{"title":"High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones","googleId":"F7nd0tonkvIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302491","googleCitationCount":14,"googleAuthor":"M Giraud","doi":"10.1016/j.leukres.2016.11.009","elsevierAuthor":"Salson M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"9"},{"title":"Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis","googleId":"wG3wwnMBelYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300966","googleCitationCount":11,"googleAuthor":"","doi":"10.1016/j.leukres.2017.03.013","elsevierAuthor":"Guo Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"7"},{"title":"Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical …","googleId":"0HUXAI-bhisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302442","googleCitationCount":13,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.004","elsevierAuthor":"Drusbosky L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"12"},{"title":"Survival outcomes in iron chelated and non-chelated patients with lower-risk myelodysplastic syndromes: review and pooled analysis of observational studies","googleId":"Ms5QW61B1oUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/28343141/","googleCitationCount":13,"googleAuthor":"M Al Yami","doi":"10.1016/j.leukres.2017.03.007,","elsevierAuthor":"Abraham I.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"8"},{"title":"Expression of autophagy related genes in chronic lymphocytic leukemia is associated with disease course","googleId":"l84wFWKBQbUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306136","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2017.12.007","elsevierAuthor":"Kong Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6"},{"title":"Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an …","googleId":"U4yNZdamYk8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302091","googleCitationCount":8,"googleAuthor":"AMR Dos Santos","doi":"10.1016/j.leukres.2018.09.003","elsevierAuthor":"de Carvalho D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"7"},{"title":"High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction","googleId":"DfSvg_GPkTQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300183","googleCitationCount":9,"googleAuthor":"P Bhatia","doi":"10.1016/j.leukres.2018.01.012","elsevierAuthor":"Singh M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"6"},{"title":"Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway","googleId":"As_92CNcaRQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300577","googleCitationCount":12,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.005","elsevierAuthor":"Zhao P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"8"},{"title":"MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sezary syndrome patients","googleId":"r7WCALSaxZcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302508","googleCitationCount":21,"googleAuthor":"KM Kodigepalli","doi":"10.1016/j.leukres.2016.11.010","elsevierAuthor":"Kohnken R.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"13"},{"title":"Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia","googleId":"2fBycH8qaFAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304319","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.011","elsevierAuthor":"Tan J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"1 August 2017","elsevierCitationCount":"7"},{"title":"Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic …","googleId":"V4Rqo61dfLoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305180","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.010","elsevierAuthor":"Xu M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"7"},{"title":"Enhanced perforin expression associated with dasatinib therapy in natural killer cells","googleId":"xzvyfVWjwGYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300493","googleCitationCount":7,"googleAuthor":"K Miura","doi":"10.1016/j.leukres.2018.02.014","elsevierAuthor":"Iriyama N.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"7"},{"title":"Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia","googleId":"p-_dESqgEVIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306008","googleCitationCount":9,"googleAuthor":"D Zhan","doi":"10.1016/j.leukres.2017.12.001","elsevierAuthor":"Zhan D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"8"},{"title":"Combination of cabazitaxel and plicamycin induces cell death in drug resistant B-cell acute lymphoblastic leukemia","googleId":"6Pz3y1BCYLgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301796","googleCitationCount":6,"googleAuthor":"WJ Geldenhuys","doi":"10.1016/j.leukres.2018.08.002","elsevierAuthor":"Nair R.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"4"},{"title":"Therapeutic options for leukemic transformation in patients with myeloproliferative neoplasms","googleId":"7bMn5MP5RmEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305623","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.009","elsevierAuthor":"Khan M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"8"},{"title":"Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome","googleId":"dhP1E61TdH0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830081X","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2018.04.003","elsevierAuthor":"Sasada K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"7"},{"title":"miR-137 downregulates c-kit expression in acute myeloid leukemia","googleId":"wXWLmpB_9mwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300395","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.028","elsevierAuthor":"Hu Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"9"},{"title":"Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature","googleId":"dTctN_hGZ_QJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304903","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.009","elsevierAuthor":"Norsworthy K.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"6"},{"title":"Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS","googleId":"JPrT2IpQZeIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300699","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.03.007","elsevierAuthor":"Boch T.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5"},{"title":"Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55–65 years with Philadelphia chromosome-negative acute …","googleId":"KKTesrZwHD8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300729","googleCitationCount":8,"googleAuthor":"JM Ribera","doi":"10.1016/j.leukres.2018.03.010","elsevierAuthor":"Ribera J.M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5"},{"title":"The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review","googleId":"Thx2sw2ptewJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730084X","googleCitationCount":16,"googleAuthor":"L Falchi","doi":"10.1016/j.leukres.2017.03.008","elsevierAuthor":"Boddu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"9"},{"title":"Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy","googleId":"w_5JFkDIaiMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305532","googleCitationCount":9,"googleAuthor":"M Rahmati","doi":"10.1016/j.leukres.2017.10.007","elsevierAuthor":"Fakhimahmadi A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"6"},{"title":"Evaluation of the European LeukemiaNet recommendations for predicting outcomes of patients with acute myeloid leukemia treated in low-and middle-income …","googleId":"2Md5hRLX1KAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304708","googleCitationCount":11,"googleAuthor":"AFT Ribeiro","doi":"10.1016/j.leukres.2017.07.005","elsevierAuthor":"Benicio M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"9"},{"title":"Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia","googleId":"xDTU-zeeTf0J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306021","googleCitationCount":7,"googleAuthor":"B Snetsinger","doi":"10.1016/j.leukres.2017.12.003","elsevierAuthor":"Cull A.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"4"},{"title":"HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia","googleId":"qOiNCG38qvQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304861","googleCitationCount":8,"googleAuthor":"R Cusano","doi":"10.1016/j.leukres.2017.08.005","elsevierAuthor":"Caocci G.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"7"},{"title":"TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome","googleId":"xRyYbLcFvsgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304296","googleCitationCount":5,"googleAuthor":"SH Jung","doi":"10.1016/j.leukres.2018.10.004","elsevierAuthor":"Kim Y.J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2"},{"title":"Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute …","googleId":"BCf11r2IGeQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304332","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.013","elsevierAuthor":"Gu B.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"7"},{"title":"TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia","googleId":"eM0Pw4Rd_QwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302169","googleCitationCount":5,"googleAuthor":"MS Brassesco","doi":"10.1016/j.leukres.2018.09.010","elsevierAuthor":"Brassesco M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"5"},{"title":"Reduced ADAMTS-13 level negatively correlates with inflammation factors in plasma of acute myeloid leukemia patients","googleId":"96FNcSwgJh8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302673","googleCitationCount":12,"googleAuthor":"C Liu","doi":"10.1016/j.leukres.2016.12.004","elsevierAuthor":"Liu C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-02-01","elsevierCoverDisplayDate":"1 February 2017","elsevierCitationCount":"12"},{"title":"DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia","googleId":"kUApXid4K2IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730543X","googleCitationCount":16,"googleAuthor":"BG Dedeoglu","doi":"10.1016/j.leukres.2017.10.006","elsevierAuthor":"Ozdogan H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"14"},{"title":"Circular RNA expression profiles are significantly altered in mice bone marrow stromal cells after total body irradiation","googleId":"ndSNAR4I5XIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301127","googleCitationCount":9,"googleAuthor":"R Huang","doi":"10.1016/j.leukres.2018.05.010","elsevierAuthor":"Zhang J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"3"},{"title":"Therapy of older persons with acute myeloid leukaemia","googleId":"qfO_h-nabmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304423","googleCitationCount":12,"googleAuthor":"RP Gale","doi":"10.1016/j.leukres.2017.05.020","elsevierAuthor":"Krug U.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"6"},{"title":"Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy","googleId":"jOVUWT4hClUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304629","googleCitationCount":16,"googleAuthor":"TH Kim","doi":"10.1016/j.leukres.2017.06.009","elsevierAuthor":"Kim T.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"9"},{"title":"High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic …","googleId":"FGwVO66E9lwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305635","googleCitationCount":16,"googleAuthor":"A Candoni","doi":"10.1016/j.leukres.2017.10.010","elsevierAuthor":"Candoni A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"10"},{"title":"Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia","googleId":"rmb7gNC7eFsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304186","googleCitationCount":10,"googleAuthor":"A Gopalakrishnapillai","doi":"10.1016/j.leukres.2017.05.004","elsevierAuthor":"Gopalakrishnapillai A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"4"},{"title":"Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation","googleId":"eUrjFXsrxHoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300620","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.02.006","elsevierAuthor":"Gao L.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"4"},{"title":"Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study","googleId":"5Xe6qLNipsoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730485X","googleCitationCount":9,"googleAuthor":"YJ Kim","doi":"10.1016/j.leukres.2017.08.004","elsevierAuthor":"Lee J.H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"6"},{"title":"Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma","googleId":"goR6tB-3J3cJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305714","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.001","elsevierAuthor":"Liu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"3"},{"title":"Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma–proliferation centres are characterized by high miR-92a and miR-155 and …","googleId":"AKH7zv1trYoJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730098X","googleCitationCount":9,"googleAuthor":"A Matolcsy","doi":"10.1016/j.leukres.2017.04.002","elsevierAuthor":"Szurián K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"9"},{"title":"Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?","googleId":"I0aVseyB64YJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301802","googleCitationCount":6,"googleAuthor":"RP Gale","doi":"10.1016/j.leukres.2018.08.011","elsevierAuthor":"Yang S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4"},{"title":"Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP","googleId":"LOE6AwiZAiEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301589","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.014","elsevierAuthor":"Kim S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6"},{"title":"Outcomes and changes in code status of patients with acute myeloid leukemia undergoing induction chemotherapy who were transferred to the intensive care unit","googleId":"Rd9kJBgcmlIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305258","googleCitationCount":8,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.017","elsevierAuthor":"Ahmed T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"3"},{"title":"A lower ALC/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified","googleId":"d5g5XKv6UawJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301644","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.07.020","elsevierAuthor":"Li Q.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4"},{"title":"CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation","googleId":"RgOUdaJIZBUJ","googleLink":"https://pubmed.ncbi.nlm.nih.gov/30401521/","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.10.007,","elsevierAuthor":"Unnikrishnan A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4"},{"title":"Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study","googleId":"zCk5TRrhuOcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305271","googleCitationCount":14,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.019","elsevierAuthor":"Visani G.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"12"},{"title":"Secreted Wnt antagonists in leukemia: A road yet to be paved","googleId":"WO620v870EgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300730","googleCitationCount":5,"googleAuthor":"M Pehlivan","doi":"10.1016/j.leukres.2018.03.011","elsevierAuthor":"Pehlivan M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"2"},{"title":"Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome","googleId":"6t33cae37zEJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730440X","googleCitationCount":8,"googleAuthor":"P Jain","doi":"10.1016/j.leukres.2017.05.018","elsevierAuthor":"Jain P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"7"},{"title":"Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish …","googleId":"ymVZ-ocoelIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305647","googleCitationCount":8,"googleAuthor":"X Calvo","doi":"10.1016/j.leukres.2017.10.011","elsevierAuthor":"Nomdedeu M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"2"},{"title":"Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA","googleId":"xYk9rkJkdecJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300250","googleCitationCount":8,"googleAuthor":"M Yaghmaie","doi":"10.1016/j.leukres.2018.01.019","elsevierAuthor":"Ghavamzadeh A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"0"},{"title":"Lifetime physical inactivity is associated with increased risk for Hodgkin and non-Hodgkin lymphoma: a case-control study","googleId":"j6iBjPethGcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300766","googleCitationCount":6,"googleAuthor":"KT Soh","doi":"10.1016/j.leukres.2018.03.014","elsevierAuthor":"Etter J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"4"},{"title":"Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence","googleId":"qzZJiZQtFZgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304812","googleCitationCount":9,"googleAuthor":"CR Cogle","doi":"10.1016/j.leukres.2017.07.008","elsevierAuthor":"Cogle C.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"4"},{"title":"Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation","googleId":"IFCEPvkzBBAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304666","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.001","elsevierAuthor":"Choi P.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"6"},{"title":"A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia","googleId":"ikfGF73UvQIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618304612","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2018.10.018","elsevierAuthor":"Fries C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-12-01","elsevierCoverDisplayDate":"December 2018","elsevierCitationCount":"3"},{"title":"Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: introducing a parameter quantifying CD33 expression on CD34+ cells","googleId":"bpeOpDdvcesJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830153X","googleCitationCount":7,"googleAuthor":"MG Della Porta","doi":"10.1016/j.leukres.2018.07.009","elsevierAuthor":"Ogata K.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"6"},{"title":"The impact of the neutrophil: lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma","googleId":"V9-NCR-QhpsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300468","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.011","elsevierAuthor":"Beltrán B.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"6"},{"title":"ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation","googleId":"BunkWzO3MlQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300523","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.017","elsevierAuthor":"Liu J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"3"},{"title":"Helios expression in regulatory T cells promotes immunosuppression, angiogenesis and the growth of leukemia cells in pediatric acute lymphoblastic leukemia","googleId":"0X6PipREWisJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300420","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.007","elsevierAuthor":"Li X.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"4"},{"title":"Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day+ 30 after allo-HSCT","googleId":"QxVwgq_le4kJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300140","googleCitationCount":9,"googleAuthor":"","doi":"10.1016/j.leukres.2017.01.014","elsevierAuthor":"Drokov M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"4"},{"title":"Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia","googleId":"drjZYYOofOcJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305726","googleCitationCount":6,"googleAuthor":"P Collin","doi":"10.1016/j.leukres.2017.11.002","elsevierAuthor":"Sajwani F.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"5"},{"title":"3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis","googleId":"AiNcAFLFOeAJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617306094","googleCitationCount":6,"googleAuthor":"Z Hu","doi":"10.1016/j.leukres.2017.12.004","elsevierAuthor":"Hu Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-02-01","elsevierCoverDisplayDate":"February 2018","elsevierCitationCount":"4"},{"title":"Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines","googleId":"_LqmfqjbFxUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305672","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.014","elsevierAuthor":"Zhao W.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"4"},{"title":"PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy","googleId":"WmTu4OIRVKgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212616302454","googleCitationCount":10,"googleAuthor":"","doi":"10.1016/j.leukres.2016.11.005","elsevierAuthor":"Zhang Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-01-01","elsevierCoverDisplayDate":"1 January 2017","elsevierCitationCount":"5"},{"title":"Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells","googleId":"sVMPMUKovdUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301255","googleCitationCount":6,"googleAuthor":"S Das","doi":"10.1016/j.leukres.2018.06.005","elsevierAuthor":"Das S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"4"},{"title":"Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML","googleId":"TYS9MoWHDmgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301152","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2018.05.013","elsevierAuthor":"Janiszewska H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"3"},{"title":"p53 deletion promotes myeloma cells invasion by upregulating miR19a/CXCR5","googleId":"C-aNe9kNyh8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730468X","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.07.003","elsevierAuthor":"Yue Z.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-09-01","elsevierCoverDisplayDate":"September 2017","elsevierCitationCount":"4"},{"title":"Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase …","googleId":"BnDFIirRMzYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300481","googleCitationCount":7,"googleAuthor":"D Hiwase","doi":"10.1016/j.leukres.2018.02.013","elsevierAuthor":"Hiwase D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"5"},{"title":"A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia","googleId":"1yWt9P6sTMgJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301279","googleCitationCount":5,"googleAuthor":"AL Bryant","doi":"10.1016/j.leukres.2018.06.006","elsevierAuthor":"Bryant A.L.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-07-01","elsevierCoverDisplayDate":"July 2018","elsevierCitationCount":"5"},{"title":"Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States","googleId":"ih1_km84eScJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301310","googleCitationCount":6,"googleAuthor":"S Murty","doi":"10.1016/j.leukres.2018.06.010","elsevierAuthor":"Bell J.A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"4"},{"title":"AML refractory to primary induction with Ida-FLAG has a poor clinical outcome","googleId":"tvhMiph-rqYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830047X","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.02.012","elsevierAuthor":"Kavanagh S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-05-01","elsevierCoverDisplayDate":"May 2018","elsevierCitationCount":"5"},{"title":"NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells","googleId":"UF6blnmV20IJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300031","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.01.003","elsevierAuthor":"Okabe-Kado J.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-03-01","elsevierCoverDisplayDate":"March 2018","elsevierCitationCount":"5"},{"title":"Chk1 inhibitors overcome imatinib resistance in chronic myeloid leukemia cells","googleId":"QKZLca93HAkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305854","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.11.007","elsevierAuthor":"Lei H.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7"},{"title":"CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML","googleId":"-JgEp3bydZwJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301851","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.007","elsevierAuthor":"Anderson E.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"2"},{"title":"Anti-angiogenic and anti-multiple myeloma effects of oprozomib (OPZ) alone and in combination with pomalidomide (Pom) and/or dexamethasone (Dex)","googleId":"0yrBc-vmF3EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300711","googleCitationCount":9,"googleAuthor":"CS Wang","doi":"10.1016/j.leukres.2017.03.002","elsevierAuthor":"Sanchez E.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-06-01","elsevierCoverDisplayDate":"1 June 2017","elsevierCitationCount":"6"},{"title":"Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data","googleId":"M0vnar0XF5gJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301760","googleCitationCount":4,"googleAuthor":"F Ferraro","doi":"10.1016/j.leukres.2018.07.024","elsevierAuthor":"Ferraro F.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"2"},{"title":"Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: portrait of a rare clinical entity","googleId":"tquHbmDNlSsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301292","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2018.06.008","elsevierAuthor":"Barzilai M.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"5"},{"title":"Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center.(Positive effect of erythropoietin±prednisone …","googleId":"ewCKHeOgZ0AJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618300778","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.03.015","elsevierAuthor":"Jonasova A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-06-01","elsevierCoverDisplayDate":"June 2018","elsevierCitationCount":"3"},{"title":"Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: from the Japanese central review study","googleId":"FnaaIJY4cOQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301243","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2018.06.003","elsevierAuthor":"Matsuda A.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-11-01","elsevierCoverDisplayDate":"November 2018","elsevierCitationCount":"4"},{"title":"Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia","googleId":"ofVVJyP-tRIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261830184X","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.006","elsevierAuthor":"Manukyan G.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-09-01","elsevierCoverDisplayDate":"September 2018","elsevierCitationCount":"3"},{"title":"Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era","googleId":"cZVc3F6vi3sJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304435","googleCitationCount":7,"googleAuthor":"","doi":"10.1016/j.leukres.2017.05.021","elsevierAuthor":"Chen H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"4"},{"title":"Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine","googleId":"-u2SzWWON-wJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305660","googleCitationCount":6,"googleAuthor":"MA Sekeres","doi":"10.1016/j.leukres.2017.10.013","elsevierAuthor":"Sébert M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"5"},{"title":"The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech …","googleId":"fI-zR-42NZIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302029","googleCitationCount":3,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.019","elsevierAuthor":"Belada D.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"2"},{"title":"The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma","googleId":"_uBcNJiM8zkJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300012","googleCitationCount":8,"googleAuthor":"X Hu","doi":"10.1016/j.leukres.2017.01.001","elsevierAuthor":"Hu X.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-03-01","elsevierCoverDisplayDate":"1 March 2017","elsevierCitationCount":"4"},{"title":"ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia","googleId":"Qr6AfPkgSKQJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305192","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2017.09.011","elsevierAuthor":"Sahai T.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"3"},{"title":"Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing","googleId":"2c03jLbauvUJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305167","googleCitationCount":9,"googleAuthor":"T Umezu","doi":"10.1016/j.leukres.2017.09.008","elsevierAuthor":"Azuma K.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-11-01","elsevierCoverDisplayDate":"November 2017","elsevierCitationCount":"8"},{"title":"The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians","googleId":"YT14u0huAlYJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S014521261730509X","googleCitationCount":6,"googleAuthor":"K Kim","doi":"10.1016/j.leukres.2017.09.001","elsevierAuthor":"Kim S.Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"6"},{"title":"In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome","googleId":"OHUHdEwe8VsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305404","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2017.10.003","elsevierAuthor":"Kojima S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-12-01","elsevierCoverDisplayDate":"December 2017","elsevierCitationCount":"3"},{"title":"Preclinical activity of FF-10501-01, a novel inosine-5′-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia","googleId":"yrrp4bH9pacJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304381","googleCitationCount":6,"googleAuthor":"ZS Bohannan","doi":"10.1016/j.leukres.2017.05.016","elsevierAuthor":"Yang H.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-08-01","elsevierCoverDisplayDate":"August 2017","elsevierCitationCount":"5"},{"title":"Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia","googleId":"IZUDaUshlH8J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300851","googleCitationCount":6,"googleAuthor":"I Dyagil","doi":"10.1016/j.leukres.2017.03.009","elsevierAuthor":"Bilous N.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-07-01","elsevierCoverDisplayDate":"1 July 2017","elsevierCitationCount":"4"},{"title":"Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland …","googleId":"Op7d5RqIVfIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304873","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.006","elsevierAuthor":"Sakihama S.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"7"},{"title":"Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes","googleId":"g3E4JDS675UJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305969","googleCitationCount":4,"googleAuthor":"H Wang","doi":"10.1016/j.leukres.2017.11.010","elsevierAuthor":"Liu P.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-04-01","elsevierCoverDisplayDate":"April 2018","elsevierCitationCount":"3"},{"title":"Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A","googleId":"RT603xVgr90J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618301097","googleCitationCount":4,"googleAuthor":"","doi":"10.1016/j.leukres.2018.05.007","elsevierAuthor":"Kelaidi C.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-08-01","elsevierCoverDisplayDate":"August 2018","elsevierCitationCount":"3"},{"title":"Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia","googleId":"SEni_AauXnsJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617300437","googleCitationCount":7,"googleAuthor":"A Gopalakrishnapillai","doi":"10.1016/j.leukres.2017.01.030","elsevierAuthor":"Quagliano A.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-05-01","elsevierCoverDisplayDate":"1 May 2017","elsevierCitationCount":"4"},{"title":"Iron chelation therapy in lower IPSS risk myelodysplastic syndromes; which subtypes benefit?","googleId":"mQocQbVX88EJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617305830","googleCitationCount":6,"googleAuthor":"SA Wong","doi":"10.1016/j.leukres.2017.11.005","elsevierAuthor":"Wong S.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-01-01","elsevierCoverDisplayDate":"January 2018","elsevierCitationCount":"7"},{"title":"Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for …","googleId":"96k2hQz-g44J","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302066","googleCitationCount":6,"googleAuthor":"","doi":"10.1016/j.leukres.2018.08.022","elsevierAuthor":"Miyazaki Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"5"},{"title":"TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.","googleId":"8frtu7xSRtMJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212617304940","googleCitationCount":5,"googleAuthor":"","doi":"10.1016/j.leukres.2017.08.013","elsevierAuthor":"Tamai M.","publicationName":"Leukemia Research","elsevierCoverDate":"2017-10-01","elsevierCoverDisplayDate":"October 2017","elsevierCitationCount":"2"},{"title":"Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation","googleId":"gpuwsYaLkLIJ","googleLink":"https://www.sciencedirect.com/science/article/pii/S0145212618302108","googleCitationCount":4,"googleAuthor":"Y Abaza","doi":"10.1016/j.leukres.2018.09.004","elsevierAuthor":"Abaza Y.","publicationName":"Leukemia Research","elsevierCoverDate":"2018-10-01","elsevierCoverDisplayDate":"October 2018","elsevierCitationCount":"4"}]